BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 1040] [Cited by in F6Publishing: 1129] [Article Influence: 260.0] [Reference Citation Analysis]
Number Citing Articles
1 China L, Thorburn D. The Postoperative Patient. The Liver in Systemic Disease 2023. [DOI: 10.1002/9781119802181.ch6] [Reference Citation Analysis]
2 Menon J, Shanmugam N, Valamparampil J, Vij M, Kumar V, Munirathnam D, Hakeem A, Rammohan A, Rela M. Outcomes of liver transplantation in children with Langerhans cell histiocytosis: Experience from a quaternary care center. Pediatric Blood & Cancer 2023;70. [DOI: 10.1002/pbc.30024] [Reference Citation Analysis]
3 Cianni R, Riu P, de Rubeis G, Ventroni G. Endovascular Treatments of Hepatocellular Carcinoma. Hepatocellular Carcinoma 2023. [DOI: 10.1007/978-3-031-09371-5_9] [Reference Citation Analysis]
4 Tsuruoka M, Inoue J, Ouchi K, Uno K, Itami H, Ninomiya M, Iwata T, Sano A, Sato K, Onuki M, Sawahashi S, Koike T, Masamune A. A Case of Duodenal Variceal Rupture during Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma. Intern Med 2023. [DOI: 10.2169/internalmedicine.0629-22] [Reference Citation Analysis]
5 Xie Y, He C, Wang W. A potential novel inflammation biomarker for predicting the prognosis of decompensated liver cirrhosis. Annals of Medicine 2022;54:3201-3210. [DOI: 10.1080/07853890.2022.2142277] [Reference Citation Analysis]
6 Ishtiaq SM, Arshad MI, Khan JA. PPARγ signaling in hepatocarcinogenesis: Mechanistic insights for cellular reprogramming and therapeutic implications. Pharmacology & Therapeutics 2022;240:108298. [DOI: 10.1016/j.pharmthera.2022.108298] [Reference Citation Analysis]
7 Lv Y, Bai W, Zhu X, Xue H, Zhao J, Zhuge Y, Sun J, Zhang C, Ding P, Jiang Z, Zhu X, Ren W, Li Y, Zhang K, Zhang W, Li K, Wang Z, Luo B, Li X, Yang Z, Wang Q, Guo W, Xia D, Yang C, Pan Y, Yin Z, Fan D, Han G. CLIF-C AD score predicts survival benefit from pre-emptive TIPS in individuals with Child-Pugh B cirrhosis and acute variceal bleeding. JHEP Reports 2022;4:100621. [DOI: 10.1016/j.jhepr.2022.100621] [Reference Citation Analysis]
8 Heinrich S, Austgen T, Castven D, Hess M, Labenz C, Kirstein M, Zimpel C, Stockhoff L, Maasoumy B, Heinrich B, Wedemeyer HH, Galle PR, Binder H, Nguyen‐tat M, Marquardt JU. Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome. UEG Journal 2022. [DOI: 10.1002/ueg2.12337] [Reference Citation Analysis]
9 Enomoto H, Takashima T, Nishimura T, Aizawa N, Ikeda N, Yuri Y, Okamoto M, Yoshihara K, Yoshioka R, Kawata S, Ota S, Nakano R, Shiomi H, Iijima H. Liver cirrhosis in Japan: Future global trends in the era of progressive antiviral therapy. Portal Hypertension & Cirrhosis 2022. [DOI: 10.1002/poh2.30] [Reference Citation Analysis]
10 Mani I, Alexopoulos T, Vasilieva L, Alexopoulou A. Serum troponin is elevated in acute decompensation and acute-on-chronic liver failure and is associated with severity of liver disease and short-term mortality. Scandinavian Journal of Gastroenterology 2022. [DOI: 10.1080/00365521.2022.2131333] [Reference Citation Analysis]
11 Tan M, Adjetey A, Wee C, Perry I, Corbett C, Olajide A, Yamamoto A, Owen J, Mumtaz S. Decompensated cirrhosis: targeted training of acute medical teams to improve quality of care in first 24 hours. Br J Nurs 2022;31:1112-1119. [DOI: 10.12968/bjon.2022.31.21.1112] [Reference Citation Analysis]
12 Du X, Wei X, Ma L, Liu X, Guo H, Liu Y, Zhang J. Higher levels of neutrophil percentage-to-albumin ratio predict increased mortality risk in patients with liver cirrhosis: a retrospective cohort study. European Journal of Gastroenterology & Hepatology 2022;Publish Ahead of Print. [DOI: 10.1097/meg.0000000000002470] [Reference Citation Analysis]
13 Swaroop S, Arora U, Biswas S, Vaishnav M, Pathak P, Agarwal A, Golla R, Thakur B, Coshic P, Andriyas V, Gupta K, Elhence A, Nayak B, Kumar R, Shalimar. Therapeutic plasma‐exchange improves short‐term, but not long‐term, outcomes in patients with acute‐on‐chronic liver failure: A propensity score‐matched analysis. J of Clinical Apheresis 2022. [DOI: 10.1002/jca.22033] [Reference Citation Analysis]
14 Laleman W, Praktiknjo M, Lauridsen MM, Bonne L, Vanderschueren E, Verslype C, Krag A, Trebicka J, Maleux G. Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take? Metab Brain Dis 2022. [DOI: 10.1007/s11011-022-01121-2] [Reference Citation Analysis]
15 Kharitonova LA, Grigoriev KI. Liver cirrhosis in children. Ross vestn perinatol pediatr 2022;67:78-88. [DOI: 10.21508/1027-4065-2022-67-5-78-88] [Reference Citation Analysis]
16 Zhang L, Fang X, Wang S, Ma S, Zhang J, Dong X, Dai J, Liu C, Gao Y. Integrated Analysis of mRNA and lncRNA Expression Profiles Reveals Regulatory Networks Associated with Decompensated Cirrhosis. Journal of Immunology Research 2022;2022:1-13. [DOI: 10.1155/2022/1805216] [Reference Citation Analysis]
17 Rodríguez S, Motta FD, Balbinotto Neto G, Brandão A. WAITING LIST FOR LIVER TRANSPLANTATION: CLINICAL AND ECONOMIC BURDEN. Arq Gastroenterol 2022. [DOI: 10.1590/s0004-2803.202204000-87] [Reference Citation Analysis]
18 Würstle S, Hapfelmeier A, Karapetyan S, Studen F, Isaakidou A, Schneider T, Schmid RM, von Delius S, Gundling F, Triebelhorn J, Burgkart R, Obermeier A, Mayr U, Heller S, Rasch S, Lahmer T, Geisler F, Chan B, Turner PE, Rothe K, Spinner CD, Schneider J. A Novel Machine Learning-Based Point-Score Model as a Non-Invasive Decision-Making Tool for Identifying Infected Ascites in Patients with Hydropic Decompensated Liver Cirrhosis: A Retrospective Multicentre Study. Antibiotics 2022;11:1610. [DOI: 10.3390/antibiotics11111610] [Reference Citation Analysis]
19 Tergast TL, Schulte B, Griemsmann M, Kahlhöfer J, Dörge P, Hinrichs JB, Kraft ARM, Schmidt JJ, Behrendt P, Wedemeyer H, Cornberg M, Maasoumy B. Application of CT contrast medium is not associated with an increased risk for acute kidney injury in patients with decompensated cirrhosis. Aliment Pharmacol Ther 2022. [DOI: 10.1111/apt.17289] [Reference Citation Analysis]
20 Liu YB, Chen MK. Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions. World J Gastroenterol 2022; 28(41): 5910-5930 [DOI: 10.3748/wjg.v28.i41.5910] [Reference Citation Analysis]
21 Philipp M, Blattmann T, Bienert J, Fischer K, Hausberg L, Kröger JC, Heller T, Weber MA, Lamprecht G. Transjugular intrahepatic portosystemic shunt vs conservative treatment for recurrent ascites: A propensity score matched comparison. World J Gastroenterol 2022; 28(41): 5944-5956 [DOI: 10.3748/wjg.v28.i41.5944] [Reference Citation Analysis]
22 Song Y, Liu C, Xiao Z, Du L, Zhu S, Xiang H, Wang Z, Liu F. Interferon-γ secreted by recruited Th1 cells in peritoneal cavity inhibits the formation of malignant ascites.. [DOI: 10.21203/rs.3.rs-2049525/v1] [Reference Citation Analysis]
23 Dhaliwal A, Merhzad H, Karkhanis S, Tripathi D. Covered transjugular intrahepatic portosystemic stent-shunt vs large volume paracentesis in patients with cirrhosis: A real-world propensity score-matched study. World J Clin Cases 2022; 10(31): 11313-11324 [DOI: 10.12998/wjcc.v10.i31.11313] [Reference Citation Analysis]
24 Jachs M, Mandorfer M. Update zum Management der portalen Hypertonie nach Baveno VII – Was ist für die Praxis relevant? J Gastroenterol Hepatol Erkr 2022. [DOI: 10.1007/s41971-022-00138-9] [Reference Citation Analysis]
25 Fortea JI, Crespo J, Puente Á. Cirrhosis, a Global and Challenging Disease. JCM 2022;11:6512. [DOI: 10.3390/jcm11216512] [Reference Citation Analysis]
26 Ahmad T, Alam S, Islam S, Azam G, Alam M, Hasan SN, Mustafa G, Hossain M, Ali MA, Khan M. Position statement of Hepatology Society, Dhaka, Bangladesh onManagement of acute variceal bleeding in a resource-limited setting. iLIVER 2022. [DOI: 10.1016/j.iliver.2022.11.004] [Reference Citation Analysis]
27 Tacke F, Cornberg M, Sterneck M, Trebicka J, Settmacher U, Bechstein WO, Berg T, Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), vertreten durch Frank Tacke, Markus Cornberg, Martina Sterneck, Jonel Trebicka, Thomas Berg, Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), vertreten durch Wolf Bechstein. S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Registernummer: 021-031 – Stand 15. Juni 2022. Z Gastroenterol 2022;60:1678-1698. [DOI: 10.1055/a-1934-1989] [Reference Citation Analysis]
28 Centonze L, Gorga G, De Carlis R, Bernasconi D, Lauterio A, Carbonaro L, Vella I, Sgrazzutti C, Incarbone N, Rizzetto F, Valsecchi MG, Vanzulli A, De Carlis L. Clinical Impact of Spontaneous Portosystemic Shunts in Liver Transplantation: A Comprehensive Assessment Through Total Shunt Area Measurement. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004391] [Reference Citation Analysis]
29 Zhao L, Wu Q, Wang L, Xia Y, Tie J, Xu J, Wu H, Wei B, Zhuge Y, Chen C, Sun X, Zhang C, Wang G. Real–World outcomes of transjugular intrahepatic portosystemic shunt combined with embolization: A multicenter retrospective study.. [DOI: 10.21203/rs.3.rs-2107946/v1] [Reference Citation Analysis]
30 Wu HHL, Athwal VS, Kalra PA, Chinnadurai R. COVID-19 and hepatorenal syndrome. World J Gastroenterol 2022; 28(39): 5666-5678 [DOI: 10.3748/wjg.v28.i39.5666] [Reference Citation Analysis]
31 Dunne P, Finkel J, Khan F, Lachlan N, Patch D, Tripathi D, Stanley A, Hayes P. Effect of time to pre-emptive transjugular intrahepatic portosystemic shunt on patient outcome, a UK multicentre cohort study. Aliment Pharmacol Ther 2022. [PMID: 36256485 DOI: 10.1111/apt.17252] [Reference Citation Analysis]
32 Vogg J, Maier-Stocker C, Munker S, Mehrl A, Schlosser S, Tews HC, Gülow K, Müller M, Schmid S. Hepatic perfusion as a new predictor of prognosis and mortality in critical care patients with acute-on-chronic liver failure. Front Med (Lausanne) 2022;9:1008450. [PMID: 36300192 DOI: 10.3389/fmed.2022.1008450] [Reference Citation Analysis]
33 Weichselbaum L, Lepida A, Marot A, Trépo E, Moreno C, Deltenre P. Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta-analysis. United European Gastroenterol J 2022;10:874-87. [PMID: 36217553 DOI: 10.1002/ueg2.12300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Bai Z, Wang L, Lin H, Tacke F, Cheng G, Qi X. Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis. JCM 2022;11:5928. [DOI: 10.3390/jcm11195928] [Reference Citation Analysis]
35 Zhu LC, Wu W, Zou B, Gan DK, Lin X, Zhou W, Xiong ML. Efficacy predictors of third-generation cephalosporins in treating spontaneous bacterial peritonitis. Medicine (Baltimore) 2022;101:e30164. [PMID: 36221348 DOI: 10.1097/MD.0000000000030164] [Reference Citation Analysis]
36 Erstad BL. Why Do the Mechanistic Actions of Albumin Not Translate Into Tangible Clinical Benefits? Ann Pharmacother 2022. [DOI: 10.1177/10600280221126629] [Reference Citation Analysis]
37 Giri S, Harindranath S, Patwardhan N, Kale A, Shukla A. Post-Paracentesis Ascitic Fluid Leak in Patients with Cirrhosis of Liver and its Management: A Prospective Study. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.10.007] [Reference Citation Analysis]
38 Chen Z, Qiu Z, Wang G, Wang G, Jiang W, Gao F. Safety and effectiveness of transjugular intrahepatic portosystemic shunt in hepatocellular carcinoma patients with portal hypertension: a systematic review and meta-analysis. Clinical Radiology 2022. [DOI: 10.1016/j.crad.2022.09.126] [Reference Citation Analysis]
39 Noureddin M, Harrison SA. NASH Cirrhosis Trials And Major Adverse Liver Outcomes: Big Data Needed. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.10.022] [Reference Citation Analysis]
40 Matchett CL, Simonetto DA, Kamath PS. Renal Insufficiency in Patients with Cirrhosis. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.08.010] [Reference Citation Analysis]
41 Nanchal RS, Warrillow S. Terlipressin: Leading the Water to the Thirsty*. Critical Care Medicine 2022;50:1533-5. [DOI: 10.1097/ccm.0000000000005635] [Reference Citation Analysis]
42 Crocombe D, Ahmed N, Balakrishnan I, Bordea E, Chau M, China L, Corless L, Danquah V, Dehbi HM, Dillon JF, Forrest EH, Freemantle N, Gear DP, Hollywood C, Hunter R, Jeyapalan T, Kallis Y, McPherson S, Munteanu I, Portal J, Richardson P, Ryder SD, Virk A, Wright G, O'Brien A. ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trial. Trials 2022;23:812. [PMID: 36167573 DOI: 10.1186/s13063-022-06727-6] [Reference Citation Analysis]
43 Ostojic A, Petrovic I, Silovski H, Kosuta I, Sremac M, Mrzljak A. Approach to persistent ascites after liver transplantation. World J Hepatol 2022; 14(9): 1739-1746 [DOI: 10.4254/wjh.v14.i9.1739] [Reference Citation Analysis]
44 Vaz J, Strömberg U, Midlöv P, Eriksson B, Buchebner D, Hagström H. Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients. J Intern Med 2022. [PMID: 36166276 DOI: 10.1111/joim.13570] [Reference Citation Analysis]
45 Chu J, Yang Y, Liu Y, Pei L, Zhou Y, Lu T, Zhang Y, Hu H, Li Y, Yang F, Lin S. Bacterial Infections Confer a Risk of Progression to Acute-on-Chronic Liver Failure in Patients with HBV-Related Compensated Cirrhosis During Severe Hepatitis Flares. Infect Dis Ther 2022. [PMID: 36151452 DOI: 10.1007/s40121-022-00695-9] [Reference Citation Analysis]
46 Zanetto A, Pelizzaro F, Campello E, Bulato C, Balcar L, Gu W, Gavasso S, Saggiorato G, Zeuzem S, Russo FP, Mandorfer M, Reiberger T, Trebicka J, Burra P, Simioni P, Senzolo M. Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis. J Hepatol 2022:S0168-8278(22)03110-5. [PMID: 36150575 DOI: 10.1016/j.jhep.2022.09.005] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
47 Huang Y, Zhao L, He R, Li S, Liu C, Qi X, Li J. A strategy for varices screening based on acoustic radiation force impulse combined with platelet (CHESS2001): An alternative of Baveno VI criteria. Hepatol Commun 2022. [PMID: 36121707 DOI: 10.1002/hep4.2076] [Reference Citation Analysis]
48 Igna R, Gîrleanu I, Cojocariu C, Huiban L, Muzîca C, Sîngeap A, Sfarti C, Chiriac S, Petrea OC, Zenovia S, Nastasa R, Cuciureanu T, Stafie R, Stratina E, Rotaru A, Stanciu C, Blaj M, Trifan A. The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure. JCM 2022;11:5410. [DOI: 10.3390/jcm11185410] [Reference Citation Analysis]
49 Regner KR, Kanduri SR, Velez JCQ. Management of AKI in Patients with Cirrhosis. Curr Treat Options Gastro 2022;20:295-315. [DOI: 10.1007/s11938-022-00398-7] [Reference Citation Analysis]
50 Sun L, Ding P, Mao W, Wu J, Sehirli AÖ. D-Dimer-to-Albumin Ratio: A Novel Indicator to Predict Poor Outcomes in Patients with HBV-Associated Decompensated Cirrhosis. BioMed Research International 2022;2022:1-6. [DOI: 10.1155/2022/9062383] [Reference Citation Analysis]
51 Zhu CX, Yang L, Zhao H, Zhang Y, Tu S, Guo J, Yan D, Hu CX, Lu HF, Xu KJ, Huang JR, Li LJ. Impact of cirrhosis-related complications on posttransplant survival in patients with acute-on-chronic liver failure. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00205-3. [PMID: 36151023 DOI: 10.1016/j.hbpd.2022.09.004] [Reference Citation Analysis]
52 Bassegoda O, Rivera-Esteban J, Serra I, Morillas R, Broquetas T, Vergara M, Rodriguez A, Aracil C, Virolés S, Carrión JA, Pardo A, Rodríguez-Tajes S, Serra-Burriel M, Pericàs JM, Augustin S, Ginès P, Graupera I. High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study. Hepatol Commun 2022. [PMID: 36073343 DOI: 10.1002/hep4.2056] [Reference Citation Analysis]
53 Tan YY, Gong J, Liu DL. Endoscopic tissue adhesive injection for gastric varices secondary to hepatic cirrhosis: Complications and management strategies. Shijie Huaren Xiaohua Zazhi 2022; 30(17): 775-782 [DOI: 10.11569/wcjd.v30.i17.775] [Reference Citation Analysis]
54 de Mattos ÂZ, Simonetto DA, Terra C, Farias AQ, Bittencourt PL, Pase THS, Toazza MR, de Mattos AA, Alliance of Brazilian Centers for Cirrhosis Care – the ABC Group. Albumin administration in patients with cirrhosis: Current role and novel perspectives. World J Gastroenterol 2022; 28(33): 4773-4786 [DOI: 10.3748/wjg.v28.i33.4773] [Reference Citation Analysis]
55 Kazankov K, Novelli S, Chatterjee DA, Phillips A, Balaji A, Raja M, Foster G, Tripathi D, Boddu R, Kumar R, Jalan R, Mookerjee RP. Evaluation of CirrhoCare® - A digital-health solution for home management of patients with cirrhosis. J Hepatol 2022:S0168-8278(22)03066-5. [PMID: 36087864 DOI: 10.1016/j.jhep.2022.08.034] [Reference Citation Analysis]
56 Ma B, Shang T, Huang J, Tu Z, Wang Y, Han Y, Wen X, Jin Q. The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study. Front Med 2022;9. [DOI: 10.3389/fmed.2022.904414] [Reference Citation Analysis]
57 Huang C, Lee C, Chang C. Spontaneous Bacterial Peritonitis in Decompensated Liver Cirrhosis—A Literature Review. Livers 2022;2:214-232. [DOI: 10.3390/livers2030018] [Reference Citation Analysis]
58 Ngu NL, Saxby E, Worland T, Anderson P, Stothers L, Figredo A, Hunter J, Elford A, Ha P, Hartley I, Roberts A, Seah D, Tambakis G, Liew D, Rogers B, Sievert W, Bell S, Le S. A home-based, multidisciplinary liver optimisation programme for the first 28 days after an admission for acute-on-chronic liver failure (LivR well): a study protocol for a randomised controlled trial. Trials 2022;23:744. [PMID: 36064596 DOI: 10.1186/s13063-022-06679-x] [Reference Citation Analysis]
59 Pande G, Hatti M, Rai MK, Rai P, Kumar K, Vp K, Nehra A, Kumar S, Ranjan Rout S, Mishra SK, Kumar D, Kumar U, Mishra P, Majeed A, Saraswat VA, Singh K, Singh H, Misra DP, Agarwal V. . JIR 2022;Volume 15:5027-39. [DOI: 10.2147/jir.s377494] [Reference Citation Analysis]
60 Helzberg JH, Henson JB, Muir AJ. Recent updates in preemptive transjugular intrahepatic portosystemic shunt for acute variceal bleeding. Clin Liver Dis (Hoboken) 2022;20:97-101. [PMID: 36187370 DOI: 10.1002/cld.1243] [Reference Citation Analysis]
61 Schmid B, Busch HJ, Thimme R, Bettinger D. [Preclinical and clinical management of patients with acute gastrointestinal bleeding]. Dtsch Med Wochenschr 2022;147:1212-20. [PMID: 36070739 DOI: 10.1055/a-1728-9137] [Reference Citation Analysis]
62 Verma S. Letter: long-term abdominal drains in cirrhosis - a solution or a new problem? Aliment Pharmacol Ther 2022;56:924-5. [PMID: 35934858 DOI: 10.1111/apt.17156] [Reference Citation Analysis]
63 Pereira GH, Peixoto HR, Giusti ML, Souza ML, Victor LB, Fernandes F, Perez RM, Villela-nogueira CA. Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study. The Brazilian Journal of Infectious Diseases 2022;26:102697. [DOI: 10.1016/j.bjid.2022.102697] [Reference Citation Analysis]
64 Igna R, Gîrleanu I, Cojocariu C, Muzîca C, Huiban L, Sfarti C, Cuciureanu T, Chiriac S, Sîngeap A, Petrea OC, Stafie R, Zenovia S, Năstasă R, Stratina E, Rotaru A, Stanciu C, Trifan A, Blaj M. The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy. Diagnostics 2022;12:2077. [DOI: 10.3390/diagnostics12092077] [Reference Citation Analysis]
65 Rodriguez Mauriz R, Monzó P, Rudi Sola N, Villagrasa A, Borràs Trias L. Use of human albumin solution in a secondary hospital: an observational, retrospective, cross-sectional study.. [DOI: 10.1101/2022.08.23.22279130] [Reference Citation Analysis]
66 Mohamed AA, Salah W, Hassan MB, Eldeeb HH, Adaroas AS, Khattab RA, Abostate HM, Soliman MY, Habba E, Abd-elsalam S, Abo-amer YE. MCP1, CRP and Procalcitonin as Novel Diagnostic Markers in Cirrhotic Patients with Spontaneous Bacterial Peritonitis. TOBIOMJ 2022;12. [DOI: 10.2174/18753183-v12-e2206270] [Reference Citation Analysis]
67 Lins PRG, Narciso RC, Ferraz LR, Pereira VG, Ferraz-Neto BH, De Almeida MD, Dos Santos BFC, Dos Santos OFP, Monte JCM, Júnior MSD, Batista MC. Modelling kidney outcomes based on MELD eras - impact of MELD score in renal endpoints after liver transplantation. BMC Nephrol 2022;23:294. [PMID: 35999518 DOI: 10.1186/s12882-022-02912-6] [Reference Citation Analysis]
68 Li TT, Wang ZR, Yao WQ, Linghu EQ, Wang FS, Shi L. Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges. Stem Cells Transl Med 2022:szac053. [PMID: 35993521 DOI: 10.1093/stcltm/szac053] [Reference Citation Analysis]
69 Zhang Y, Xie L, Li F, Huo C, Miao Y, Wang L, Ding C. Analysis of hope level and its influencing factors in patients with decompensated cirrhosis. Nurs Open 2022. [PMID: 36054484 DOI: 10.1002/nop2.1328] [Reference Citation Analysis]
70 Latona A, Hill K, Connelly A, Stuart K, Wood P. Prothrombinex®-VF in chronic liver disease: Friend or foe? Emerg Med Australas 2022. [PMID: 35993256 DOI: 10.1111/1742-6723.14058] [Reference Citation Analysis]
71 Wu H, Hou W, Zhang W, Wang Z, Guo S, Chen D, Li Z, Wei F, Hu Z. Clinical evaluation of bacterial DNA using an improved droplet digital PCR for spontaneous bacterial peritonitis diagnosis. Front Cell Infect Microbiol 2022;12:876495. [DOI: 10.3389/fcimb.2022.876495] [Reference Citation Analysis]
72 Gantzel RH, Aagaard NK, Vilstrup H, Watson H, Grønbaek H, Jepsen P. Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality. Hepatol Commun 2022. [PMID: 35972345 DOI: 10.1002/hep4.2065] [Reference Citation Analysis]
73 Würstle S, Hapfelmeier A, Karapetyan S, Studen F, Isaakidou A, Schneider T, Schmid RM, von Delius S, Gundling F, Triebelhorn J, Burgkart R, Obermeier A, Mayr U, Heller S, Rasch S, Lahmer T, Geisler F, Chan B, Turner PE, Rothe K, Spinner CD, Schneider J. Novel machine learning-based point-score model as a non-invasive decision-making tool for infected ascites in patients with hydropic decompensated liver cirrhosis: A retrospective multicentre study.. [DOI: 10.21203/rs.3.rs-1930434/v1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Freire MP, Rinaldi M, Terrabuio DRB, Furtado M, Pasquini Z, Bartoletti M, de Oliveira TA, Nunes NN, Lemos GT, Maccaro A, Siniscalchi A, Laici C, Cescon M, D Albuquerque LAC, Morelli MC, Song ATW, Abdala E, Viale P, Filho ADPC, Giannella M. Prediction models for carbapenem-resistant Enterobacterales carriage at liver transplantation: A multicenter retrospective study. Transpl Infect Dis 2022;:e13920. [PMID: 35942941 DOI: 10.1111/tid.13920] [Reference Citation Analysis]
75 Wei X, Du X, Liu Y, Wu J, Zhang J. High plasma soluble thrombomodulin levels indicated poor prognosis of decompensated liver cirrhosis: a prospective cohort study. Eur J Gastroenterol Hepatol 2022. [PMID: 35946457 DOI: 10.1097/MEG.0000000000002428] [Reference Citation Analysis]
76 Xin Y, Cao F, Yang H, Zhang X, Chen Y, Cao X, Zhou X, Li X, Zhou J. Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. Front Immunol 2022;13:929141. [DOI: 10.3389/fimmu.2022.929141] [Reference Citation Analysis]
77 Vaara ST, Forni LG, Joannidis M. Subphenotypes of acute kidney injury in adults. Curr Opin Crit Care 2022. [PMID: 35942680 DOI: 10.1097/MCC.0000000000000970] [Reference Citation Analysis]
78 Seshadri A, Appelbaum R, Carmichael SP, Cuschieri J, Hoth J, Kaups KL, Kodadek L, Kutcher ME, Pathak A, Rappold J, Rudnick SR, Michetti CP. Management of Decompensated Cirrhosis in the Surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document. Trauma Surg Acute Care Open 2022;7:e000936. [DOI: 10.1136/tsaco-2022-000936] [Reference Citation Analysis]
79 Ben Khaled N, Allgeier J, Lutz T, Weber S, Lange CM. Medikamentöse Therapie bei Patienten mit Leberzirrhose. Gastroenterologie 2022;17:335-347. [DOI: 10.1007/s11377-022-00635-6] [Reference Citation Analysis]
80 Danielsen KV, Wiese S, Busk T, Nabilou P, Kronborg TM, Petersen CL, Hove JD, Møller S, Bendtsen F. Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study. Am J Gastroenterol 2022;117:1269-1278. [DOI: 10.14309/ajg.0000000000001847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Sharma S, Roy A. Recompensation in cirrhosis: Current evidence and future directions. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.08.002] [Reference Citation Analysis]
82 Li YG, Yu ZJ, Li A, Ren ZG. Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions. World J Gastroenterol 2022; 28(28): 3555-3572 [DOI: 10.3748/wjg.v28.i28.3555] [Reference Citation Analysis]
83 Weil-Verhoeven D, Di Martino V, Stirnimann G, Cervoni JP, Nguyen-Khac E, Thévenot T. Alfapump® implantable device in management of refractory ascites: An update. World J Hepatol 2022; 14(7): 1344-1356 [DOI: 10.4254/wjh.v14.i7.1344] [Reference Citation Analysis]
84 Biswas S, Vaishnav M, Pathak P, Gunjan D, Mahapatra SJ, Kedia S, Rout G, Thakur B, Nayak B, Kumar R, Shalimar. Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease. World J Hepatol 2022; 14(7): 1421-1437 [DOI: 10.4254/wjh.v14.i7.1421] [Reference Citation Analysis]
85 Lee HA, Kwak J, Cho SB, Lee YS, Jung YK, Kim JH, Kim SU, An H, Yim HJ, Yeon JE, Seo YS. Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis. BMC Gastroenterol 2022;22:355. [PMID: 35883035 DOI: 10.1186/s12876-022-02428-1] [Reference Citation Analysis]
86 Howell J, Majumdar A, Fink M, Byrne M, Mccaughan G, Strasser SI, Crawford M, Hodgkinson P, Stuart KA, Tallis C, Chen J, Wigg A, Jones R, Jaques B, Jeffrey G, Adams L, Wallace MC, Gane E, Thompson A, Gow P. The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New Zealand. Transplantation Direct 2022;8:e1345. [DOI: 10.1097/txd.0000000000001345] [Reference Citation Analysis]
87 Liu H, Zhang Q, Gao F, Yu H, Jiang Y, Wang X. Platelet Count/Spleen Thickness Ratio and the Risk of Variceal Bleeding in Cirrhosis With Esophagogastric Varices. Front Med 2022;9. [DOI: 10.3389/fmed.2022.870351] [Reference Citation Analysis]
88 Zhang H, Zhang Q, Li S, Xie B. Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis. J Clin Gastroenterol 2022. [PMID: 35830548 DOI: 10.1097/MCG.0000000000001732] [Reference Citation Analysis]
89 Wang L, Cao Z, Zhang L, Li J, Lv W. The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. Front Immunol 2022;13:923599. [DOI: 10.3389/fimmu.2022.923599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Ibrahim RS, El-Mezayen NS, El-Banna AA. Alleviation of liver cirrhosis and associated portal-hypertension by Astragalus species in relation to their UPLC-MS/MS metabolic profiles: a mechanistic study. Sci Rep 2022;12:11884. [PMID: 35831335 DOI: 10.1038/s41598-022-15958-1] [Reference Citation Analysis]
91 Liang H, Si H, Liu M, Yuan L, Ma R, Zhang G, Yang J, Mo Z, Zhao Q. Non-Invasive Prediction Models for Esophageal Varices and Red Signs in Patients With Hepatitis B Virus-Related Liver Cirrhosis. Front Mol Biosci 2022;9:930762. [DOI: 10.3389/fmolb.2022.930762] [Reference Citation Analysis]
92 Sarma MS, Gopan A. Management of Liver Related Ascites in Children. Annals of Pediatric Gastroenterology & Hepatology 2022;3:3-4. [DOI: 10.5005/jp-journals-11009-0101] [Reference Citation Analysis]
93 Wu W, Zhang H, Zeng Z, Wang X, Kong D. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis. Scand J Gastroenterol 2022;:1-9. [PMID: 35802771 DOI: 10.1080/00365521.2022.2094724] [Reference Citation Analysis]
94 Escudero VJ, Mercadal J, Molina-andújar A, Piñeiro GJ, Cucchiari D, Jacas A, Carramiñana A, Poch E. New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide. Front Nephrol 2022;2. [DOI: 10.3389/fneph.2022.879766] [Reference Citation Analysis]
95 Paternostro R, Trauner M. Current treatment of non-alcoholic fatty liver disease. J Intern Med 2022. [PMID: 35796150 DOI: 10.1111/joim.13531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Lindvig KP, Wernberg CW, Kjaergaard M, Thorhauge KH, Alnor AB, Thiele M, Krag A. Only one-third of referrals for fatty liver disease are on time: real-world study reveals opportunities to avoid unnecessary and delayed referrals. Scand J Gastroenterol 2022;:1-8. [PMID: 35793386 DOI: 10.1080/00365521.2022.2094725] [Reference Citation Analysis]
97 Rodríguez-vargas G, Santos-moreno P, Rubio-rubio J, Bautista-niño P, Echeverri D, Gutiérrez-castañeda L, Sierra-matamoros F, Navarrete S, Aparicio A, Saenz L, Rojas-villarraga A. Vascular Age, Metabolic Panel, Cardiovascular Risk and Inflammaging in Patients With Rheumatoid Arthritis Compared With Patients With Osteoarthritis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.894577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Abbas N, Rajoriya N, Elsharkawy AM, Chauhan A. Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived? Expert Rev Gastroenterol Hepatol 2022. [PMID: 35786130 DOI: 10.1080/17474124.2022.2097070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
99 Celik F, Bektas H. The role of nursing in the hepatic rehabilitation of patients with liver cirrhosis. Gastrointestinal Nursing 2022;20:S18-S25. [DOI: 10.12968/gasn.2022.20.sup6.s18] [Reference Citation Analysis]
100 Berlakovich G. Indikationen und Kontraindikationen zur Lebertransplantation in Bezug auf aktuelle Leitlinien. J Gastroenterol Hepatol Erkr 2022;20:38-44. [DOI: 10.1007/s41971-022-00125-0] [Reference Citation Analysis]
101 Wang T, Tan W, Wang X, Zheng X, Huang Y, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Yan H, Zheng Y, Zhang W, Yin S, Gu W, Zhang Y, Dong F, Wei J, Deng G, Xiang X, Zhou Y, Hou Y, Zhang Q, Xiong S, Liu J, Long L, Chen R, Chen J, Jiang X, Luo S, Chen Y, Jiang C, Zhao J, Ji L, Mei X, Li J, Li T, Zheng R, Zhou X, Ren H, Shi Y, Li H. Role of precipitants on transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Singh K. Spontaneous Regression of Hepatocellular Carcinoma From Autoinfarction and Implications on Liver Transplantation. ACG Case Rep J 2022;9:e00825. [DOI: 10.14309/crj.0000000000000825] [Reference Citation Analysis]
103 Flores-calderón J, Cisneros-garza L, Chávez-barrera J, Vázquez-frias R, Reynoso-zarzosa F, Martínez-bejarano D, Consuelo-sánchez A, Reyes-apodaca M, Zárate-mondragón F, Sánchez-soto M, Alcántara-garcía R, González-ortiz B, Ledesma-ramírez S, Espinosa-saavedra D, Cura-esquivel I, Macías-flores J, Hinojosa-lezama J, Hernández-chávez E, Zárate-guerrero J, Gómez-navarro G, Bilbao-chávez L, Sosa-arce M, Flores-fong L, Lona-reyes J, Estrada-arce E, Aguila-cano R. Consensus on the management of complications of cirrhosis of the liver in pediatrics. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2022.06.011] [Reference Citation Analysis]
104 Cisneros-garza L, González-huezo M, Moctezuma-velázquez C, Ladrón de Guevara-cetina L, Vilatobá M, García-juárez I, Alvarado-reyes R, Álvarez-treviño G, Allende-pérez S, Bornstein-quevedo L, Calderillo-ruiz G, Carrillo-martínez M, Castillo-barradas M, Cerda-reyes E, Félix-leyva J, Gabutti-thomas J, Guerrero-ixtlahuac J, Higuera-de la Tijera F, Huitzil-melendez D, Kimura-hayama E, López-hernández P, Malé-velázquez R, Méndez-sánchez N, Morales-ruiz M, Ruíz-garcía E, Sánchez-ávila J, Torrecillas-torres L. II Consenso mexicano de carcinoma hepatocelular. Parte II: tratamiento. Revista de Gastroenterología de México 2022;87:362-379. [DOI: 10.1016/j.rgmx.2022.01.006] [Reference Citation Analysis]
105 Cisneros-garza L, González-huezo M, Moctezuma-velázquez C, Ladrón de Guevara-cetina L, Vilatobá M, García-juárez I, Alvarado-reyes R, Álvarez-treviño G, Allende-pérez S, Bornstein-quevedo L, Calderillo-ruiz G, Carrillo-martínez M, Castillo-barradas M, Cerda-reyes E, Félix-leyva J, Gabutti-thomas J, Guerrero-ixtlahuac J, Higuera-de la Tijera F, Huitzil-melendez D, Kimura-hayama E, López-hernández P, Malé-velázquez R, Méndez-sánchez N, Morales-ruiz M, Ruíz-garcía E, Sánchez-ávila J, Torrecillas-torres L. The second Mexican consensus on hepatocellular carcinoma. Part II: Treatment. Revista de Gastroenterología de México (English Edition) 2022;87:362-379. [DOI: 10.1016/j.rgmxen.2022.01.004] [Reference Citation Analysis]
106 Jiao P, Chen XY, Zheng HY, Qin J, Li C, Zhang XL. Anticoagulation after transjugular intrahepatic portosystemic shunt for portal hypertension: A systematic review and meta analysis. Medicine (Baltimore) 2022;101:e29742. [PMID: 35777012 DOI: 10.1097/MD.0000000000029742] [Reference Citation Analysis]
107 Martínez Herreros Á, Sangro B, García Rodriguez A, Pérez Grijalba V. Analysis of the albumin‐bilirubin score as an indicator of improved liver function among hepatitis C virus patients with sustained viral response after direct‐acting antiviral therapy. JGH Open 2022;6:496-502. [DOI: 10.1002/jgh3.12779] [Reference Citation Analysis]
108 Téllez L, Sánchez Rodríguez E, Rodríguez de Santiago E, Llovet L, Gómez-Outomuro A, Díaz-Fontenla F, Álvarez López P, García-Eliz M, Amaral C, Sánchez-Torrijos Y, Fortea JI, Ferre-Aracil C, Rodríguez-Perálvarez M, Abadía M, Gómez-Camarero J, Olveira A, Calleja JL, Crespo J, Romero M, Hernández-Guerra M, Berenguer M, Riveiro-Barciela M, Salcedo M, Rodríguez M, Londoño MC, Albillos A. Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study. Aliment Pharmacol Ther 2022;56:131-43. [PMID: 35470447 DOI: 10.1111/apt.16926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Nabilou P, Danielsen KV, Kimer N, Hove JD, Bendtsen F, Møller S. Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity? PLoS ONE 2022;17:e0270603. [DOI: 10.1371/journal.pone.0270603] [Reference Citation Analysis]
110 Reiche W, Deliwala S, Chandan S, Mohan BP, Dhindsa B, Ramai D, Perisetti A, Rangray R, Mukherjee S. Spontaneous bacterial empyema in cirrhosis: A systematic review and meta-analysis. World J Hepatol 2022; 14(6): 1258-1268 [DOI: 10.4254/wjh.v14.i6.1258] [Reference Citation Analysis]
111 Rim CH, Park S, Yoon WS, Shin IS, Park HC. Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses. Int J Radiat Biol 2022;:1-30. [PMID: 35758976 DOI: 10.1080/09553002.2022.2094020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 Nagashima K, Irisawa A, Kashima K, Sakuma F, Minaguchi T, Yamamiya A, Yamabe A, Hoshi K, Tominaga K, Iijima M, Goda K. The Risk of Bleeding in Small/Straight Esophageal Varices with Red Color Sign on Endoscopy: A Retrospective Analysis from the Natural Course. Healthcare 2022;10:1193. [DOI: 10.3390/healthcare10071193] [Reference Citation Analysis]
113 Bera C, Wong F. Management of hepatorenal syndrome in liver cirrhosis: a recent update. Therap Adv Gastroenterol 2022;15:17562848221102679. [PMID: 35721838 DOI: 10.1177/17562848221102679] [Reference Citation Analysis]
114 Mazzola M, Madonna R, Badagliacca R, Caterina R. Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside. Vascul Pharmacol 2022;145:107022. [PMID: 35738494 DOI: 10.1016/j.vph.2022.107022] [Reference Citation Analysis]
115 Kalo E, Sheriff N, Isaac M, Baig A, Read S, Ahlenstiel G. A Call for Implementation of an Evidence-Based, Quality Improvement, Decompensated Cirrhosis Discharge Care Bundle in Australia. Livers 2022;2:97-104. [DOI: 10.3390/livers2020007] [Reference Citation Analysis]
116 Chung BK, Øgaard J, Reims HM, Karlsen TH, Melum E. Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis. Hepatol Commun 2022. [PMID: 35726350 DOI: 10.1002/hep4.2001] [Reference Citation Analysis]
117 Fischer P, Pandrea S, Dan Grigorescu M, Stefanescu H, Tefas C, Hadade A, Procopet B, Ionescu D. The threat of carbapenem resistance in Eastern Europe in patients with decompensated cirrhosis admitted to intensive care unit. Dig Liver Dis 2022:S1590-8658(22)00510-2. [PMID: 35732546 DOI: 10.1016/j.dld.2022.05.011] [Reference Citation Analysis]
118 Verma N, Singh S, Roy A, Valsan A, Garg P, Pradhan P, Chakrabarti A, Singh M. Cirrhosis and fungal infections-a cocktail for catastrophe: A systematic review and meta-analysis with machine learning. Mycoses 2022. [PMID: 35713607 DOI: 10.1111/myc.13482] [Reference Citation Analysis]
119 Fu KY, Hsieh ML, Chen JA, Hsieh VC. Association between medication adherence and disease outcomes in patients with hepatitis B-related cirrhosis: a population-based case-control study. BMJ Open 2022;12:e059856. [PMID: 35697446 DOI: 10.1136/bmjopen-2021-059856] [Reference Citation Analysis]
120 Macken L, Corrigan M, Prentice W, Finlay F, Mcdonagh J, Rajoriya N, Salmon C, Donnelly M, Evans C, Ganai B, Bedlington J, Steer S, Wright M, Hudson B, Verma S. Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus document. Frontline Gastroenterol 2022;13:e116-25. [DOI: 10.1136/flgastro-2022-102128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Gananandan K, Mookerjee R, Jalan R. Use of Non-selective Beta blockers in Decompensated Cirrhosis and ACLF. Curr Hepatology Rep 2022;21:29-36. [DOI: 10.1007/s11901-022-00584-2] [Reference Citation Analysis]
122 Song Y, Wang Y, Zang C, Yang X, Li Z, Wu L, Li K. Prognostic Nomograms for Hospital Survival and Transplant-Free Survival of Patients with Hepatorenal Syndrome: A Retrospective Cohort Study. Diagnostics 2022;12:1417. [DOI: 10.3390/diagnostics12061417] [Reference Citation Analysis]
123 Mesropyan N, Kupczyk PA, Dold L, Praktiknjo M, Chang J, Isaak A, Endler C, Kravchenko D, Bischoff LM, Sprinkart AM, Pieper CC, Kuetting D, Jansen C, Attenberger UI, Luetkens JA. Assessment of liver cirrhosis severity with extracellular volume fraction MRI. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13340-9] [Reference Citation Analysis]
124 Kasper P, Tacke F, Michels G. [Action algorithm: decompensated alcoholic liver cirrhosis in the emergency department]. Med Klin Intensivmed Notfmed 2022. [PMID: 35661227 DOI: 10.1007/s00063-022-00933-5] [Reference Citation Analysis]
125 Tergast TL, Griemsmann M, Stockhoff L, Heidrich B, Schirmer H, Lenzen H, Wedemeyer H, Cornberg M, Jaeckel E, Maasoumy B. Home-based, tunnelled peritoneal drainage system as an alternative treatment option for patients with refractory ascites. Aliment Pharmacol Ther 2022. [PMID: 35656633 DOI: 10.1111/apt.17066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
126 Robbins J, Mujumdar S, Tholey DM. Portal Hypertension and Current Endoscopic Management. Digestive Disease Interventions 2022;06:063-074. [DOI: 10.1055/s-0042-1745861] [Reference Citation Analysis]
127 Mccafferty BJ, El Khudari H, Salei A, Gunn AJ. Variceal Hemorrhage: Decompression, Obliteration, or Both? Digestive Disease Interventions 2022;06:094-103. [DOI: 10.1055/s-0041-1742100] [Reference Citation Analysis]
128 Lesmana CRA, Nababan SH, Kalista KF, Kurniawan J, Jasirwan COM, Sulaiman AS, Hasan I, Gani RA. Impact of endoscopic ultrasound examination for deep esophageal collateral veins evaluation in liver cirrhosis patients prior to endoscopic treatment: A case series. Portal Hypertension & Cirrhosis 2022;1:76-81. [DOI: 10.1002/poh2.19] [Reference Citation Analysis]
129 Săbiescu DM, Kamal AM, Kamal CK, Alexandru DO, Mitruț P. Liver damage in the context of SARS-CoV-2. Covid-19 treatment and its effects on the liver. J Med Life 2022;15:727-34. [PMID: 35928369 DOI: 10.25122/jml-2022-0177] [Reference Citation Analysis]
130 Li Z, Ling Y, Yuan X, Liu X, Huang W, Chen Q, Wang J, Chen Y, Xu M, Wu B. Impact of albumin infusion on prognosis of intensive care unit patients with congestive heart failure-hypoalbuminemia overlap: a retrospective cohort study. J Thorac Dis 2022;14:2235-46. [PMID: 35813730 DOI: 10.21037/jtd-22-648] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Sobh M, Abdalbary M, Abdelsalam M, Mohamed AE. Renal Dysfunction in Patients with Liver Cirrhosis. Digestive Disease Interventions 2022;06:131-136. [DOI: 10.1055/s-0042-1746192] [Reference Citation Analysis]
132 Dunne PDJ, Young D, Chuah CS, Hayes PC, Tripathi D, Leithead J, Smith LA, Gaya DR, Forrest E, Stanley AJ. Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial. Aliment Pharmacol Ther 2022;55:1581-7. [PMID: 35322892 DOI: 10.1111/apt.16901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
133 Wright M, Woodland H, Hudson B. Symptom control in advanced chronic liver disease: integrating anticipatory palliative and supportive care. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2022-102114] [Reference Citation Analysis]
134 ELshamy RM, Oda MS, Saeed MA, Ramadan RA. A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital. Eur J Gastroenterol Hepatol 2022;34:655-63. [PMID: 35352700 DOI: 10.1097/MEG.0000000000002328] [Reference Citation Analysis]
135 Santos Lucio A, Rodríguez Tirado I, Aparicio Serrano A, Jurado García J, Barrera Baena P, González Galilea N, Poyato González A, Pleguezuelo Navarro M, Costán Rodero G, Casáis Juanena L, Montero Álvarez JL, de la Mata M, Hervás Molina AJ, Rodríguez-perálvarez ML. Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programme. Gastroenterología y Hepatología (English Edition) 2022;45:450-456. [DOI: 10.1016/j.gastre.2021.07.003] [Reference Citation Analysis]
136 European Association for the Study of the Liver. Electronic address: jhepatology@easloffice.eu., European Association for the Study of the Liver. EASL Clinical Practice Guidelines on Sclerosing Cholangitis. J Hepatol 2022:S0168-8278(22)00326-9. [PMID: 35738507 DOI: 10.1016/j.jhep.2022.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
137 Villanueva C, Torres F, Sarin SK, Shah HA, Tripathi D, Brujats A, Rodrigues SG, Bhardwaj A, Azam Z, Hayes PC, Jindal A, Abid S, Alvarado E, Bosch J; Carvedilol-IPD-MA-group, From the PREDESCI study (Ref. 7)., From the study by Shah HA et al (Ref.16)., From the study by Tripathi D et al (Ref.14)., From the study by Bhardwaj A et al (Ref.15)., Baveno Cooperation: an EASL Consortium. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. J Hepatol 2022:S0168-8278(22)00336-1. [PMID: 35661713 DOI: 10.1016/j.jhep.2022.05.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
138 Sarma MS, Ravindranath A. Pediatric acute viral hepatitis with atypical variants: Clinical dilemmas and natural history. World J Hepatol 2022; 14(5): 944-955 [DOI: 10.4254/wjh.v14.i5.944] [Reference Citation Analysis]
139 Sarma MS, Ravindranath A. Pediatric acute viral hepatitis with atypical variants: Clinical dilemmas and natural history. WJH 2022;14:945-56. [DOI: 10.4254/wjh.v14.i5.945] [Reference Citation Analysis]
140 Mücke VT, Peiffer K, Kessel J, Schwarzkopf KM, Bojunga J, Zeuzem S, Finkelmeier F, Mücke MM. Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding. PLoS ONE 2022;17:e0268638. [DOI: 10.1371/journal.pone.0268638] [Reference Citation Analysis]
141 Liu C, Li J, Wong YJ, Xie Q, Hirooka M, Enomoto H, Kim TH, Hanafy AS, He R, Koizumi Y, Hiasa Y, Nishimura T, Iijima H, Jung YK, Yim HJ, Ma J, Zeng QL, Sarin SK, Qi X. ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study. Hepatol Int 2022. [PMID: 35606627 DOI: 10.1007/s12072-022-10345-4] [Reference Citation Analysis]
142 Ke Q, Wang Z, Huang X, Li L, Wu W, Qiu L, Jiao Y, Xie Y, Peng X, Liu J, Guo W. Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts. Ann Hepatol 2022;:100725. [PMID: 35623551 DOI: 10.1016/j.aohep.2022.100725] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Ratnasekera IU, Johnson A, Powell EE, Henderson A, Irvine KM, Valery PC. Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: A population-based study. Medicine (Baltimore) 2022;101:e29217. [PMID: 35608422 DOI: 10.1097/MD.0000000000029217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
144 Lisman T, Caldwell SH, Intagliata NM. Haemostatic alterations and management of haemostasis in patients with cirrhosis. J Hepatol 2022;76:1291-305. [PMID: 35589251 DOI: 10.1016/j.jhep.2021.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Caraceni P, O'Brien A, Gines P. Long-term albumin treatment in patients with cirrhosis and ascites. J Hepatol 2022;76:1306-17. [PMID: 35589252 DOI: 10.1016/j.jhep.2022.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
146 Qi X, Bai Z, Zhu Q, Cheng G, Chen Y, Dang X, Ding H, Han J, Han L, He Y, Ji F, Jin H, Li B, Li H, Li Y, Li Z, Liu B, Liu F, Liu L, Lin S, Ma D, Meng F, Qi R, Ren T, Shao L, Tang S, Tang Y, Teng Y, Wang C, Wang R, Wu Y, Xu X, Yang L, Yuan J, Yuan S, Yang Y, Zhao Q, Zhang W, Yang Y, Guo X, Xie W. Practice guidance for the use of terlipressin for liver cirrhosis–related complications. Therap Adv Gastroenterol 2022;15:175628482210982. [DOI: 10.1177/17562848221098253] [Reference Citation Analysis]
147 Huang Y, Zhang W, Xiang H, Liu Y, Yuan L, Zhang L, Hu S, Xia D, Li J, Gao M, Wang X, Qi X, Peng L, Song Y, Zhou X, Zeng J, Tan X, Deng M, Fang H, Qi S, He S, He Y, Ye B, Wu W, Dang T, Shao J, Wei W, Hu J, Yong X, He C, Bao J, Zhang Y, Zhang G, Ji R, Bo Y, Yan W, Li H, Wang Y, Li M, Wang F, Lian J, Liu C, Cao P, Liu Z, Liu A, Zhao L, Li S, Wu Y, Gu Y, Wang Y, Fang Y, Jiang P, Wu B, Liu C, Qi X. Treatment Strategies in Emergency Endoscopy for Acute Esophageal Variceal Bleeding (CHESS1905): A Nationwide Cohort Study. Front Med (Lausanne) 2022;9:872881. [PMID: 35572990 DOI: 10.3389/fmed.2022.872881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
148 Heni M, Karlas T. [69-year-old patient with chronic epigastric swelling]. Dtsch Med Wochenschr 2022;147:585-6. [PMID: 35545066 DOI: 10.1055/a-1800-1973] [Reference Citation Analysis]
149 Velarde-Ruiz Velasco JA, García-Jiménez ES, Aldana-Ledesma JM, Tapia-Calderón DK, Tornel-Avelar AI, Lazcano-Becerra M, Chávez-Ramírez RM, Cano-Contreras AD, Remes-Troche JM, Colunga-Lozano LE, Montaño-Loza A. Evaluation and management of emergencies in the patient with cirrhosis. Rev Gastroenterol Mex (Engl Ed) 2022:S2255-534X(22)00029-9. [PMID: 35570104 DOI: 10.1016/j.rgmxen.2022.05.001] [Reference Citation Analysis]
150 Shabunin AV, Parfenov IP, Minina MG, Bedin VV, Drozdov PA, Levina ON, Mikhayliants GS, Nesterenko IV, Makeev DA, Zhuravel OS, Ongoev NA. Liver transplant program at Botkin Hospital. Experience of 100 surgeries. RJTAO 2022;24:23-30. [DOI: 10.15825/1995-1191-2022-2-23-30] [Reference Citation Analysis]
151 Napoleone L, Solé C, Juanola A, Ma AT, Carol M, Pérez-Guasch M, Rubio AB, Cervera M, Avitabile E, Bassegoda O, Gratacós-Ginès J, Morales-Ruiz M, Fabrellas N, Graupera I, Pose E, Crespo G, Solà E, Ginès P. Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcome. Hepatol Commun 2022. [PMID: 35535681 DOI: 10.1002/hep4.1963] [Reference Citation Analysis]
152 Castro-Narro G, Moctezuma-Velázquez C, Male-Velázquez R, Trejo-Estrada R, Bosques FJ, Moreno-Alcántar R, Rodríguez-Hernández H, Bautista-Santos A, Córtez-Hernández C, Cerda-Reyes E, Pérez-Escobar J, Aldana-Ledesma JM, Aguirre-Valadez J, Ruiz-Velasco JAV, Contreras-Omaña R, Miranda-Zazueta G, Reyes-Bastidas MDR, Meza-Cardona JM, Chávez-Tapia N, Fernández-Pérez NJ, García-Jiménez ES, Torre A. POSITION STATEMENT ON THE USE OF ALBUMIN IN LIVER CIRRHOSIS. Ann Hepatol 2022;:100708. [PMID: 35550187 DOI: 10.1016/j.aohep.2022.100708] [Reference Citation Analysis]
153 Kristensen H, Kimer N, Møller S. Indications and methods for measuring portal hypertension in cirrhosis. Scand J Gastroenterol 2022;:1-9. [PMID: 35514215 DOI: 10.1080/00365521.2022.2065889] [Reference Citation Analysis]
154 Seven G, Musayeva G, Seven OO, Herdan E, Ince AT, Senturk H. Comparison of endoscopic ultrasound-guided coil deployment with and without cyanoacrylate injection for gastric varices. Arab J Gastroenterol 2022:S1687-1979(22)00031-4. [PMID: 35525707 DOI: 10.1016/j.ajg.2022.04.004] [Reference Citation Analysis]
155 Guo H, Zhang M, Zhang N, Yin X, Cheng Y, Gu L, Wang X, Xiao J, Wang Y, Zou X, Zhuge Y, Zhang F. Number of endoscopic sessions to eradicate varices identifies high risk of rebleeding in cirrhotic patients. BMC Gastroenterol 2022;22:213. [PMID: 35505293 DOI: 10.1186/s12876-022-02283-0] [Reference Citation Analysis]
156 Flores-calderón J, Cisneros-garza L, Chávez-barrera J, Vázquez-frias R, Reynoso-zarzosa F, Martínez-bejarano D, Consuelo-sánchez A, Reyes-apodaca M, Zárate-mondragón F, Sánchez-soto M, Alcántara-garcía R, González-ortiz B, Ledesma-ramírez S, Espinosa-saavedra D, Cura-esquivel I, Macías-flores J, Hinojosa-lezama J, Hernández-chávez E, Zárate-guerrero J, Gómez-navarro G, Bilbao-chávez L, Sosa-arce M, Flores-fong L, Lona-reyes J, Estrada-arce E, Aguila-cano R. Consenso del manejo de las complicaciones de la cirrosis hepática en pediatría. Revista de Gastroenterología de México 2022. [DOI: 10.1016/j.rgmx.2022.03.012] [Reference Citation Analysis]
157 Yang Y, Liang X, Yang S, He X, Huang M, Shi W, Luo J, Duan C, Feng X, Fu S, Lu L. Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110384] [Reference Citation Analysis]
158 Mir BA, Majeed T, Chauhan A. A New Window to Favorable Outcome in Acute-on-Chronic Liver Failure. Am J Gastroenterol 2022;117:815-815. [DOI: 10.14309/ajg.0000000000001703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Pouriki S, Alexopoulos T, Vasilieva L, Vrioni G, Alexopoulou A. Rectal colonization by resistant bacteria is associated with infection by the colonizing strain and high mortality in decompensated cirrhosis. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.05.013] [Reference Citation Analysis]
160 Giri S, Sundaram S. Early versus delayed endoscopic therapy in acute variceal bleeding: the jury is still out. Eur J Gastroenterol Hepatol 2022;34:585. [PMID: 35421023 DOI: 10.1097/MEG.0000000000002311] [Reference Citation Analysis]
161 Premkumar M, Anand AC. Overview of Complications in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.04.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Keimburg SA, Theysohn J, Buechter M, Rashidi-alavijeh J, Willuweit K, Schneider H, Wetter A, Maasoumy B, Lange C, Wedemeyer H, Markova AA. FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts. Biomedicines 2022;10:1018. [DOI: 10.3390/biomedicines10051018] [Reference Citation Analysis]
163 Kim JH, Kim SE, Song DS, Kim HY, Yoon EL, Kim TH, Jung YK, Suk KT, Jun BG, Yim HJ, Kwon JH, Lee SW, Kang SH, Kim MY, Jeong SW, Jang JY, Yoo JJ, Kim SG, Jin YJ, Cheon GJ, Kim BS, Seo YS, Kim HS, Sinn DH, Chung WJ, Kim HY, Lee HA, Nam SW, Kim IH, Suh JI, Kim JH, Chae HB, Sohn JH, Cho JY, Kim YJ, Yang JM, Park JG, Kim W, Cho HC, Kim DJ. Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration. J Clin Med 2022;11:2463. [PMID: 35566588 DOI: 10.3390/jcm11092463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Biolato M, Paratore M, Di Gialleonardo L, Marrone G, Grieco A. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence? World J Hepatol 2022; 14(4): 682-695 [DOI: 10.4254/wjh.v14.i4.682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
165 Gantzel RH, Kjær MB, Jepsen P, Aagaard NK, Watson H, Gluud LL, Grønbæk H. Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis. World J Hepatol 2022; 14(4): 827-845 [DOI: 10.4254/wjh.v14.i4.827] [Reference Citation Analysis]
166 Chi X, Jiang L, Yuan Y, Huang X, Yang X, Hochwald S, Liu J, Huang H. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02279-w] [Reference Citation Analysis]
167 Labenz C, Arslanow A, Nguyen-Tat M, Nagel M, Wörns MA, Reichert MC, Heil FJ, Mainz D, Zimper G, Römer B, Binder H, Farin-Glattacker E, Fichtner U, Graf E, Stelzer D, Van Ewijk R, Ortner J, Velthuis L, Lammert F, Galle PR. Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL. J Hepatol 2022:S0168-8278(22)00244-6. [PMID: 35472313 DOI: 10.1016/j.jhep.2022.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
168 Zhou Y, Zeng J, Song L, Wang C. Clinical characteristics and treatment of terlipressin-induced ischemic skin necrosis: A synthesis of 35 literature reported cases. J Clin Pharm Ther 2022. [PMID: 35460093 DOI: 10.1111/jcpt.13671] [Reference Citation Analysis]
169 Ma AT, Juanola A, Solà E. Assessment of kidney function in cirrhosis: Are we moving closer to accurate estimation of glomerular filtration rate? Liver Int 2022;42:957-9. [PMID: 35447007 DOI: 10.1111/liv.15238] [Reference Citation Analysis]
170 Maiwall R, Kumar A, Pasupuleti SSR, Hidam AK, Tevethia H, Kumar G, Sahney A, Mitra LG, Sarin SK. A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. J Hepatol 2022:S0168-8278(22)00239-2. [PMID: 35460725 DOI: 10.1016/j.jhep.2022.03.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
171 Qiu Z, Wang G, Yan H, Qi H, Zuo M, Wang G, Jiang W, Chen Z, Xue J, Lu L, Zhang F, Gao F. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension. Eur Radiol 2022. [PMID: 35441840 DOI: 10.1007/s00330-022-08705-7] [Reference Citation Analysis]
172 Deleuran T, Watson H, Vilstrup H, Jepsen P. Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascites. Ann Hepatol 2022;:100711. [PMID: 35447366 DOI: 10.1016/j.aohep.2022.100711] [Reference Citation Analysis]
173 García‐tsao G. Ascites and its complications. Yamada's Textbook of Gastroenterology 2022. [DOI: 10.1002/9781119600206.ch98] [Reference Citation Analysis]
174 Kamath PS, Song LMWK. Management of upper gastrointestinal hemorrhage related to portal hypertension. Yamada's Textbook of Gastroenterology 2022. [DOI: 10.1002/9781119600206.ch124] [Reference Citation Analysis]
175 Wang W, Pan CC, Zhao WY, Sheng JY, Wu QQ, Chen SS. Comments on “Effect of type 2 diabetes mellitus in the prognosis of acute-on-chronic liver failure patients in China”. World J Gastroenterol 2022; 28(14): 1499-1502 [DOI: 10.3748/wjg.v28.i14.1499] [Reference Citation Analysis]
176 Yang Q, Tong Y, Pi B, Yu H, Lv F. Influence of Metabolic Risk Factors on the Risk of Bacterial Infections in Hepatitis B-Related Cirrhosis: A 10-Year Cohort Study. Front Med 2022;9:847091. [DOI: 10.3389/fmed.2022.847091] [Reference Citation Analysis]
177 Wang X, Jamil K. Pharmacokinetic and pharmacodynamic analyses of terlipressin in patients with hepatorenal syndrome. AAPS Open 2022;8. [DOI: 10.1186/s41120-022-00052-7] [Reference Citation Analysis]
178 Minjares RO, Martin P, Carrion AF. Chronic Kidney Disease After Liver Transplantation. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.006] [Reference Citation Analysis]
179 Cannella R, Tselikas L, Douane F, Cauchy F, Rautou P, Duran R, Ronot M. Imaging-guided interventions modulating portal venous flow: evidence and controversies. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100484] [Reference Citation Analysis]
180 Zanetto A, Campello E, Bulato C, Gavasso S, Saggiorato G, Shalaby S, Burra P, Angeli P, Senzolo M, Simioni P. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Kulkarni AV, Ravikumar ST, Tevethia H, Premkumar M, Kumar K, Sharma M, Gupta R, Rao PN, Reddy DN. Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study. Sci Rep 2022;12:5503. [PMID: 35365736 DOI: 10.1038/s41598-022-09505-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Effenberger M, Widjaja AA, Grabherr F, Schaefer B, Grander C, Mayr L, Schwaerzler J, Enrich B, Moser P, Fink J, Pedrini A, Jaschke N, Kirchmair A, Pfister A, Hausmann B, Bale R, Putzer D, Zoller H, Schafer S, Pjevac P, Trajanoski Z, Oberhuber G, Adolph T, Cook S, Tilg H. Interleukin-11 drives human and mouse alcohol-related liver disease. Gut 2022:gutjnl-2021-326076. [PMID: 35365572 DOI: 10.1136/gutjnl-2021-326076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Kulkarni AV, Tirumalle S, Premkumar M, Kumar K, Fatima S, Rapole B, Simhadri V, Gora BA, Sasikala M, Gujjarlapudi D, Yelamanchili S, Sharma M, Gupta R, Rao PN, Reddy DN. Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial. Am J Gastroenterol 2022;117:607-16. [PMID: 35041634 DOI: 10.14309/ajg.0000000000001611] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
184 Feldman S, Russo A, Ceccarelli G, Borrazzo C, Madge C, Venditti M, Merli M. Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients with Liver Cirrhosis. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.04.016] [Reference Citation Analysis]
185 Barry K, Finn A. Salmonella typhimurium as a causative agent of spontaneous bacterial peritonitis. BMJ Case Rep 2022;15:e249550. [DOI: 10.1136/bcr-2022-249550] [Reference Citation Analysis]
186 Velarde-ruiz Velasco J, García-jiménez E, Aldana-ledesma J, Tapia-calderón D, Tornel-avelar A, Lazcano-becerra M, Chávez-ramírez R, Cano-contreras A, Remes-troche J, Colunga-lozano L, Montaño-loza A. Evaluación y manejo de emergencias en el paciente con cirrosis. Revista de Gastroenterología de México 2022;87:198-215. [DOI: 10.1016/j.rgmx.2021.11.002] [Reference Citation Analysis]
187 Tosetti G, Farina E, Caccia R, Sorge A, Berzuini A, Valenti L, Prati D, Tripodi A, Lampertico P, Primignani M. Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian association for the study of the liver (AISF). Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.03.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
188 Graupera I, Isus L, Coll M, Pose E, Díaz A, Vallverdú J, Rubio-tomás T, Martínez-sánchez C, Huelin P, Llopis M, Solé C, Fondevila C, Lozano JJ, Sancho-bru P, Ginès P, Aloy P. Molecular characterization of chronic liver disease dynamics: from liver fibrosis to acute-on-chronic liver failure. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100482] [Reference Citation Analysis]
189 Buccheri S, Da BL. Hepatorenal Syndrome. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.002] [Reference Citation Analysis]
190 Patel B, Serper M, Ruckdeschel E, Partington SL, Andrade L, Tobin L, Kim Y, Hoteit MA. Clinical complications of liver disease in adults after the Fontan operation. International Journal of Cardiology Congenital Heart Disease 2022. [DOI: 10.1016/j.ijcchd.2022.100371] [Reference Citation Analysis]
191 Bridwell RE, Long B, Ramzy M, Gottlieb M. Balloon Tamponade for the Management of Gastrointestinal Bleeding. J Emerg Med 2022;62:545-58. [PMID: 35065859 DOI: 10.1016/j.jemermed.2021.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
192 Gonzalez SA, Velez JCQ. Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 With Terlipressin. Am J Gastroenterol 2022;117:520-523. [DOI: 10.14309/ajg.0000000000001628] [Reference Citation Analysis]
193 Raja SS, Batey RG, Edwards S, Aung HH. Standards of liver cirrhosis care in Central Australia. World J Hepatol 2022; 14(3): 559-569 [DOI: 10.4254/wjh.v14.i3.559] [Reference Citation Analysis]
194 Wei B, Huang Z, Tang C. Optimal Treatment for Patients With Cavernous Transformation of the Portal Vein. Front Med 2022;9:853138. [DOI: 10.3389/fmed.2022.853138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Toniutto P. Special Issue "New Therapies of Liver Diseases". J Clin Med 2022;11:1798. [PMID: 35407406 DOI: 10.3390/jcm11071798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Venkitaraman A, De A, Verma N, Kumari S, Leishangthem B, Sharma RR, Kalra N, Grover S, Singh V. Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT. Hepatol Int 2022. [PMID: 35322373 DOI: 10.1007/s12072-022-10314-x] [Reference Citation Analysis]
197 Triantos C, Kalafateli M, Assimakopoulos SF, Karaivazoglou K, Mantaka A, Aggeletopoulou I, Spantidea PI, Tsiaoussis G, Rodi M, Kranidioti H, Goukos D, Manolakopoulos S, Gogos C, Samonakis DN, Daikos GL, Mouzaki A, Thomopoulos K. Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis. Front Med (Lausanne) 2022;9:836306. [PMID: 35308545 DOI: 10.3389/fmed.2022.836306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
198 Zhuang Z, Ma J, Ju S, Gu G, Zhang W, Yang M, Zhang Z, Ma L, Yan Z, Luo J. A new alternative technique for the guidance of transjugular intrahepatic portosystemic shunt creation using DSA overlay reference. Acta Radiol 2022;:2841851221086963. [PMID: 35313745 DOI: 10.1177/02841851221086963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Zhang T, Ye B, Shen J. Prognostic value of albumin-related ratios in HBV-associated decompensated cirrhosis. J Clin Lab Anal 2022;:e24338. [PMID: 35297102 DOI: 10.1002/jcla.24338] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
200 Schulz MS, Gu W, Schnitzbauer AA, Trebicka J. Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure. Transpl Int 2022;35:10108. [DOI: 10.3389/ti.2022.10108] [Reference Citation Analysis]
201 Krutikov ES, Vostrikova AN, Krutikova MS. Hepatorenal syndrome: criteria and problems of diagnosis (part II). jour 2022;3:20-25. [DOI: 10.21886/2712-8156-2022-3-1-20-25] [Reference Citation Analysis]
202 Nakazawa M, Imai Y, Sugawara K, Uchida Y, Saitoh Y, Fujii Y, Uchiya H, Ando S, Nakayama N, Tomiya T, Mochida S. Long-term outcomes of patients with cirrhosis presenting with bleeding gastric varices. PLoS ONE 2022;17:e0264359. [DOI: 10.1371/journal.pone.0264359] [Reference Citation Analysis]
203 Farrugia A, Mori F. Therapeutic solutions of human albumin - The possible effect of process-induced molecular alterations on clinical efficacy and safety. J Pharm Sci 2022:S0022-3549(22)00111-3. [PMID: 35276228 DOI: 10.1016/j.xphs.2022.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., European Association for the Study of the Liver. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol 2022:S0168-8278(21)02033-X. [PMID: 35300861 DOI: 10.1016/j.jhep.2021.09.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 18.0] [Reference Citation Analysis]
205 Kulkarni AV, Rabiee A, Mohanty A. Management of Portal Hypertension. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
206 D’oliveira RAC, Pereira LCD, Codes L, Rocha MDS, Bittencourt PL. ANALYSIS OF HEALTHCARE ASSOCIATED AND HOSPITAL ACQUIRED INFECTIONS IN CRITICALLY ILL PATIENTS WITH CIRRHOSIS. Arq Gastroenterol 2022;59:102-9. [DOI: 10.1590/s0004-2803.202200001-18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Rekow M. The Kidney and Friends. Physician Assistant Clinics 2022. [DOI: 10.1016/j.cpha.2021.11.011] [Reference Citation Analysis]
208 Grover I, Singh N, Gunjan D, Pandey RM, Chandra Sati H, Saraya A. Comparison of Anthropometry, Bioelectrical Impedance, and Dual-energy X-ray Absorptiometry for Body Composition in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022;12:467-74. [DOI: 10.1016/j.jceh.2021.05.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
209 Haderer M, Neubert P, Rinner E, Scholtis A, Broncy L, Gschwendtner H, Kandulski A, Pavel V, Mehrl A, Brochhausen C, Schlosser S, Gülow K, Kunst C, Müller M. Novel pathomechanism for spontaneous bacterial peritonitis: disruption of cell junctions by cellular and bacterial proteases. Gut 2022;71:580-92. [PMID: 33707230 DOI: 10.1136/gutjnl-2020-321663] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
210 Schreyer AG, Lüth S, Ringe KI. Bildgebung in der zirrhotischen Leber – warum, wie und was ist LI-RADS? Radiologie up2date 2022;22:69-84. [DOI: 10.1055/a-1561-9413] [Reference Citation Analysis]
211 Stoffers P, Guckenbiehl S, Welker MW, Zeuzem S, Lange CM, Trebicka J, Herrmann E, Welsch C. Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation. PLoS One 2022;17:e0263989. [PMID: 35176084 DOI: 10.1371/journal.pone.0263989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
212 Lashen SA, Shamseya MM, Madkour MA, Abdel Salam RM, Mostafa SS. β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study. World J Hepatol 2022; 14(2): 429-441 [DOI: 10.4254/wjh.v14.i2.429] [Reference Citation Analysis]
213 Garrido I, Marques M, Liberal R, Cardoso H, Lopes S, Macedo G. Wilson disease in Northern Portugal: a long-term follow-up study. Orphanet J Rare Dis 2022;17:82. [PMID: 35197085 DOI: 10.1186/s13023-022-02245-5] [Reference Citation Analysis]
214 Duah A, Duah F, Ampofo-boobi D, Addo BP, Osei-poku F, Agyei-nkansah A, Bellini MI. Acute Kidney Injury in Patients with Liver Cirrhosis: Prevalence, Predictors, and In-Hospital Mortality at a District Hospital in Ghana. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/4589767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
215 Sychev DA, Parusov AI, Loranskaya ID, Denisenko NP, Akmalova KA, Sozaeva ZA, Turkina OL, Zastrozhin MS. CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis. Terapevticheskii arkhiv 2022;94:200-8. [DOI: 10.26442/00403660.2022.02.201371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Ballester M, Gallego J, Fiorillo A, Casanova-ferrer F, Giménez-garzó C, Escudero-garcía D, Tosca J, Ríos M, Montón C, Durbán L, Ballester J, Benlloch S, Urios A, San-miguel T, Kosenko E, Serra M, Felipo V, Montoliu C. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-06416-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
217 Yu Z, Zhang T, Shen J, Flora SJS. Low Hemoglobin-to-Red Cell Distribution Width Ratio Is Associated with Mortality in Patients with HBV-Related Decompensated Cirrhosis. BioMed Research International 2022;2022:1-6. [DOI: 10.1155/2022/5754790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Kondo T, Koroki K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Ogasawara S, Ooka Y, Nakamoto S, Chiba T, Arai M, Kato J, Kuboki S, Ohtsuka M, Kato N. Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma. PLoS One 2022;17:e0261619. [PMID: 35085277 DOI: 10.1371/journal.pone.0261619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Onorato L, Monari C, Capuano S, Grimaldi P, Coppola N. Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative Review. Antibiotics 2022;11:232. [DOI: 10.3390/antibiotics11020232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Gow PJ, Sinclair M, Thwaites PA, Angus PW, Chapman B, Terbah R, Testro AG. Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis. Eur J Gastroenterol Hepatol 2022;34:206-12. [PMID: 32976193 DOI: 10.1097/MEG.0000000000001950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Li M, Li K, Tang S, Lv Y, Wang Q, Wang Z, Luo B, Niu J, Zhu Y, Guo W, Bai W, Wang E, Xia D, Wang Z, Li X, Yuan J, Yin Z, Trebicka J, Han G. Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100448] [Reference Citation Analysis]
222 Fox R, Stenning K, Slee A, Macnaughtan J, Davies N. Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies. Analytical Biochemistry 2022. [DOI: 10.1016/j.ab.2022.114581] [Reference Citation Analysis]
223 Cabibbo G, Aghemo A, Lai Q, Masarone M, Montagnese S, Ponziani FR. Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.01.122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
224 Chen H, Zhang Y, Zheng J, Shi L, He Y, Niu Y, Lei J, Zhao Y, Xia H, Chen T. Application of mNGS in the Etiological Diagnosis of Thoracic and Abdominal Infection in Patients With End-Stage Liver Disease. Front Cell Infect Microbiol 2021;11:741220. [PMID: 35071029 DOI: 10.3389/fcimb.2021.741220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
225 Voss A, Schroeder R, Schulz S, Haueisen J, Vogler S, Horn P, Stallmach A, Reuken P. Detection of Liver Dysfunction Using a Wearable Electronic Nose System Based on Semiconductor Metal Oxide Sensors. Biosensors (Basel) 2022;12:70. [PMID: 35200331 DOI: 10.3390/bios12020070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
226 Jindal A, Sharma S, Agarwal S, Kumar M, Saraya A, Sarin SK. Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria. Hepatol Int. [DOI: 10.1007/s12072-021-10280-w] [Reference Citation Analysis]
227 Manrai M, Dawra S, Kapoor R, Srivastava S, Singh A. Anemia in cirrhosis: An underestimated entity. World J Clin Cases 2022; 10(3): 777-789 [DOI: 10.12998/wjcc.v10.i3.777] [Reference Citation Analysis]
228 Krag A, Roskams T, Pinzani M, Mueller S. Diagnostic challenges in patients with alcohol-related liver disease. Z Gastroenterol 2022;60:45-57. [PMID: 35042253 DOI: 10.1055/a-1713-4372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Park H, Lo-Ciganic WH, Huang J, Wu Y, Henry L, Peter J, Sulkowski M, Nelson DR. Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysis. Hepatology 2022. [PMID: 35034373 DOI: 10.1002/hep.32347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Draper B, Yee WL, Pedrana A, Kyi KP, Qureshi H, Htay H, Naing W, Thompson AJ, Hellard M, Howell J. Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients. Lancet Reg Health West Pac 2022;20:100359. [PMID: 35024676 DOI: 10.1016/j.lanwpc.2021.100359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Meine TC, Becker LS, Dewald CLA, Maschke SK, Maasoumy B, Jaeckel E, Wedemeyer H, Wacker FK, Meyer BC, Hinrichs JB. Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Portal Vein Obliteration for Portal Vein Recanalization: Feasibility, Safety and Effectiveness. Cardiovasc Intervent Radiol 2022. [PMID: 35018502 DOI: 10.1007/s00270-021-03054-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
232 Mukund A, Rana S, Mohan C, Kalra N, Baijal SS. Indian College of Radiology and Imaging Evidence-Based Guidelines for Interventions in Portal Hypertension and Its Complications. Indian J Radiol Imaging. [DOI: 10.1055/s-0041-1740235] [Reference Citation Analysis]
233 Will V, Rodrigues SG, Berzigotti A. Current treatment options of refractory ascites in liver cirrhosis - A systematic review and meta-analysis. Dig Liver Dis 2022:S1590-8658(21)00894-X. [PMID: 35016859 DOI: 10.1016/j.dld.2021.12.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
234 Chang J, Matheja A, Krzycki S, Lutz P, Böhling N, Glückert K, Weismüller TJ, van Beekum C, Manekeller S, Jansen C, Kalff JC, Strassburg CP, Praktiknjo M. Model for end-stage liver disease underestimates mortality of patients with acute-on-chronic liver failure waiting for liver transplantation. Dig Liver Dis 2022:S1590-8658(21)00899-9. [PMID: 34996730 DOI: 10.1016/j.dld.2021.12.011] [Reference Citation Analysis]
235 Dong Y, Sun D, Wang Y, Du Q, Zhang Y, Han R, Teng M, Zhang T, Shi L, Zheng G, Dong Y, Wang T. Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure. BMC Infect Dis 2022;22:23. [PMID: 34983426 DOI: 10.1186/s12879-021-07018-2] [Reference Citation Analysis]
236 Nawghare P, Jain S, Chandnani S, Bansal S, Patel S, Debnath P, Rane S, Deshmukh R, Rathi P, Contractor Q. Predictors of Severity and Mortality in Chronic Liver Disease Patients With COVID-19 During the Second Wave of the Pandemic in India. Cureus 2022. [DOI: 10.7759/cureus.20891] [Reference Citation Analysis]
237 Durleshter V, Korochanskaya N, Murashko D, Basenko M. Risk factors of surgical treatment in patients with liver cirrhosis. Khir Z im N I Pirogova 2022. [DOI: 10.17116/hirurgia202203164] [Reference Citation Analysis]
238 Gambino C, Piano S, Angeli P. Cardiopulmonary Complications in Cirrhotic Patient with the Prospective of Liver Transplant. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_8] [Reference Citation Analysis]
239 Bazerbachi F, Levy MJ, Wongkeesong LM. Endoscopic Treatment of Portal Hypertension and Its Complications. Techniques and Innovations in Gastrointestinal Endoscopy 2022;24:76-89. [DOI: 10.1016/j.tige.2021.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Valsan A, Roy A, Singh V. Approach to Variceal Hemorrhage. Clinical Rounds in Hepatology 2022. [DOI: 10.1007/978-981-16-8448-7_11] [Reference Citation Analysis]
241 Prado V, Hernández-tejero M, Mücke MM, Marco F, Gu W, Amoros A, Toapanta D, Reverter E, Peña-ramirez CDL, Altenpeter L, Bassegoda O, Mezzano G, Aziz F, Juanola A, Rodríguez-tajes S, Chamorro V, López D, Reyes M, Hogardt M, Kempf VA, Ferstl PG, Zeuzem S, Martínez JA, Vila J, Arroyo V, Trebicka J, Fernandez J. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2021.12.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
242 Khanna A, Goel A, Tripathi D. Portal Hypertension: Varices. In Clinical Practice 2022. [DOI: 10.1007/978-3-031-10012-3_5] [Reference Citation Analysis]
243 Villanueva C, Tripathi D, Rodrigues SG, Torres F, Ripoll C, Bosch J. β-Blockers to Prevent Decompensation of Cirrhosis in Compensated Patients With Clinically Significant Portal Hypertension. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_34] [Reference Citation Analysis]
244 La Mura V, Turco L, Larrue H, Bureau C. Prevention of Variceal Bleeding and Rebleeding. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_48] [Reference Citation Analysis]
245 Vanderschueren E, Van der Merwe S, Laleman W. Novel Approaches and Disease Modifiers to Alter the Course of Cirrhotic Portal Hypertension. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_25] [Reference Citation Analysis]
246 Moctezuma-velazquez C, Castro-narro G, Simó P, Viayna E, Aceituno S, Soler M, Torre A. Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Lv Y, Han G. Special Settings: Acute Variceal Bleeding and Portal Vein Thrombosis in Cirrhosis. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_45] [Reference Citation Analysis]
248 Shovlin CL. Pulmonary Arteriovenous Malformations. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-08-102723-3.00086-x] [Reference Citation Analysis]
249 Jachs M, Reiberger T. Non-selective Beta Blockers in Liver Cirrhosis. Pharmacotherapy for Liver Cirrhosis and Its Complications 2022. [DOI: 10.1007/978-981-19-2615-0_8] [Reference Citation Analysis]
250 Gilbert-kawai N, Hogan B, Milan Z. Perioperative management of patients with liver disease. BJA Education 2022. [DOI: 10.1016/j.bjae.2021.11.006] [Reference Citation Analysis]
251 Rêgo HMC, Medronha EF, Junior EZ, Tovo CV, de Mattos AA. Transjugular intrahepatic portosystemic shunt with transhepatic portal vein puncture guided by ultrasound: a technical alternative. Eur J Gastroenterol Hepatol 2022;34:112-6. [PMID: 34748302 DOI: 10.1097/MEG.0000000000002174] [Reference Citation Analysis]
252 Khan S, Cain O, Rajoriya N. Alcohol Related Liver Disease. Men’s Health and Wellbeing 2022. [DOI: 10.1007/978-3-030-84752-4_11] [Reference Citation Analysis]
253 Nathwani R, Selvapatt N, Dhar A. Liver Decompensation and Acute on Chronic Liver Failure. In Clinical Practice 2022. [DOI: 10.1007/978-3-031-10012-3_4] [Reference Citation Analysis]
254 Venkitaraman A, Roy A, Singh V. Ascites and Spontaneous Bacterial Peritonitis. Clinical Rounds in Hepatology 2022. [DOI: 10.1007/978-981-16-8448-7_8] [Reference Citation Analysis]
255 Bergasa NV. Complications of Liver Disease. Clinical Cases in Hepatology 2022. [DOI: 10.1007/978-1-4471-4715-2_15] [Reference Citation Analysis]
256 李 倩. Risk Factors Analysis and Treatment of Spontaneous Bacterial Peritonitis in Decompensated Cirrhosis. MD 2022;12:172-179. [DOI: 10.12677/md.2022.122027] [Reference Citation Analysis]
257 马 立. Application and Research Progress of Imaging in Primary Liver Cancer. ACM 2022;12:6582-6587. [DOI: 10.12677/acm.2022.127950] [Reference Citation Analysis]
258 Amedei A, Gitto S, Campani C, Marra F. Probiotics and the gut-liver axis. Probiotics 2022. [DOI: 10.1016/b978-0-323-85170-1.00003-8] [Reference Citation Analysis]
259 Wong F, Sauerbruch T. Terlipressin in Liver Cirrhosis. Pharmacotherapy for Liver Cirrhosis and Its Complications 2022. [DOI: 10.1007/978-981-19-2615-0_10] [Reference Citation Analysis]
260 Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, Graupera I, Ginès P, Solà E, Hernaez R. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut 2022;71:148-55. [PMID: 33436495 DOI: 10.1136/gutjnl-2020-322161] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 26.0] [Reference Citation Analysis]
261 Protopapas AA, Papagiouvanni I, Fragkou N, Alevroudis E, Sinakos E, Goulis I. Estimation of glomerular filtration rate in patients with cirrhosis: evaluation of equations currently used in clinical practice and validation of Royal Free Hospital cirrhosis glomerular filtration rate. Eur J Gastroenterol Hepatol 2022;34:84-91. [PMID: 32956187 DOI: 10.1097/MEG.0000000000001935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
262 Samonakis DN, Gatselis N, Bellou A, Sifaki-Pistolla D, Mela M, Demetriou G, Thalassinos E, Rigopoulou EI, Kevrekidou P, Tziortziotis I, Azariadi K, Kavousanaki M, Digenakis E, Vassiliadis T, Kouroumalis EA, Dalekos GN. Spontaneous bacterial peritonitis: a prospective Greek multicenter study of its epidemiology, microbiology, and outcomes. Ann Gastroenterol 2022;35:80-7. [PMID: 34987293 DOI: 10.20524/aog.2021.0674] [Reference Citation Analysis]
263 Sukowati CHC, Tiribelli C. Adult Stem Cell Therapy as Regenerative Medicine for End-Stage Liver Disease. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/5584_2022_719] [Reference Citation Analysis]
264 Lamatsch S, Sittner R, Tacke F, Engelmann C. Novel drug discovery strategies for the treatment of decompensated cirrhosis. Expert Opin Drug Discov 2021;:1-10. [PMID: 34971342 DOI: 10.1080/17460441.2022.2020755] [Reference Citation Analysis]
265 Abu-Freha N, Michael T, Poupko L, Estis-Deaton A, Aasla M, Abu-Freha O, Etzion O, Nesher L. Spontaneous Bacterial Peritonitis among Cirrhotic Patients: Prevalence, Clinical Characteristics, and Outcomes. J Clin Med 2021;11:227. [PMID: 35011969 DOI: 10.3390/jcm11010227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
266 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
267 Gao Y, Wei L, Zhang DD, Chen Y, Hou B. SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites. J Clin Transl Hepatol 2021;9:795-7. [PMID: 34966642 DOI: 10.14218/JCTH.2021.00418] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
268 Law MF, Ho R, Law KWT, Cheung CKM. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World J Hepatol 2021; 13(12): 1850-1874 [DOI: 10.4254/wjh.v13.i12.1850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Zhuang YP, Wang SQ, Pan ZY, Zhong HJ, He XX. Differences in complications between hepatitis B-related cirrhosis and alcohol-related cirrhosis. Open Med (Wars) 2022;17:46-52. [PMID: 34950772 DOI: 10.1515/med-2021-0401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
270 Fründt T, Kuballa L, Lütgehetman M, Nörz D, Arend H, Brehm TT, Schulze Zur Wiesch J, Horvatits T, Horvatits K, Huber S, Wege H, Kluwe J. Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic. PLoS One 2021;16:e0258450. [PMID: 34941875 DOI: 10.1371/journal.pone.0258450] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
271 Nordmann T, Schlabe S, Feldt T, Gobbi F, Krieg A, Bode JG, Fuchs A, Kraef C, Praktiknjo M, Trebicka J, Ramharter M, Addo MM, Strassburg C, Lohse AW, Luedde T, Schmiedel S, Orth HM. TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature. PLoS Negl Trop Dis 2021;15:e0010065. [PMID: 34932562 DOI: 10.1371/journal.pntd.0010065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Liu S, Meng Q, Xu Y, Zhou J. Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion. Gastroenterol Rep (Oxf) 2021;9:505-20. [PMID: 34925848 DOI: 10.1093/gastro/goab040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
273 Ye J, Huang Y, Sun Y, Shao C, Zhang S, Wang W, Zhong B. Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis. Ann Transl Med 2021;9:1613. [PMID: 34926657 DOI: 10.21037/atm-21-3142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
274 Reißing J, Lutz P, Frissen M, Ibidapo-Obe O, Reuken PA, Wirtz TH, Stengel S, Quickert S, Rooney M, Große K, Zimmermann HW, Trautwein C, Stallmach A, Bruns T. Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality. JHEP Rep 2022;4:100391. [PMID: 34917912 DOI: 10.1016/j.jhepr.2021.100391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 de Mattos ÂZ, Terra C, Farias AQ, Bittencourt PL, Alliance of Brazilian Centers for Cirrhosis Care–the ABC Group. Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies. World J Gastrointest Endosc 2021; 13(12): 628-637 [DOI: 10.4253/wjge.v13.i12.628] [Reference Citation Analysis]
276 Smethurst K, Gallacher J, Jopson L, Majiyagbe T, Johnson A, Copeman P, Mansour D, Mcpherson S. Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2021-102021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
277 Tangcheewinsirikul N, Moonla C, Uaprasert N, Pittayanon R, Rojnuckarin P. Viscoelastometric versus standard coagulation tests to guide periprocedural transfusion in adults with cirrhosis: A meta-analysis of randomized controlled trials. Vox Sang 2021. [PMID: 34911140 DOI: 10.1111/vox.13225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
278 Hsu LI, Chen JW, Lin DT, Wei ST, Hou SM. The continued decline of plasma transfusions in Taiwan: An 11-year population-based study. Vox Sang 2021. [PMID: 34905221 DOI: 10.1111/vox.13222] [Reference Citation Analysis]
279 Reiberger T. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Hepatol Commun 2021. [PMID: 34904404 DOI: 10.1002/hep4.1855] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
280 Kim JH, Choe WH, Lee SY, Kwon SY, Sung IK, Park HS. Comparative study for predictability of type 1 gastric variceal rebleeding after endoscopic variceal ligation: High-frequency intraluminal ultrasound study. World J Clin Cases 2021; 9(34): 10566-10575 [PMID: 35004988 DOI: 10.12998/wjcc.v9.i34.10566] [Reference Citation Analysis]
281 Osman KT, Nayfeh T, Abdelfattah AM, Alabdallah K, Hasan B, Firwana M, Alabaji H, Elkhabiry L, Mousa J, Prokop LJ, Murad MH, Gordon F. Secondary Prophylaxis of Gastric Variceal Bleeding: A Systematic Review and Network Meta-Analysis. Liver Transpl 2021. [PMID: 34860458 DOI: 10.1002/lt.26383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
282 Simonetti RG, Perricone G, Gluud C. Albumin for people with liver cirrhosis and bacterial infections. Cochrane Database of Systematic Reviews 2021;2021. [DOI: 10.1002/14651858.cd014636] [Reference Citation Analysis]
283 Bai Z, Wang R, Cheng G, Ma D, Ibrahim M, Chawla S, Qi X. Outcomes of early versus delayed endoscopy in cirrhotic patients with acute variceal bleeding: a systematic review with meta-analysis. Eur J Gastroenterol Hepatol 2021;33:e868-76. [PMID: 35048654 DOI: 10.1097/MEG.0000000000002282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
284 Zhong BY, Tang HH, Wang WS, Shen J, Zhang S, Li WC, Yin Y, Yang J, Liu F, Ni CF, Zhao JB, Zhu XL. Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol 2021;33:e153-60. [PMID: 33177378 DOI: 10.1097/MEG.0000000000001989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
285 Bergamin I, Meyer-herbon P, Künzler-heule P, Semela D. Klinisches Management von Patienten mit Leberzirrhose. Schweiz Gastroenterol 2021;2:119-127. [DOI: 10.1007/s43472-021-00058-8] [Reference Citation Analysis]
286 Tan M, Menon S. A nurse-led day-case gastroenterology service in the emergency department. Gastrointestinal Nursing 2021;19:S18-S23. [DOI: 10.12968/gasn.2021.19.sup10.s18] [Reference Citation Analysis]
287 Li J, Tang S, Zhao J, Zhang C, Jiang Z, Xue H, Sun J, Zhu X, Ren W, Zhu X, Wang Q, Wang E, Lv Y, Guo S, Wang Z, Yang Q, Wang Z, Niu J, Yin Z, Xia J, Fan D, Han G. Long-term survival prediction for transjugular intrahepatic portosystemic shunt in severe cirrhotic ascites: assessment of ten prognostic models. Eur J Gastroenterol Hepatol 2021;33:1547-55. [PMID: 32868654 DOI: 10.1097/MEG.0000000000001890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
288 Keshava SN, Moses V, Sharma A, Ahmed M, Narayanan S, Padmanabhan A, Goel A, Zachariah U, Eapen C. Technical and Medium-Term Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt with Fluoroscopy and Additional Trans-abdominal Ultrasound Guidance. Indian J Radiol Imaging 2022;31:858-66. [DOI: 10.1055/s-0041-1735928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
289 Khan F, Tripathi D. Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions. World J Gastroenterol 2021; 27(44): 7612-7624 [PMID: 34908802 DOI: 10.3748/wjg.v27.i44.7612] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
290 Dhar J, Samanta J. Role of endoscopic ultrasound in the field of hepatology: Recent advances and future trends. World J Hepatol 2021; 13(11): 1459-1483 [PMID: 34904024 DOI: 10.4254/wjh.v13.i11.1459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
291 Ostojic Z, Ostojic A, Bulum J, Mrzljak A. Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease. World J Cardiol 2021; 13(11): 599-607 [PMID: 34909126 DOI: 10.4330/wjc.v13.i11.599] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
292 Giri S, Kasturi S, Darak H. Albumin for AKI in cirrhosis - Sham therapy or effective? Liver Int 2022;42:258-9. [PMID: 34817914 DOI: 10.1111/liv.15114] [Reference Citation Analysis]
293 Mani I, Vrioni G, Hadziyannis E, Alexopoulos T, Vasilieva L, Tsiriga A, Tsiamis C, Tsakris A, Dourakis SP, Alexopoulou A. Bacterial DNA is a prognostic factor for mortality in patients who recover from spontaneous bacterial peritonitis. Ann Gastroenterol 2021;34:852-61. [PMID: 34815652 DOI: 10.20524/aog.2021.0665] [Reference Citation Analysis]
294 Currais P, Nunes G, Patita M, Coimbra É, Fonseca J. SX-ELLA Danis-Stent for Refractory Acute Esophageal Variceal Bleeding. GE Port J Gastroenterol. [DOI: 10.1159/000520273] [Reference Citation Analysis]
295 Labenz C, Kostev K, Galle PR, Wörns MA, Schattenberg JM. Prescription rates of common medications in patients with decompensated cirrhosis in Germany. Z Gastroenterol 2021. [PMID: 34820806 DOI: 10.1055/a-1676-4822] [Reference Citation Analysis]
296 Du H, Zhong B, Zhang P, Wang W, Shen J, Zhang S, Li W, Tang H, Zhou L, Yang W, Zhu X. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding: A series of six cases and literature review. J Interv Med 2021;4:49-52. [PMID: 34805948 DOI: 10.1016/j.jimed.2020.10.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
297 Santos A, Coelho R, Silva M, Morais R, Cardoso H, Macedo G. A Predictive Model for Avoiding Follow-Up Paracentesis in Spontaneous Bacterial Peritonitis. GE Port J Gastroenterol. [DOI: 10.1159/000519934] [Reference Citation Analysis]
298 Chandna S, Zarate ER, Gallegos-Orozco JF. Management of Decompensated Cirrhosis and Associated Syndromes. Surg Clin North Am 2022;102:117-37. [PMID: 34800381 DOI: 10.1016/j.suc.2021.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
299 Wang PL, Silver SA, Djerboua M, Thanabalasingam S, Zarnke S, Flemming JA. Recovery From Acute Kidney Injury Requiring Dialysis in Patients With Cirrhosis: A Population-Based Study. Am J Kidney Dis 2021:S0272-6386(21)01000-3. [PMID: 34808296 DOI: 10.1053/j.ajkd.2021.09.025] [Reference Citation Analysis]
300 Korochanskaya NV, Durleshter VM, Serikova SN, Usova OA, Bacenko MA, Serikov SS. Patient- oriented approach to management of patients with hepatic cirrhosis. jour 2021. [DOI: 10.31146/1682-8658-ecg-192-8-142-149] [Reference Citation Analysis]
301 Zia HA, Aby ES, Rabiee A. An Update on the Management of Esophageal Variceal Hemorrhage. Clin Liver Dis (Hoboken) 2021;18:179-83. [PMID: 34745574 DOI: 10.1002/cld.1108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Haque LY, Garcia-Tsao G. A Historical Overview of Spontaneous Bacterial Peritonitis: From Rare to Resistant. Clin Liver Dis (Hoboken) 2021;18:63-75. [PMID: 34745584 DOI: 10.1002/cld.1122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Kaczmarek DJ, Kupczyk P, Schultheiß M, Chang J, Jansen C, Trebicka J, Weismüller T, Vilz TO, Luu AM, Attenberger U, Strassburg CP, Meyer C, Praktiknjo M. TIPS for the management of stomal variceal bleeding due to cirrhotic and non-cirrhotic portal hypertension. Z Gastroenterol 2021. [PMID: 34741298 DOI: 10.1055/a-1508-6446] [Reference Citation Analysis]
304 Tranah TH, Kronsten VT, Shawcross DL. Implications and Management of Cirrhosis-Associated Immune Dysfunction Before and After Liver Transplantation. Liver Transpl 2021. [PMID: 34738724 DOI: 10.1002/lt.26353] [Reference Citation Analysis]
305 Wu F, Yu J, Gan H, Zhang H, Tian D, Zheng D. Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Sci Rep 2021;11:21743. [PMID: 34741082 DOI: 10.1038/s41598-021-01201-w] [Reference Citation Analysis]
306 Jiménez-Gutiérrez JM, García-Juárez I, Olivas-Martinez A, Ruiz I. One-year outcome of patients with cirrhosis who developed spontaneous bacterial empyema: A cohort study. J Dig Dis 2021. [PMID: 34738327 DOI: 10.1111/1751-2980.13066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
307 Lu HL, Xuan FF, Luo YC, Qin X. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt. Abdom Radiol (NY) 2021;46:5417-27. [PMID: 34302511 DOI: 10.1007/s00261-021-03214-5] [Reference Citation Analysis]
308 Ozersari S, Ünal B, Kemal Çabuk A, Eren Hazir K, Çağri Şimşek E, Ekmekci C, Küçükukur M, Betül Paköz Z, Günay S, Sari C. The prognostic value of P-wave dispersion and left atrial functions assessed with three-dimensional echocardiography in patients with cirrhosis. Eur J Gastroenterol Hepatol 2021;33:1441-50. [PMID: 33741802 DOI: 10.1097/MEG.0000000000002129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
309 Kalia S, Nath P, Pathak M, Anand AC. Treatment of Muscle Cramps in Patients With Cirrhosis of Liver: A Systematic Review. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.10.147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Chiu WC, Shan JC, Yang YH, Chen VC, Chen PC. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder. Drug Alcohol Depend 2021;228:109096. [PMID: 34600254 DOI: 10.1016/j.drugalcdep.2021.109096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
311 Guo H, Zhang F, Yin X, Zhang M, Xiao J, Wang Y, Zhang B, Zhang W, Zou X, Zhuge Y. Endoscopic therapy + β-blocker vs. covered transjugular intrahepatic portosystemic shunt for prevention of variceal rebleeding in cirrhotic patients with hepatic venous pressure gradient ≥16 mmHg. Eur J Gastroenterol Hepatol 2021;33:1427-35. [PMID: 32868650 DOI: 10.1097/MEG.0000000000001872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
312 Kogiso T, Ogasawara Y, Sagawa T, Taniai M, Tokushige K. Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan. JGH Open 2021;5:1298-1305. [DOI: 10.1002/jgh3.12672] [Reference Citation Analysis]
313 Zhai S, Cui Q, Dong F, Wen S, Si M, Chen Q. Clinical efficacy of transjugular intrahepatic portosystemic shunt created through left or right branches of the portal vein: A meta-analysis. Journal of Interventional Medicine 2021;4:190-6. [DOI: 10.1016/j.jimed.2021.08.002] [Reference Citation Analysis]
314 Zhang YR, Wang H, Zhou N, Zhang YD, Lin Y, Wu LY, Wei SF, Ma YY, Wang CX. A Multidisciplinary Team Approach to the Treatment of Liver Cirrhosis. J Inflamm Res 2021;14:5443-50. [PMID: 34712056 DOI: 10.2147/JIR.S328334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Kapila N, Gonzalez A, Rosado JM, Flocco G, Salomon F, Abusaif M, Hussain I, Moor MA, Modaresi-Esfeh J, Castro FJ. Safety of anti-TNF agents in patients with compensated cirrhosis: a case-control study. Therap Adv Gastroenterol 2021;14:17562848211037094. [PMID: 34707687 DOI: 10.1177/17562848211037094] [Reference Citation Analysis]
316 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Frühbeck G, Dicker D, Woodward E, Korenjak M, Willemse J, Koek GH, Vinker S, Ungan M, Mendive JM, Lionis C. Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep 2021;3:100322. [PMID: 34693236 DOI: 10.1016/j.jhepr.2021.100322] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
318 El-shayeb A, El-mallah S, Deghady A, El-hewely S, Elwazzan D. Validity of serum leukotriene B4 as a marker of decompensated liver cirrhosis in chronic HCV patients: leukotriene B4 in decompensated liver cirrhosis. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00152-1] [Reference Citation Analysis]
319 An Y, Xu X, Ren T, Tong Z, Romeiro FG, Mancuso A, Guo X, Qi X. Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients. Int J Gen Med 2021;14:6713-24. [PMID: 34675632 DOI: 10.2147/IJGM.S326192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
320 Chaney A. A Review for the Practicing Clinician: Hepatorenal Syndrome, a Form of Acute Kidney Injury, in Patients with Cirrhosis. Clin Exp Gastroenterol 2021;14:385-96. [PMID: 34675586 DOI: 10.2147/CEG.S323778] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
321 Nababan SHH, Mansjoer A, Fauzi A, Gani RA. Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia. BMC Gastroenterol 2021;21:392. [PMID: 34670501 DOI: 10.1186/s12876-021-01972-6] [Reference Citation Analysis]
322 Kim TH, Um SH, Lee YS, Yim SY, Jung YK, Seo YS, Kim JH, An H, Yim HJ, Yeon JE, Byun KS. Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy. Aliment Pharmacol Ther 2022;55:83-96. [PMID: 34662436 DOI: 10.1111/apt.16658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
323 Hussain I, Wong YJ, Lohan R, Lin S, Kumar R. Does preemptive transjugular intrahepatic portosystemic shunt improve survival after acute variceal bleeding? Systematic review, meta-analysis, and trial sequential analysis of randomized trials. J Gastroenterol Hepatol 2021. [PMID: 34665473 DOI: 10.1111/jgh.15714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
324 He X, Chen L, Chen H, Feng Y, Zhu B, Yang C. Diagnostic Accuracy of Procalcitonin for Bacterial Infection in Liver Failure: A Meta-Analysis. Bioinorg Chem Appl 2021;2021:5801139. [PMID: 34646316 DOI: 10.1155/2021/5801139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
325 Michel M, Hess C, Kaps L, Kremer WM, Hilscher M, Galle PR, Moehler M, Schattenberg JM, Wörns MA, Labenz C, Nagel M. Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis. Sci Rep 2021;11:20506. [PMID: 34654829 DOI: 10.1038/s41598-021-00119-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
326 Horvatits T, Hübener P, Touma M, Horvatits K, Fischer L, Lohse AW, Sterneck M. Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survival. Ann Hepatol 2021;:100559. [PMID: 34656773 DOI: 10.1016/j.aohep.2021.100559] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
327 Kronborg TM, Ytting H, Hobolth L, Møller S, Kimer N. Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study. Front Med (Lausanne) 2021;8:718896. [PMID: 34631742 DOI: 10.3389/fmed.2021.718896] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
328 Ioannou P, Karakonstantis S, Schouten J, Kostyanev T, Charani E, Vlahovic-Palcevski V, Kofteridis DP; supported by the ESCMID Study Group for Antimicrobial Stewardship (ESGAP). Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review. Clin Microbiol Infect 2021:S1198-743X(21)00569-3. [PMID: 34653572 DOI: 10.1016/j.cmi.2021.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
329 Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet 2021;398:1359-76. [PMID: 34543610 DOI: 10.1016/S0140-6736(21)01374-X] [Cited by in Crossref: 84] [Cited by in F6Publishing: 99] [Article Influence: 84.0] [Reference Citation Analysis]
330 Patel RK, Chandel K, Tripathy TP, Mukund A. Complications of transjugular intrahepatic portosystemic shunt (TIPS) in the era of the stent graft - What the interventionists need to know? Eur J Radiol 2021;144:109986. [PMID: 34619618 DOI: 10.1016/j.ejrad.2021.109986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
331 Costa E Silva PP, Codes L, Rios FF, Esteve CP, Valverde Filho MT, Lima DOC, de Almeida Filho GF, Morais MCA, Lima BC, Chagas PBO, Boa-Sorte N, Bittencourt PL. Comparison of General and Liver-Specific Prognostic Scores in Their Ability to Predict Mortality in Cirrhotic Patients Admitted to the Intensive Care Unit. Can J Gastroenterol Hepatol 2021;2021:9953106. [PMID: 34608435 DOI: 10.1155/2021/9953106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
332 Bello FPS, Cardoso S, Tannuri AC, Preto-Zamperlini M, Schvartsman C, Farhat SCL. Acute upper gastrointestinal bleeding due to portal hypertension in children: What is the best timing of endoscopy? Dig Liver Dis 2021:S1590-8658(21)00779-9. [PMID: 34625365 DOI: 10.1016/j.dld.2021.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
333 Grensemann J, Pfaffendorf C, Wicha SG, König C, Roedl K, Jarczak D, Iwersen-Bergmann S, Manthey C, Kluge S, Fuhrmann V. Voriconazole Pharmacokinetics Are Not Altered in Critically Ill Patients with Acute-on-Chronic Liver Failure and Continuous Renal Replacement Therapy: An Observational Study. Microorganisms 2021;9:2087. [PMID: 34683408 DOI: 10.3390/microorganisms9102087] [Reference Citation Analysis]
334 Oblizajek NR, Kamath PS. Resolution of Loculated Chylous Ascites Using Intraperitoneal Fibrinolytic Therapy. Hepatology 2021;74:2293-5. [PMID: 33738838 DOI: 10.1002/hep.31816] [Reference Citation Analysis]
335 Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti AS; HRS-HARMONY study investigators. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. Am J Kidney Dis 2021:S0272-6386(21)00890-8. [PMID: 34606933 DOI: 10.1053/j.ajkd.2021.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
336 Li P, Chen Y, Zhang W, Yang H. CSOG MFM Committee Guideline: Clinical Management Guidelines for Acute Fatty Liver of Pregnancy in China (2021). Maternal-Fetal Medicine 2021;3:238-45. [DOI: 10.1097/fm9.0000000000000121] [Reference Citation Analysis]
337 Storni F, Stirnimann J, Banz V, De Gottardi A, Stirnimann G. Treatment of refractory ascites with an automated low flow ascites pump in patients awaiting liver transplantation. Journal of Liver Transplantation 2021;4:100037. [DOI: 10.1016/j.liver.2021.100037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
338 Luo X, Xiang T, Wu J, Wang X, Zhu Y, Xi X, Yan Y, Yang J, García-Pagán JC, Yang L. Endoscopic Cyanoacrylate Injection Versus Balloon-Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Bleeding: A Randomized Controlled Trial. Hepatology 2021;74:2074-84. [PMID: 33445218 DOI: 10.1002/hep.31718] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
339 Ponzo P, Campion D, Rizzo M, Roma M, Caviglia GP, Giovo I, Rizzi F, Bonetto S, Saracco GM, Alessandria C. Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: Impact on renal function. Digestive and Liver Disease 2021. [DOI: 10.1016/j.dld.2021.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
340 Stockhoff L, Muellner-Bucsics T, Markova AA, Schultalbers M, Keimburg SA, Tergast TL, Hinrichs JB, Simon N, Gerbel S, Manns MP, Mandorfer M, Cornberg M, Meyer BC, Wedemeyer H, Reiberger T, Maasoumy B. Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS. Hepatol Commun 2021. [PMID: 34585537 DOI: 10.1002/hep4.1829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
341 Solé C, Ma AT, Solà E, Carol M, Fabrellas N, Juanola A, Napoleone L, Gratacós-Ginès J, Bassegoda O, Cervera M, Pérez M, Rubio AB, Avitabile E, Morales-Ruiz M, Graupera I, Pose E, Kamath PS, Ginès P. Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome. Liver Int 2021;41:2729-32. [PMID: 34569697 DOI: 10.1111/liv.15069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
342 Bardi E, Mulder RL, van Dalen EC, Bhatt NS, Ruble KA, Burgis J, Castellino SM, Constine LS, den Hoed CM, Green DM, Koot BGP, Levitt G, Szonyi L, Wallace WH, Skinner R, Hudson MM, Kremer LCM, Effinger KE, Bresters D. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group. Cancer Treat Rev 2021;100:102296. [PMID: 34571378 DOI: 10.1016/j.ctrv.2021.102296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
343 Gambino C, Piano S, Angeli P. Acute-on-Chronic Liver Failure in Cirrhosis. J Clin Med 2021;10:4406. [PMID: 34640424 DOI: 10.3390/jcm10194406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
344 Merkel M, Schneider C, Greinert R, Zipprich A, Ripoll C, Lammert F, Reichert MC. Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant. Hepatol Commun 2021;5:1755-66. [PMID: 34558822 DOI: 10.1002/hep4.1753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
345 Yoo JJ, Kwon JH, Kim YS, Nam SW, Park JW, Kim HY, Kim CW, Shin SK, Chon YE, Jang ES, Jeong SH, Lee JW, Song DS, Yang JM, Lee SW, Lee HL, Jung YK, Yim HJ, Lee B, Kim SG, Kim JH. The Role of Urinary N-Acetyl-β-d-glucosaminidase in Cirrhotic Patients with Acute Kidney Injury: Multicenter, Prospective Cohort Study. J Clin Med 2021;10:4328. [PMID: 34640346 DOI: 10.3390/jcm10194328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
346 Isfordink CJ, Maan R, de Man RA, van Erpecum KJ, van der Meer AJ. Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection? Eur J Intern Med 2021:S0953-6205(21)00296-X. [PMID: 34563447 DOI: 10.1016/j.ejim.2021.08.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
347 Wu Q, Mao W. New prognostic factor for hepatitis B virus-related decompensated cirrhosis: Ratio of monocytes to HDL-cholesterol. J Clin Lab Anal 2021;35:e24007. [PMID: 34545611 DOI: 10.1002/jcla.24007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
348 Miah N, Ryan A, Oztumer CA, Saleh M. First presentation of portal hypertension complicated by hepatopulmonary syndrome. BMJ Case Rep 2021;14:e244712. [PMID: 34544713 DOI: 10.1136/bcr-2021-244712] [Reference Citation Analysis]
349 Zhao W, Xue N, Cui P, Liu L, Wang Y, Zhang X, Tang Y, Du H, Nan Y. Plasma YAP1 predicts esophageal varices and the risk of variceal bleeding in liver cirrhosis. Biomark Med 2021;15:1411-22. [PMID: 34533050 DOI: 10.2217/bmm-2020-0573] [Reference Citation Analysis]
350 Kulkarni AV, Kumar P, Sharma M, Ravikumar ST, Tevethia H, Vasireddy S, Gupta R, Reddy DN, Rao PN. Midodrine Improves the Tolerability of Diuretics in Patients with Acute-on-Chronic Liver Failure-A Pilot Study. J Clin Exp Hepatol 2021;11:573-8. [PMID: 34511818 DOI: 10.1016/j.jceh.2020.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
351 Torres-Valencia J, Quevedo-Mori A, Untiveros-Mayorga F. Hypoxemia, high alveolar-arterial gradient, and bubbles in both sides of heart: A case of hepatopulmonary syndrome in the setting of COVID-19 pandemic. Clin Case Rep 2021;9:e04204. [PMID: 34512977 DOI: 10.1002/ccr3.4204] [Reference Citation Analysis]
352 Juanola A, Graupera I, Elia C, Piano S, Solé C, Carol M, Pérez-Guasch M, Bassegoda O, Escudé L, Rubio AB, Cervera M, Napoleone L, Avitabile E, Ma AT, Fabrellas N, Pose E, Morales-Ruiz M, Jiménez W, Torres F, Crespo G, Solà E, Ginès P. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis. J Hepatol 2021:S0168-8278(21)02029-8. [PMID: 34530063 DOI: 10.1016/j.jhep.2021.08.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
353 Tripathi PR, Sen Sarma M, Yachha SK, Aggarwal A, Bhatia V, Kumar A, Srivastava A, Poddar U. Relative Adrenal Insufficiency in Decompensated Cirrhotic Children: Does It Affect Outcome? Am J Gastroenterol 2021. [PMID: 34506335 DOI: 10.14309/ajg.0000000000001486] [Reference Citation Analysis]
354 Kalo E, Read S, Ahlenstiel G. Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension. Livers 2021;1:147-79. [DOI: 10.3390/livers1030014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
355 Chang J, Meinke J, Geck M, Hebest M, Böhling N, Dolscheid-Pommerich R, Stoffel-Wagner B, Kristiansen G, Overhaus M, Peyman LO, Klein S, Uschner FE, Brol MJ, Vilz TO, Lingohr P, Kalff JC, Jansen C, Strassburg CP, Wehner S, Trebicka J, Praktiknjo M. Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models. Front Physiol 2021;12:720898. [PMID: 34489738 DOI: 10.3389/fphys.2021.720898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Praharaj DL, Anand AC. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
357 Caraceni P, Vargas V, Solà E, Alessandria C, de Wit K, Trebicka J, Angeli P, Mookerjee RP, Durand F, Pose E, Krag A, Bajaj JS, Beuers U, Ginès P; Liverhope Consortium. The Use of Rifaximin in Patients With Cirrhosis. Hepatology 2021;74:1660-73. [PMID: 33421158 DOI: 10.1002/hep.31708] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 27.0] [Reference Citation Analysis]
358 Guibal A, Seiller I, Khemissa F, Aufranc V, Rehim M, Fryder I, Farouil G, Chevallier P. Recommandations opérationnelles en radiologie interventionnelle : destruction tumorale percutanée des tumeurs hépatiques. Journal d'imagerie diagnostique et interventionnelle 2021;4:231-7. [DOI: 10.1016/j.jidi.2021.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
359 Jachs M, Hartl L, Schaufler D, Desbalmes C, Simbrunner B, Eigenbauer E, Bauer DJM, Paternostro R, Schwabl P, Scheiner B, Bucsics T, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut 2021;70:1758-67. [PMID: 33199442 DOI: 10.1136/gutjnl-2020-322712] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 26.0] [Reference Citation Analysis]
360 Kalambokis GN, Christaki M, Tsiakas I, Despotis G, Fillipas-Ntekouan S, Fotopoulos A, Tsiouris S, Xourgia X, Lakkas L, Pappas K, Michalis LK, Sergianiti F, Baltayiannis G, Christodoulou D, Koustousi C, Aggelis N, Milionis H. Conversion of Propranolol to Carvedilol Improves Renal Perfusion and Outcome in Patients With Cirrhosis and Ascites. J Clin Gastroenterol 2021;55:721-9. [PMID: 32991355 DOI: 10.1097/MCG.0000000000001431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
361 Cheng CY, Kung CT, Wu KH, Chen FC, Cheng HH, Cheng FJ, Huang JB, Su CM. Liver cirrhosis affects serum lactate level measurement while assessing disease severity in patients with sepsis. Eur J Gastroenterol Hepatol 2021;33:1201-8. [PMID: 32576767 DOI: 10.1097/MEG.0000000000001826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
362 Strainiene S, Peciulyte M, Strainys T, Stundiene I, Savlan I, Liakina V, Valantinas J. Management of Flood syndrome: What can we do better? World J Gastroenterol 2021; 27(32): 5297-5305 [PMID: 34539133 DOI: 10.3748/wjg.v27.i32.5297] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Vaz K, Efthymiou M, Vaughan R, Testro AG, Lew HB, Pu LZCT, Chandran S. Unpacking the challenge of gastric varices: A review on indication, timing and modality of therapy. World J Hepatol 2021; 13(8): 868-878 [PMID: 34552693 DOI: 10.4254/wjh.v13.i8.868] [Reference Citation Analysis]
364 Bai Z, Cheng G, Méndez-Sánchez N, Qi X. Human albumin infusion strategy in liver cirrhosis: liberal or restrictive? Ann Transl Med 2021;9:1114. [PMID: 34430555 DOI: 10.21037/atm-21-2136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
365 Queck A, Uschner FE, Ferstl PG, Schulz M, Brol MJ, Praktiknjo M, Schierwagen R, Klein S, Strassburg CP, Meyer C, Jansen C, Berres ML, Trebicka J. Role of circulating angiogenin levels in portal hypertension and TIPS. PLoS One 2021;16:e0256473. [PMID: 34432848 DOI: 10.1371/journal.pone.0256473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Pantea R, Meister P, Neuhaus JP, Nowak K, Paul A, Saner FH. [Surgery in patients with liver cirrhosis]. Chirurg 2021;92:838-45. [PMID: 33459796 DOI: 10.1007/s00104-020-01319-z] [Reference Citation Analysis]
367 Effenberger M, Grabherr F, Schaefer B, Grander C, Mayr L, Schwärzler J, Enrich B, Moser P, Fink J, Pedrini A, Jaschke N, Freund M, Loizides A, Bale R, Putzer D, Widjaja AA, Schafer S, Cook SA, Zoller H, Oberhuber G, Adolph TE, Tilg H. Interleukin-11 plays a key role in human and mouse alcohol-related liver disease.. [DOI: 10.1101/2021.08.24.456749] [Reference Citation Analysis]
368 Zanetto A, Shalaby S, Feltracco P, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Recent Advances in the Management of Acute Variceal Hemorrhage. J Clin Med 2021;10:3818. [PMID: 34501265 DOI: 10.3390/jcm10173818] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
369 Tay PWL, Xiao J, Tan DJH, Ng C, Lye YN, Lim WH, Teo VXY, Heng RRY, Yeow MWX, Lum LHW, Tan EXX, Kew GS, Lee GH, Muthiah MD. An Epidemiological Meta-Analysis on the Worldwide Prevalence, Resistance, and Outcomes of Spontaneous Bacterial Peritonitis in Cirrhosis. Front Med (Lausanne) 2021;8:693652. [PMID: 34422858 DOI: 10.3389/fmed.2021.693652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
370 Pimentel R, Leitão J, Gregório C, Santos L, Carvalho A, Figueiredo P. Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Shift in the Microbial Pattern? A Retrospective Analysis. GE Port J Gastroenterol. [DOI: 10.1159/000518585] [Reference Citation Analysis]
371 Kasper P, Steffen HM, Michels G. [Cirrhotic cardiomyopathy]. Dtsch Med Wochenschr 2021;146:1070-6. [PMID: 34416775 DOI: 10.1055/a-1321-9523] [Reference Citation Analysis]
372 Bakulin IG, Oganezova IA, Skalinskaya MI, Skazyvaeva EV. Liver cirrosis and complication risk management. Terapevticheskii arkhiv 2021;93:963-968. [DOI: 10.26442/00403660.2021.08.200917] [Reference Citation Analysis]
373 Santos Lucio A, Rodríguez Tirado I, Aparicio Serrano A, Jurado García J, Barrera Baena P, González Galilea Á, Poyato González A, Pleguezuelo Navarro M, Costán Rodero G, Casáis Juanena L, Montero Álvarez JL, de la Mata M, Hervás Molina AJ, Rodríguez-Perálvarez ML. Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programme. Gastroenterol Hepatol 2021:S0210-5705(21)00228-4. [PMID: 34400186 DOI: 10.1016/j.gastrohep.2021.07.010] [Reference Citation Analysis]
374 Javaid N, Iqbal AZ, Hameeda M. NUTRITIONAL MANAGEMENT OF LIVER CIRRHOSIS AND ITS COMPLICATIONS IN HOSPITALIZED PATIENTS. Arq Gastroenterol 2021;58:246-52. [PMID: 34287534 DOI: 10.1590/S0004-2803.202100000-43] [Reference Citation Analysis]
375 Maccali C, Augustinho FC, Zocche TL, Silva TE, Narciso-Schiavon JL, Schiavon LL. NEUTROPHIL-LYMPHOCYTE RATIO PREDICTS SHORT-TERM MORTALITY IN PATIENTS HOSPITALIZED FOR ACUTE DECOMPENSATION OF CIRRHOSIS. Arq Gastroenterol 2021;58:131-8. [PMID: 34287528 DOI: 10.1590/S0004-2803.202100000-23] [Reference Citation Analysis]
376 Petroni ML, Brodosi L, Marchignoli F, Sasdelli AS, Caraceni P, Marchesini G, Ravaioli F. Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges. Nutrients 2021;13:2748. [PMID: 34444908 DOI: 10.3390/nu13082748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
377 Zhou Y, Ma J, Ju S, Zhang Z, Zhang W, Yang M, Zhou X, Yan Z, Luo J. Efficacy of puncturing different portal vein branch during transjugular intrahepatic portosystemic shunt with 8 mm covered stent: a propensity-score analysis. Eur J Gastroenterol Hepatol 2021;33:1110-6. [PMID: 33741800 DOI: 10.1097/MEG.0000000000002133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
378 Marques de Sá I, Bibi M, Moura M, Carvalhana S, Cortez-Pinto H. No evidence of benefit of routine ascitic fluid analysis in refractory ascites undergoing therapeutic paracentesis. Eur J Gastroenterol Hepatol 2021;33:942. [PMID: 33908390 DOI: 10.1097/MEG.0000000000002119] [Reference Citation Analysis]
379 Campion B, Larrey E, Wagner M, Rudler M, Thabut D, Allaire M. Portal hypertension, advanced hepatocellular carcinoma and therapy by atezolizumab-bevacizumab: a "menage à trois" ! Clin Res Hepatol Gastroenterol 2021;:101785. [PMID: 34384926 DOI: 10.1016/j.clinre.2021.101785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
380 Ueno M, Mano T, Kayahara T, Mizuno M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding: Is evidence adequate? J Gastroenterol Hepatol 2021. [PMID: 34368981 DOI: 10.1111/jgh.15652] [Reference Citation Analysis]
381 Hadjivasilis A, Tzanis A, Ioakim KJ, Poupoutsi I, Agouridis AP, Kouis P. The diagnostic accuracy of ascitic calprotectin for the early diagnosis of spontaneous bacterial peritonitis: systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2021;33:312-8. [PMID: 32541235 DOI: 10.1097/MEG.0000000000001813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
382 Abdelsameea E, Alsebaey A, Abdel-samiee M, Abdel-razek W, Salama M, Waked I. Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients. Expert Review of Anti-infective Therapy 2021;19:1053-9. [DOI: 10.1080/14787210.2021.1864326] [Reference Citation Analysis]
383 Long B, Koyfman A, Gottlieb M. What is the Efficacy of Initial Therapies for Bleeding from Esophageal Varices in Adult Patients With Cirrhosis? Ann Emerg Med 2021:S0196-0644(21)00423-6. [PMID: 34353644 DOI: 10.1016/j.annemergmed.2021.05.014] [Reference Citation Analysis]
384 Chen D, Wen S, Wu Z, Gu Y, Chen Y, Chen X, Zhang Y, Lin B, Peng L, Zheng Y, Gao Z. Association between effective hepatic blood flow and the severity and prognosis of hepatitis B virus-related acute on chronic liver failure. Eur J Gastroenterol Hepatol 2021;32:246-54. [PMID: 32282547 DOI: 10.1097/MEG.0000000000001721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
385 Siramolpiwat S, Kiattikunrat K, Soontararatpong R, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Bhanthumkomol P, Nunanun P, Issariyakulkarn N. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis. Scand J Gastroenterol 2021;:1-10. [PMID: 34338110 DOI: 10.1080/00365521.2021.1957497] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Praharaj DL, Premkumar M, Roy A, Verma N, Taneja S, Duseja A, Dhiman RK. Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
387 Biggins SW, Angeli P, Garcia-Tsao G, Ginès P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014-48. [PMID: 33942342 DOI: 10.1002/hep.31884] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 75.0] [Reference Citation Analysis]
388 Italian Association for the Study of the Liver (AISF). Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis 2021;53:1089-104. [PMID: 34321192 DOI: 10.1016/j.dld.2021.06.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
389 Hsu C, Rimassa L, Sun HC, Vogel A, Kaseb AO. Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab. Ther Adv Med Oncol 2021;13:17588359211031141. [PMID: 34377156 DOI: 10.1177/17588359211031141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
390 Pérez-cabeza De Vaca R, Vairappan B, Cortés Espinoza T, Antonio Suárez Cuenca J, Licona Cassani C, Maldonado Arriaga B, Navarro Gerrard C, Selene Morgan Penagos D, Mondragón Terán P, Chagoya De Sanchez V. Spontaneous Bacterial Peritonitis: Physiopathological Mechanism and Clinical Manifestations. Advances in Hepatology 2021. [DOI: 10.5772/intechopen.96910] [Reference Citation Analysis]
391 Bikram Hamal A. Brief Review of Portal Hypertension Related Complications. Portal Hypertension - Recent Advances 2021. [DOI: 10.5772/intechopen.96646] [Reference Citation Analysis]
392 Zhou Y, Zhang W, Zhang Z, Luo J, Gu J, Liu Q, Ma J, Yan Z, Chen S, Wang J. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol 2020;32:1235-43. [PMID: 32744824 DOI: 10.1097/MEG.0000000000001686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
393 Huang X, Jiang S, Fan X, Jiang Y, Wu L, Li F, Wang J, Chen S. Low-free triiodothyronine is associated with poor prognosis of portal hypertension in cirrhosis. Eur J Gastroenterol Hepatol 2020;32:1358-63. [PMID: 31895910 DOI: 10.1097/MEG.0000000000001658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
394 Verma N, Singh S, Syal A, Pradhan P, Singh M, Singh M. Invasive aspergillosis is a critical determinant of mortality in cirrhosis: a systematic review with meta-analysis. Med Mycol 2021:myab044. [PMID: 34308965 DOI: 10.1093/mmy/myab044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
395 Maurel P, Prémaud A, Carrier P, Essig M, Barbier L, Rousseau A, Silvain C, Causse X, Debette-Gratien M, Jacques J, Marquet P, Salamé E, Loustaud-Ratti V. Evaluation of Longitudinal Exposure to Tacrolimus as a Risk Factor of Chronic Kidney Disease Occurrence Within the First-year Post-Liver Transplantation. Transplantation 2021;105:1585-94. [PMID: 32639405 DOI: 10.1097/TP.0000000000003384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
396 Schultalbers M, Grote-Koska D, Cornberg M, Schmidt JJ, Maasoumy B; CirPK - Study Group. Plasma and ascites pharmacokinetic of meropenem in patients with decompensated liver cirrhosis and spontaneous bacterial peritonitis. J Hepatol 2021:S0168-8278(21)01914-0. [PMID: 34310999 DOI: 10.1016/j.jhep.2021.07.015] [Reference Citation Analysis]
397 Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Gopi S, Mohta S, Saraya A. Outcomes of Portal Pressure-Guided Therapy in Decompensated Cirrhosis With Index Variceal Bleed in Asian Cohort. J Clin Exp Hepatol 2021;11:443-52. [PMID: 34276151 DOI: 10.1016/j.jceh.2020.11.001] [Reference Citation Analysis]
398 Hillert A, Schultalbers M, Tergast TL, Vonberg RP, Rademacher J, Wedemeyer H, Cornberg M, Ziesing S, Maasoumy B, Höner Zu Siederdissen C. Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany. BMC Gastroenterol 2021;21:296. [PMID: 34284732 DOI: 10.1186/s12876-021-01871-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
399 Engelman D, Moreau M, Lepida A, Zaouak Y, Paesmans M, Awada A. Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity. ESMO Open 2020;5:e000695. [PMID: 32487541 DOI: 10.1136/esmoopen-2020-000695] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
400 Çelik F, Bektaş H. Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. Florence Nightingale J Nurs 2021;29:250-62. [PMID: 34263244 DOI: 10.5152/FNJN.2021.19171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
401 Wang AJ, Zheng XL, Hong JB, Zhong JW, Yu HQ, Zeng HY, Gong Y, Gan N, Wang J, You Y, Guo GH, Xie BS, Li BM, Zhu X. Cap-Assisted Endoscopic Sclerotherapy vs Ligation in the Long-Term Management of Medium Esophageal Varices: A Randomized Trial. Clin Transl Gastroenterol 2020;11:e00285. [PMID: 33512812 DOI: 10.14309/ctg.0000000000000285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
402 Cheng R, Xu J, Tan N, Luo H, Pan J, Xu X. Predictive Nomograms for Clinical Outcomes in Hepatitis B-Related Cirrhosis Patients Receiving Antiviral Therapy. Infect Drug Resist 2021;14:2707-19. [PMID: 34290509 DOI: 10.2147/IDR.S316026] [Reference Citation Analysis]
403 Yeh JH, Lo GH, Huang RY, Lin CW, Wang WL, Perng DS. Short-course vasoconstrictors are adequate for esophageal variceal bleeding after endoscopic variceal ligation: A systematic review and meta-analysis. Sci Prog 2021;104:368504211031711. [PMID: 34260315 DOI: 10.1177/00368504211031711] [Reference Citation Analysis]
404 Chow E, Khiatah B, Frugoli A. Refractory Spontaneous Bacterial Empyema in Cirrhotic Patient. Case Rep Gastrointest Med 2021;2021:6685998. [PMID: 34336312 DOI: 10.1155/2021/6685998] [Reference Citation Analysis]
405 Gupta K, Bhurwal A, Law C, Ventre S, Minacapelli CD, Kabaria S, Li Y, Tait C, Catalano C, Rustgi VK. Acute kidney injury and hepatorenal syndrome in cirrhosis. World J Gastroenterol 2021; 27(26): 3984-4003 [PMID: 34326609 DOI: 10.3748/wjg.v27.i26.3984] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
406 Flamm SL, Brown K, Wadei HM, Brown RS Jr, Kugelmas M, Samaniego-Picota M, Burra P, Poordad F, Saab S. The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin. Liver Transpl 2021;27:1191-202. [PMID: 33848394 DOI: 10.1002/lt.26072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
407 Mücke MM, Mücke VT, Graf C, Schwarzkopf KM, Ferstl PG, Fernandez J, Zeuzem S, Trebicka J, Lange CM, Herrmann E. Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol 2020;11:e00223. [PMID: 32955202 DOI: 10.14309/ctg.0000000000000223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
408 Kim JH, Im CB, Lee SS, Jeon H, Choi JW, Kim HJ, Cha RR, Cho HC, Lee JM, Ha CY, Kim HJ, Kim TH, Jung WT, Lee OJ. Impact of acute kidney injury on mortality in patients with acute variceal bleeding. BMC Gastroenterol 2021;21:290. [PMID: 34256711 DOI: 10.1186/s12876-021-01862-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
409 Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Scheiner B, Schwabl P, Stättermayer AF, Pinter M, Eigenbauer E, Quehenberger P, Trauner M, Reiberger T, Mandorfer M. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00726-6. [PMID: 34256145 DOI: 10.1016/j.cgh.2021.07.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
410 Khemichian S, Francoz C, Nadim MK. Advances in management of hepatorenal syndrome. Curr Opin Nephrol Hypertens 2021;30:501-6. [PMID: 34397647 DOI: 10.1097/MNH.0000000000000730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
411 Hasan B, Colak Y, Rashid MU, Van A, Sarvepalli D, Khalid RA, Yim Y, Rahman AU, Charles G, Castro FJ, Zervos XB, AlKhalloufi K. Risk Factors Associated With Postendoscopic Mucosal Resection Bleeding in Patients With Cirrhosis: A Retrospective Multicenter Cohort Study. J Clin Gastroenterol 2021;55:355-60. [PMID: 32796193 DOI: 10.1097/MCG.0000000000001407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
412 Simonetti RG, Perricone G, Gluud C. Vasoactive drugs for adults with cirrhosis and large ascites treated with paracentesis. Cochrane Database of Systematic Reviews 2021;2021. [DOI: 10.1002/14651858.cd014637] [Reference Citation Analysis]
413 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol 2021;56:593-619. [PMID: 34231046 DOI: 10.1007/s00535-021-01788-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 26] [Article Influence: 49.0] [Reference Citation Analysis]
414 Vibert E, Schwartz M, Olthoff KM. Advances in resection and transplantation for hepatocellular carcinoma. J Hepatol. 2020;72:262-276. [PMID: 31954491 DOI: 10.1016/j.jhep.2019.11.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 62] [Article Influence: 52.0] [Reference Citation Analysis]
415 Roohani S, Tacke F. Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance. Int J Mol Sci 2021;22:7249. [PMID: 34298870 DOI: 10.3390/ijms22147249] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
416 Michalak A, Lach T, Cichoż-Lach H. Oxidative Stress-A Key Player in the Course of Alcohol-Related Liver Disease. J Clin Med 2021;10:3011. [PMID: 34300175 DOI: 10.3390/jcm10143011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
417 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res 2021;51:725-49. [PMID: 34228859 DOI: 10.1111/hepr.13678] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 38.0] [Reference Citation Analysis]
418 Rashidi-Alavijeh J, Kahraman A, Gerken G, Theysohn JM, Willuweit K, Hoyer DP, Lange CM, Buechter M. Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation. Sci Rep 2021;11:13834. [PMID: 34226640 DOI: 10.1038/s41598-021-93392-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
419 Yang Y, Xin Y, Ye F, Liu N, Zhang X, Wang Y, Li X, Fan Q, Zhou X, Chen Y. Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors. Int J Hyperthermia 2021;38:437-46. [PMID: 33724137 DOI: 10.1080/02656736.2020.1849828] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
420 Goh L, Phua KB, Low Y, Chiang LW, Yong C, Chiou FK. Analysis of Cholangitis Rates with Extended Perioperative Antibiotics and Adjuvant Corticosteroids in Biliary Atresia. Pediatr Gastroenterol Hepatol Nutr 2021;24:366-76. [PMID: 34316471 DOI: 10.5223/pghn.2021.24.4.366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
421 Li C, Xiang W, Wu M, Zhang H, Cheng J, Yang T, Mai J, Chi X, Gao X, Ding Y, Niu J. A randomized dose-escalation study on the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of a novel recombinant human albumin in healthy subjects. Eur J Pharm Sci 2021;165:105923. [PMID: 34229078 DOI: 10.1016/j.ejps.2021.105923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
422 Adamik KN, Yozova ID. Colloids Yes or No? - a "Gretchen Question" Answered. Front Vet Sci 2021;8:624049. [PMID: 34277747 DOI: 10.3389/fvets.2021.624049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
423 El-Desoki Mahmoud EI, Abdelaziz DH, Abd-Elsalam S, Mansour NO. Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial. Front Pharmacol 2021;12:675948. [PMID: 34276366 DOI: 10.3389/fphar.2021.675948] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
424 Pose E, Coll M, Martínez-Sánchez C, Zeng Z, Surewaard BGJ, Català C, Velasco-de Andrés M, Lozano JJ, Ariño S, Fuster D, Niñerola-Bazán A, Graupera I, Muñoz É, Lozano F, Sancho-Bru P, Kubes P, Ginès P. Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections. Hepatology 2021;74:296-311. [PMID: 33219516 DOI: 10.1002/hep.31644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
425 Fernández J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: The MDRO challenge. Journal of Hepatology 2021;75:S101-17. [DOI: 10.1016/j.jhep.2020.11.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
426 Anand A, Pathak P, Shalimar. Letter to the Editor: ABIDE Model for Predicting Decompensation in Nonalcoholic Fatty Liver Disease-Related Cirrhosis. Hepatology 2021;74:529. [PMID: 33274438 DOI: 10.1002/hep.31668] [Reference Citation Analysis]
427 Bager P. Major complications of cirrhosis: the nurse's role. Gastrointestinal Nursing 2021;19:S16-17. [DOI: 10.12968/gasn.2021.19.sup6.s16] [Reference Citation Analysis]
428 Caraceni P, Abraldes JG, Ginès P, Newsome PN, Sarin SK. The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery. J Hepatol 2021;75 Suppl 1:S118-34. [PMID: 34039483 DOI: 10.1016/j.jhep.2021.01.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
429 Mohamed MMG, Rauf A, Adam A, Kheiri B, Lacasse A, El-Halawany H. Terlipressin effect on hepatorenal syndrome: Updated meta-analysis of randomized controlled trials. JGH Open 2021;5:896-901. [PMID: 34386597 DOI: 10.1002/jgh3.12600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
430 Van der Merwe S, Chokshi S, Bernsmeier C, Albillos A. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. J Hepatol 2021;75 Suppl 1:S82-S100. [PMID: 34039494 DOI: 10.1016/j.jhep.2020.11.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
431 Garcia-Pagan JC, Francoz C, Montagnese S, Senzolo M, Mookerjee RP. Management of the major complications of cirrhosis: Beyond guidelines. J Hepatol 2021;75 Suppl 1:S135-46. [PMID: 34039484 DOI: 10.1016/j.jhep.2021.01.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
432 Subedi A, Suresh Kumar VC, Sharma Subedi A, Sapkota B. A Review of Hepatorenal Syndrome. Cureus 2021;13:e16084. [PMID: 34367745 DOI: 10.7759/cureus.16084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
433 Chen Z, Ran T, Cao H, Xu F, Zhou ZH, He S. The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study. Front Med (Lausanne) 2021;8:685944. [PMID: 34262917 DOI: 10.3389/fmed.2021.685944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
434 Waguri N, Osaki A, Watanabe Y. Balloon-occluded retrograde transvenous obliteration for treatment of gastric varices. World J Hepatol 2021; 13(6): 650-661 [PMID: 34239700 DOI: 10.4254/wjh.v13.i6.650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
435 Nischalke HD, Fischer J, Klüners A, Matz-Soja M, Krämer B, Langhans B, Goeser F, Soyka M, Stickel F, Spengler U, Nattermann J, Strassburg CP, Berg T, Lutz P. A genetic variant in toll-like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitis. Liver Int 2021;41:2139-48. [PMID: 34051061 DOI: 10.1111/liv.14980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
436 Xu X, Wang H, Zhao W, Wang Y, Wang J, Qin B. Recompensation factors for patients with decompensated cirrhosis: a multicentre retrospective case-control study. BMJ Open 2021;11:e043083. [PMID: 34162632 DOI: 10.1136/bmjopen-2020-043083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
437 Kim TH, Seo YS, Kang SH, Kim MY, Kim SG, Lee HY, Lee JH, Lee YS, Kim JH, Jeong SW, Jang JY, Suk KT, Jung YK, An H, Yim HJ, Kim YS, Um SH;  Korean Study Group of Portal Hypertension. Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study. Liver Int. 2020;40:3083-3092. [PMID: 32750739 DOI: 10.1111/liv.14631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
438 Beer L, Bastati N, Ba-Ssalamah A, Pötter-Lang S, Lampichler K, Bican Y, Lauber D, Hodge J, Binter T, Pomej K, Simbrunner B, Semmler G, Trauner M, Mandorfer M, Reiberger T. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease. Liver Int 2020;40:2797-807. [PMID: 32816394 DOI: 10.1111/liv.14648] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
439 Miyamoto Y, Enomoto H, Nishikawa H, Nishimura T, Iwata Y, Nishiguchi S, Iijima H. Association of the Modified ALBI Grade With Endoscopic Findings of Gastroesophageal Varices. In Vivo 2021;35:1163-8. [PMID: 33622916 DOI: 10.21873/invivo.12364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
440 Voicu MN, Popescu F, Florescu DN, Rogoveanu I, Turcu-Stiolica A, Gheonea DI, Iovanescu VF, Iordache S, Cazacu SM, Ungureanu BS. Clostridioides difficile Infection among Cirrhotic Patients with Variceal Bleeding. Antibiotics (Basel) 2021;10:731. [PMID: 34204307 DOI: 10.3390/antibiotics10060731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
441 Simbrunner B, Trauner M, Reiberger T, Mandorfer M. Recent advances in the understanding and management of hepatorenal syndrome. Fac Rev 2021;10:48. [PMID: 34131658 DOI: 10.12703/r/10-48] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
442 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Greco G, Macciò L, Meneguzzi C, Mioni D, Palmieri VO, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Bernardi M, Addolorato G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Dig Dis Sci 2021. [PMID: 34142284 DOI: 10.1007/s10620-021-07006-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
443 Danielsen KV, Hove JD, Nabilou P, Yin M, Chen J, Zhao M, Kallemose T, Teisner AS, Siebner HR, Ehman RL, Møller S, Bendtsen F. Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis. Liver Int 2021;41:2149-58. [PMID: 34060714 DOI: 10.1111/liv.14981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
444 Paternostro R, Sieghart W, Trauner M, Pinter M. Cancer and hepatic steatosis. ESMO Open 2021;6:100185. [PMID: 34139486 DOI: 10.1016/j.esmoop.2021.100185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
445 Barber T, Toon L, Tandon P, Green LA. Eliciting and Understanding Primary Care and Specialist Mental Models of Cirrhosis Care: A Cognitive Task Analysis Study. Can J Gastroenterol Hepatol 2021;2021:5582297. [PMID: 34222136 DOI: 10.1155/2021/5582297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
446 Huang L, Yu Q, Peng H. Hemorheological Alteration in Patients with Cirrhosis Clinically Diagnosed with Portal Vein System Thrombosis After Splenectomy. Med Sci Monit 2021;27:e931157. [PMID: 34120137 DOI: 10.12659/MSM.931157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
447 Martínez J, Hernández-Gea V, Rodríguez-de-Santiago E, Téllez L, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Genescà J, Bureau C, Trebicka J, Bañares R, Krag A, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha-Ferreira C, Cañete N, Rodríguez M, Ferlitsch A, Schwarzer R, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Romero-Gomez M, Zipprich A, Casas M, Masnou H, Primignani M, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Rudler M, Alvarado E, Perez-Campuzano V, Guardascione MA, Fischer P, Bosch J, García-Pagán JC, Albillos A; International Variceal Bleeding Observational Study Group and Baveno Cooperation. Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis. J Hepatol 2021;75:342-50. [PMID: 33845059 DOI: 10.1016/j.jhep.2021.03.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
448 Dajti E, Marasco G, Ravaioli F, Colecchia L, Ferrarese A, Festi D, Colecchia A. Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness. JHEP Rep 2021;3:100289. [PMID: 34095798 DOI: 10.1016/j.jhepr.2021.100289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
449 Erstad BL. Albumin for cirrhosis-related complications. J Clin Pharm Ther 2021;46:887-94. [PMID: 34101215 DOI: 10.1111/jcpt.13461] [Reference Citation Analysis]
450 Northup PG, Lisman T, Roberts LN. Treatment of bleeding in patients with liver disease. J Thromb Haemost 2021;19:1644-52. [PMID: 33974330 DOI: 10.1111/jth.15364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
451 Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep 2021;3:100316. [PMID: 34337369 DOI: 10.1016/j.jhepr.2021.100316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
452 Hanna A, Gill I, Imam Z, Halalau A, Jamil LH. Low yield of head CT in cirrhotic patients presenting with hepatic encephalopathy. BMJ Open Gastroenterol 2021;8:e000609. [PMID: 34083228 DOI: 10.1136/bmjgast-2021-000609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
453 Johnson AL, Hayward KL. Managing medicines in alcohol-associated liver disease: a practical review. Aust Prescr 2021;44:96-106. [PMID: 34211248 DOI: 10.18773/austprescr.2021.015] [Reference Citation Analysis]
454 Tergast TL, Maasoumy B. Albumin für jeden Patienten mit hepatischer Dekompensation und Hypoalbuminämie? Gastro-News 2021;8:18-19. [DOI: 10.1007/s15036-021-2350-9] [Reference Citation Analysis]
455 Jiang TT, Liu XL, Jiang YY, Wang XB, Yang ZY. Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients. Evid Based Complement Alternat Med 2021;2021:6652858. [PMID: 34055016 DOI: 10.1155/2021/6652858] [Reference Citation Analysis]
456 Morelli MC, Rendina M, La Manna G, Alessandria C, Pasulo L, Lenci I, Bhoori S, Messa P, Biancone L, Gesualdo L, Russo FP, Petta S, Burra P; Italian Association for the Study of Liver, and the Italian Society of Nephrology. Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN). Dig Liver Dis 2021;53 Suppl 2:S49-86. [PMID: 34074490 DOI: 10.1016/j.dld.2021.03.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
457 Yang C, Liu J, Zhou C, Ma J, Song S, Qian K, Xiong B. Balloon tamponade sequentially combined with TIPS for refractory acute variceal bleeding: efficacy, safety and procedural techniques. Chin J Acad Radiol 2021;4:88-97. [DOI: 10.1007/s42058-021-00062-6] [Reference Citation Analysis]
458 Kam MLW, Nguyen TTT, Ngeow JYY. Telomere biology disorders. NPJ Genom Med 2021;6:36. [PMID: 34050178 DOI: 10.1038/s41525-021-00198-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
459 Mcallister S, Lai JC, Copeland TP, Johansen KL, Mcculloch CE, Kwong YD, Seth D, Grimes B, Ku E. Renal Recovery and Mortality Risk among Patients with Hepatorenal Syndrome Receiving Chronic Maintenance Dialysis. Kidney360 2021;2:819-827. [DOI: 10.34067/kid.0005182020] [Reference Citation Analysis]
460 Ballester MP, Lluch P, Tosca J, Capilla M, Gómez C, Moreno O, Jordán-Iborra C, Sunsundegui P, Argemi J, Guijarro J, Mínguez M. Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt. Dig Liver Dis 2021:S1590-8658(21)00220-6. [PMID: 34052179 DOI: 10.1016/j.dld.2021.04.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
461 Chevallier O, Guillen K, Comby PO, Mouillot T, Falvo N, Bardou M, Midulla M, Aho-Glélé LS, Loffroy R. Safety, Efficacy, and Outcomes of N-Butyl Cyanoacrylate Glue Injection through the Endoscopic or Radiologic Route for Variceal Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:2298. [PMID: 34070534 DOI: 10.3390/jcm10112298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
462 Adachi T, Takeuchi Y, Takaki A, Oyama A, Wada N, Onishi H, Shiraha H, Okada H. Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan. Int J Mol Sci 2021;22:5582. [PMID: 34070416 DOI: 10.3390/ijms22115582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
463 Mohanty A, Kapuria D, Canakis A, Lin H, Amat MJ, Rangel Paniz G, Placone NT, Thomasson R, Roy H, Chak E, Baffy G, Curry MP, Laine L, Rustagi T. Fresh frozen plasma transfusion in acute variceal haemorrhage: Results from a multicentre cohort study. Liver Int 2021;41:1901-8. [PMID: 33969607 DOI: 10.1111/liv.14936] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 17.0] [Reference Citation Analysis]
464 Li TH, Liu CW, Huang CC, Tsai YL, Huang SF, Yang YY, Tsai CY, Hou MC, Lin HC. Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study. J Clin Med 2021;10:2244. [PMID: 34064207 DOI: 10.3390/jcm10112244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
465 Wolter K, Praktiknjo M, Boie J, Decker G, Nadal J, Jansen C, Keller WIY, Meyer C, Trebicka J, Attenberger U, Thomas D. Glue Embolization of Gastroesophageal Varices during Transjugular Intrahepatic Portosystemic Shunt (TIPS) Improves Survival Compared to Coil-only Embolization-A Single-Center Retrospective Study. Cardiovasc Intervent Radiol 2021;44:1240-50. [PMID: 34021379 DOI: 10.1007/s00270-021-02852-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
466 Fründt T, Krause L, Hussey E, Steinbach B, Köhler D, von Felden J, Schulze K, Lohse AW, Wege H, Schwarzenbach H. Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients. Cancers (Basel) 2021;13:2484. [PMID: 34069692 DOI: 10.3390/cancers13102484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
467 Zhang Z, Ma K, Yang Z, Cheng Q, Hu X, Liu M, Liu Y, Liu T, Zhang M, Luo X, Chen T, Ning Q. Development and Validation of a Clinical Predictive Model for Bacterial Infection in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Infect Dis Ther 2021;10:1347-61. [PMID: 33991329 DOI: 10.1007/s40121-021-00454-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
468 Fischer P, Stefanescu H, Hategan R, Procopet B, Ionescu D. Bacterial infection-related acute-on-chronic liver failure: The standpoint matters! J Hepatol 2021;75:1009-10. [PMID: 33984414 DOI: 10.1016/j.jhep.2021.04.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
469 Sun YM, Chen SY, You H. Regression of liver fibrosis: evidence and challenges. Chin Med J (Engl) 2020;133:1696-702. [PMID: 32568866 DOI: 10.1097/CM9.0000000000000835] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
470 Liang RB, Zhao Y, He MK, Wen DS, Bu XY, Huang YX, Lai ZC, Xu YJ, Kan A, Wei W, Zhang YJ, Chen MS, Guo RP, Li QJ, Shi M. Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma. Front Oncol 2021;11:619461. [PMID: 34055599 DOI: 10.3389/fonc.2021.619461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
471 Yang C, Liu J, Shi Q, Huang S, Zhou C, Wang Y, Li T, Chen Y, Xiong B. Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2021. [PMID: 33973270 DOI: 10.1111/jgh.15543] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
472 Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, St Hillien SA, Kalim S, Nigwekar SU, Flood JG, Nixon A, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Regner KR, Belcher JM, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT; HRS-HARMONY study investigators. Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study. Clin Transl Gastroenterol 2021;12:e00359. [PMID: 33979307 DOI: 10.14309/ctg.0000000000000359] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
473 Yang Y, Fu S, Cao B, Hao K, Li Y, Huang J, Shi W, Duan C, Bai X, Tang K, Yang S, He X, Lu L. Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study. Hepatol Int 2021;15:730-40. [PMID: 33977364 DOI: 10.1007/s12072-021-10188-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
474 Sato S, Amano N, Sato S, Kita Y, Ikeda Y, Kabemura D, Murata A, Yatagai N, Tsuzura H, Shimada Y, Genda T. Elevated serum tyrosine concentration is associated with a poor prognosis among patients with liver cirrhosis. Hepatol Res 2021;51:786-95. [PMID: 33964118 DOI: 10.1111/hepr.13651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
475 Dong V, Nadim MK, Karvellas CJ. Post-Liver Transplant Acute Kidney Injury. Liver Transpl 2021. [PMID: 33963666 DOI: 10.1002/lt.26094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
476 Yeo YH, Hwang J, Jeong D, Dang N, Kam LY, Henry L, Park H, Cheung R, Nguyen MH. Surveillance of patients with cirrhosis remains suboptimal in the United States. J Hepatol 2021:S0168-8278(21)00307-X. [PMID: 33965477 DOI: 10.1016/j.jhep.2021.04.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
477 Zipprich A, Ripoll C. [Cirrhosis]. Dtsch Med Wochenschr 2021;146:684-97. [PMID: 33957691 DOI: 10.1055/a-1218-9159] [Reference Citation Analysis]
478 Huang J, Cai M, He X. Serum potassium levels and prognosis in HBV-associated decompensated cirrhosis. J Clin Lab Anal 2021;35:e23775. [PMID: 33951234 DOI: 10.1002/jcla.23775] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
479 Abdel Hafez H, Madani H, Abdel Alem S, Farrag A, Fathy W, Abdo M. Is Serum-Ascites Vitamin D Gradient a Valid Marker for Diagnosing Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites? Lab Med 2021:lmab019. [PMID: 33939819 DOI: 10.1093/labmed/lmab019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
480 Queck A, Ferstl P, Bruns T, Trebicka J. Infektionen und Lebertransplantation. Gastroenterologe 2021;16:186-193. [DOI: 10.1007/s11377-021-00521-7] [Reference Citation Analysis]
481 Vuille-Lessard É, Rodrigues SG, Berzigotti A. Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:253-89. [PMID: 33838850 DOI: 10.1016/j.cld.2021.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
482 Suksamai A, Chaiprasert A, Chirapongsathorn S. Serum cystatin C as a predictor of 90‐day mortality among patients admitted with complications of cirrhosis. JGH Open 2021;5:607-613. [DOI: 10.1002/jgh3.12543] [Reference Citation Analysis]
483 Piano S, Gambino C, Vettore E, Calvino V, Tonon M, Boccagni P, Gringeri E, Germani G, Burra P, Cillo U, Angeli P. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome. Hepatology 2021;73:1909-19. [PMID: 32870499 DOI: 10.1002/hep.31529] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
484 Ferstl PG, Schulz M, Trebicka J. Akute Dekompensation und akut-auf-chronisches Leberversagen. Gastroenterologe 2021;16:179-185. [DOI: 10.1007/s11377-021-00520-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
485 Kluwe J, Zipprich A. Portale Hypertension und Varizen. Gastroenterologe 2021;16:149-159. [DOI: 10.1007/s11377-021-00516-4] [Reference Citation Analysis]
486 Weng F. Comment on 'Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis'. J Viral Hepat 2021;28:1098. [PMID: 33876512 DOI: 10.1111/jvh.13515] [Reference Citation Analysis]
487 Bostan F, Çayir M, Çekin A. Spontan bakteriyel peritonit: Etken ne? Olgu sunumu. Akademik Gastroenteroloji Dergisi 2021. [DOI: 10.17941/agd.928433] [Reference Citation Analysis]
488 Kumada T. Reply to: 'Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis'. J Viral Hepat 2021;28:1099-100. [PMID: 33909939 DOI: 10.1111/jvh.13514] [Reference Citation Analysis]
489 Campello E, Zanetto A, Garcia-Tsao G, Simioni P. Reply to "Acute kidney injury in patients with decompensated cirrhosis". Dig Liver Dis 2021;53:1217-8. [PMID: 33926815 DOI: 10.1016/j.dld.2021.03.034] [Reference Citation Analysis]
490 Wong YJ, Kumar R, Chua YJJ, Ang TL. Long-term albumin infusion in decompensated cirrhosis: A review of current literature . World J Hepatol 2021; 13(4): 421-432 [PMID: 33959225 DOI: 10.4254/wjh.v13.i4.421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
491 Xiao Y, Wu D, Shi X, Liu S, Hu X, Zhou C, Tian X, Liu H, Long H, Li Z, Wang J, Tan T, Xu Y, Chen B, Liu T, Zhang H, Zheng S, Hu S, Song J, Tang J, Song J, Cheng Z, Xu W, Shen Y, Yu W, Xu Y, Li J, Zhou J, Wang F, Chen M. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study. Virulence 2021;12:1199-208. [PMID: 33870852 DOI: 10.1080/21505594.2021.1909894] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
492 Badran HM, Elsabaawy MM, Mahmoud MA, Ghanem HS, Alsebaey A, Othman W. Concordance of 24- and 48-h diagnostic follow-up ascitic fluid polymorphonuclear leukocyte count in the guidance of the antibiotic therapy in spontaneous bacterial peritonitis. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00097-5] [Reference Citation Analysis]
493 Fallowfield JA, Jimenez-Ramos M, Robertson A. Emerging synthetic drugs for the treatment of liver cirrhosis. Expert Opin Emerg Drugs 2021;26:149-63. [PMID: 33856246 DOI: 10.1080/14728214.2021.1918099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
494 Borgonovo A, Baldin C, Maggi DC, Victor L, Bansho ETO, Piedade J, Wildner LM, Guimarães L, Bazzo ML, Rocha T, Dantas-Corrêa EB, Alcântara C, Fernandes F, Narciso-Schiavon JL, Pereira GHS, Schiavon LL. Systemic Inflammatory Response Syndrome in Patients Hospitalized for Acute Decompensation of Cirrhosis. Can J Gastroenterol Hepatol 2021;2021:5581587. [PMID: 33987144 DOI: 10.1155/2021/5581587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
495 Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Brujats A, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J; PreDesCI Study Investigators. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. J Hepatol 2021;75:589-99. [PMID: 33905794 DOI: 10.1016/j.jhep.2021.04.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
496 Pörner D, Von Vietinghoff S, Nattermann J, Strassburg CP, Lutz P. Advances in the pharmacological management of bacterial peritonitis. Expert Opin Pharmacother 2021;22:1567-78. [PMID: 33878993 DOI: 10.1080/14656566.2021.1915288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
497 Tinawi M. New Trends in the Utilization of Intravenous Fluids. Cureus 2021;13:e14619. [PMID: 34040918 DOI: 10.7759/cureus.14619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
498 Verma N, Mishra S, Singh S, Kaur R, Kaur T, De A, Premkumar M, Taneja S, Duseja A, Singh M, Singh V. Feasibility, outcomes, and safety of tele-hepatology services during the COVID-19 pandemic. Hepatol Commun 2021. [PMID: 34230904 DOI: 10.1002/hep4.1732] [Reference Citation Analysis]
499 Ginès P. Robert W Schrier, an influential observer from outside Hepatology (1936-2021). J Hepatol 2021:S0168-8278(21)00180-X. [PMID: 33892988 DOI: 10.1016/j.jhep.2021.03.008] [Reference Citation Analysis]
500 Armstrong MJ, Williams FR. Prehabilitation and General Management. Liver Transplantation 2021. [DOI: 10.1002/9781119634010.ch16] [Reference Citation Analysis]
501 Nevens F, Gustot T, Laterre PF, Lasser LL, Haralampiev LE, Vargas V, Lyubomirova D, Albillos A, Najimi M, Michel S, Stoykov I, Gordillo N, Vainilovich Y, Barthel V, Clerget-Chossat N, Sokal EM. A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation. JHEP Rep 2021;3:100291. [PMID: 34169246 DOI: 10.1016/j.jhepr.2021.100291] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
502 Ni JB, Xiang XX, Wu W, Chen SY, Zhang F, Zhang M, Peng CY, Xiao JQ, Zhuge YZ, Zhang CQ. Transjugular intrahepatic portosystemic shunt in patients treated with a balloon tamponade for variceal hemorrhage without response to high doses of vasoactive drugs: A real-world multicenter retrospective study. J Dig Dis 2021;22:236-45. [PMID: 33634958 DOI: 10.1111/1751-2980.12978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
503 Mendizabal M, Ridruejo E, Piñero F, Anders M, Padilla M, Toro LG, Torre A, Montes P, Urzúa A, Gonzalez Ballerga E, Silveyra MD, Michelato D, Díaz J, Peralta M, Pages J, García SR, Gutierrez Lozano I, Macias Y, Cocozzella D, Chavez-Tapia N, Tagle M, Dominguez A, Varón A, Vera Pozo E, Higuera-de la Tijera F, Bustios C, Conte D, Escajadillo N, Gómez AJ, Tenorio L, Castillo Barradas M, Schinoni MI, Bessone F, Contreras F, Nazal L, Sanchez A, García M, Brutti J, Cabrera MC, Miranda-Zazueta G, Rojas G, Cattaneo M, Castro-Narro G, Rubinstein F, Silva MO. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection. Ann Hepatol 2021;25:100350. [PMID: 33864948 DOI: 10.1016/j.aohep.2021.100350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
504 Hoshi H, Chu PS, Yoshida A, Taniki N, Morikawa R, Yamataka K, Noguchi F, Kasuga R, Tabuchi T, Ebinuma H, Saito H, Kanai T, Nakamoto N. Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis. PLoS One 2021;16:e0250062. [PMID: 33848309 DOI: 10.1371/journal.pone.0250062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
505 Tacke F, Cornberg M, Sterneck M, Trebicka J, Settmacher U, Bechstein WO, Berg T; Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), vertreten durch Frank Tacke, Markus Cornberg, Martina Sterneck, Jonel Trebicka, Thomas Berg., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), vertreten durch Wolf Bechstein., Deutsche Transplantationsgesellschaft (DTG), vertreten durch Utz Settmacher., Die Leitlinie wird von der Deutschen Gesellschaft für Pneumologie (DGP) unterstützt. S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Register Nr. 021-031 – Stand: 07.01.21. Z Gastroenterol 2021;59:345-59. [PMID: 33845500 DOI: 10.1055/a-1372-5595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
506 Roberts D, Best LM, Freeman SC, Sutton AJ, Cooper NJ, Arunan S, Begum T, Williams NR, Walshaw D, Milne EJ, Tapp M, Csenar M, Pavlov CS, Davidson BR, Tsochatzis E, Gurusamy KS. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2021;4:CD013155. [PMID: 33837526 DOI: 10.1002/14651858.CD013155.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
507 Nababan SHH, Kalista KF, Jasirwan CO, Kurniawan J, Lesmana CRA, Sulaiman AS, Hasan I, Gani RA. Mac-2 Binding Protein Glycosylation Isomer for Screening High-Risk Esophageal Varices in Liver Cirrhotic Patient. Livers 2021;1:60-7. [DOI: 10.3390/livers1020006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
508 Roccarina D, Best LM, Freeman SC, Roberts D, Cooper NJ, Sutton AJ, Benmassaoud A, Plaz Torres MC, Iogna Prat L, Csenar M, Arunan S, Begum T, Milne EJ, Tapp M, Pavlov CS, Davidson BR, Tsochatzis E, Williams NR, Gurusamy KS. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2021;4:CD013121. [PMID: 33822357 DOI: 10.1002/14651858.CD013121.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
509 Rosa J, Arruda A, Rodrigues AL, Soares MR. Paroxysmal Nocturnal Hemoglobinuria: Case Report of a Rare Cause of Thrombosis in the Pediatric Age. J Pediatr Hematol Oncol 2021;43:e240-2. [PMID: 31842179 DOI: 10.1097/MPH.0000000000001701] [Reference Citation Analysis]
510 Lasagni A, Cadamuro M, Morana G, Fabris L, Strazzabosco M. Fibrocystic liver disease: novel concepts and translational perspectives. Transl Gastroenterol Hepatol 2021;6:26. [PMID: 33824930 DOI: 10.21037/tgh-2020-04] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
511 Reiter FP, Hadjamu NJ, Nagdyman N, Zachoval R, Mayerle J, De Toni EN, Kaemmerer H, Denk G. Congenital heart disease-associated liver disease: a narrative review. Cardiovasc Diagn Ther 2021;11:577-90. [PMID: 33968635 DOI: 10.21037/cdt-20-595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
512 Lv Y, Wang Z, Li K, Wang Q, Bai W, Yuan X, Yu T, Niu J, Yang Z, Zhu X, Zhao J, Xue H, Jiang Z, Zhuge Y, Zhang C, Sun J, Ding P, Ren W, Li Y, Zhang K, Zhang W, Guo W, Luo B, Li X, Yuan J, Han N, Zhu Y, He C, Yin Z, Fan D, Han G. Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding. Hepatology 2021;73:1478-93. [PMID: 32706906 DOI: 10.1002/hep.31478] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
513 Khoronko YV, Kozyrevskiy MA, Dmitriev AV, Volokhova AA, Spiridenko GY, Bogomolova KR. Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2021;31:39-46. [DOI: 10.22416/1382-4376-2021-31-1-39-46] [Reference Citation Analysis]
514 Zhang W, Liu L, Zhang M, Zhang F, Peng C, Zhang B, Chen J, Li L, He J, Xiao J, Feng Y, Wang X, Xiong A, Yang L, Zou X, Yu Y, Zhuge Y. Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome. J Clin Transl Hepatol 2021;9:345-52. [PMID: 34221920 DOI: 10.14218/JCTH.2020.00124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
515 Dajti E, Alemanni LV, Marasco G, Montagnani M, Azzaroli F. Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? Hepat Med 2021;13:25-36. [PMID: 33776492 DOI: 10.2147/HMER.S278077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
516 Rehm J, Patra J, Brennan A, Buckley C, Greenfield TK, Kerr WC, Manthey J, Purshouse RC, Rovira P, Shuper PA, Shield KD. The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification. Drug Alcohol Rev 2021. [PMID: 33783063 DOI: 10.1111/dar.13286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
517 Plaz Torres MC, Best LM, Freeman SC, Roberts D, Cooper NJ, Sutton AJ, Roccarina D, Benmassaoud A, Iogna Prat L, Williams NR, Csenar M, Fritche D, Begum T, Arunan S, Tapp M, Milne EJ, Pavlov CS, Davidson BR, Tsochatzis E, Gurusamy KS. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2021;3:CD013122. [PMID: 33784794 DOI: 10.1002/14651858.CD013122.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
518 Wong YJ, Kew GS, Tan PS, Chen Z, Putera M, Yip WA, Ang TL, Fock KM, Lee GH, Hsiang J, Huang DQ, Kwek A, Muthiah MD, Kumar R, Tan M, Tan J, Thurairajah PH, Teo EK, Tai BC, Lim SG. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study. Clin Res Hepatol Gastroenterol 2021;45:101598. [PMID: 33780835 DOI: 10.1016/j.clinre.2020.101598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
519 Glal KAM, Abd-Elsalam SM, Mostafa TM. Nitazoxanide versus rifaximin in preventing the recurrence of hepatic encephalopathy: A randomized double-blind controlled trial. J Hepatobiliary Pancreat Sci 2021. [PMID: 33768619 DOI: 10.1002/jhbp.947] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
520 Chang J, Bamarni A, Böhling N, Zhou X, Klein LM, Meinke J, Duerr GD, Lingohr P, Wehner S, Brol MJ, Rockstroh JK, Kalff JC, Manekeller S, Meyer C, Spengler U, Jansen C, Arroyo V, Strassburg CP, Trebicka J, Praktiknjo M. Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute-On-Chronic Liver Failure. Hepatol Commun 2021;5:1265-77. [PMID: 34278174 DOI: 10.1002/hep4.1712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
521 Regner KR. Patients with Hepatorenal Syndrome Should Be Dialyzed? COMMENTARY. Kidney360 2021;2:413-414. [DOI: 10.34067/kid.0006862020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
522 Aneja A, Scott E, Kohli R. Advances in management of end stage liver disease in children. Med J Armed Forces India 2021;77:129-37. [PMID: 33867627 DOI: 10.1016/j.mjafi.2021.03.001] [Reference Citation Analysis]
523 Edelson J, Basso JE, Rockey DC. Updated strategies in the management of acute variceal haemorrhage. Curr Opin Gastroenterol 2021;37:167-72. [PMID: 33769373 DOI: 10.1097/MOG.0000000000000723] [Reference Citation Analysis]
524 Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar. Coronavirus Disease-2019 (COVID-19) and the Liver. J Clin Transl Hepatol 2021;9:247-55. [PMID: 34007807 DOI: 10.14218/JCTH.2021.00006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
525 Stockhoff L, Schneider H, Tergast TL, Cornberg M, Maasoumy B. Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS? J Hepatol 2021;75:487-9. [PMID: 33716088 DOI: 10.1016/j.jhep.2021.02.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
526 Putera M, Teh KB, Kumar R, Wong YJ. Small esophageal varices in compensated cirrhosis patients: to treat or not to treat? J Hepatol 2021;75:491-2. [PMID: 33716090 DOI: 10.1016/j.jhep.2021.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
527 Reichert MC, Schneider C, Greinert R, Casper M, Grünhage F, Wienke A, Zipprich A, Lammert F, Ripoll C. Isolated bacterial infection without decompensation has no impact on survival of compensated patients with cirrhosis. Liver Int 2021;41:1370-8. [PMID: 33641234 DOI: 10.1111/liv.14842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
528 Larrue H, Vinel JP, Bureau C. Management of Severe and Refractory Ascites. Clin Liver Dis 2021;25:431-40. [PMID: 33838859 DOI: 10.1016/j.cld.2021.01.010] [Reference Citation Analysis]
529 Baiges A, Magaz M, Turon F, Hernández-Gea V, García-Pagán JC. Treatment of Acute Variceal Bleeding in 2021-When to Use Transjugular Intrahepatic Portosystemic Shunts? Clin Liver Dis 2021;25:345-56. [PMID: 33838854 DOI: 10.1016/j.cld.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
530 Mendoza YP, Shengir M, Bosch J, Sebastiani G, Berzigotti A. FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00271-8. [PMID: 33716139 DOI: 10.1016/j.cgh.2021.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
531 Mandorfer M, Simbrunner B. Prevention of First Decompensation in Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:291-310. [PMID: 33838851 DOI: 10.1016/j.cld.2021.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
532 López-Franco Ó, Morin JP, Cortés-Sol A, Molina-Jiménez T, Del Moral DI, Flores-Muñoz M, Roldán-Roldán G, Juárez-Portilla C, Zepeda RC. Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis. Front Neurosci 2021;15:579263. [PMID: 33790729 DOI: 10.3389/fnins.2021.579263] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
533 Ferstl P, Trebicka J. Acute Decompensation and Acute-on-Chronic Liver Failure. Clin Liver Dis 2021;25:419-30. [PMID: 33838858 DOI: 10.1016/j.cld.2021.01.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
534 Piano S, Angeli P. Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation? Clin Liver Dis 2021;25:357-72. [PMID: 33838855 DOI: 10.1016/j.cld.2021.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
535 Jachs M, Reiberger T. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach. Clin Liver Dis 2021;25:311-26. [PMID: 33838852 DOI: 10.1016/j.cld.2021.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
536 Beraldo RF, Marcondes MB, Dos Santos MNM, Grillo TG, Pires GBT, de Oliveira CV. COVID-19 in a Patient with Liver Cirrhosis. Am J Case Rep 2021;22:e929948. [PMID: 33686051 DOI: 10.12659/AJCR.929948] [Reference Citation Analysis]
537 Yang Q, Jiang XZ, Zhu YF, Lv FF. Clinical risk factors and predictive tool of bacteremia in patients with cirrhosis. J Int Med Res 2020;48:300060520919220. [PMID: 32431223 DOI: 10.1177/0300060520919220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
538 Manning C, Elzubeir A, Alam S. The role of pre-emptive Transjugular Intrahepatic Portosystemic Shunt in acute variceal bleeding: a literature review. Ther Adv Chronic Dis 2021;12:2040622321995771. [PMID: 33747427 DOI: 10.1177/2040622321995771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
539 Praktiknjo M, Abu-Omar J, Chang J, Thomas D, Jansen C, Kupczyk P, Schepis F, Garcia-Pagan JC, Merli M, Meyer C, Strassburg CP, Pieper CC, Trebicka J. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep 2021;3:100264. [PMID: 34013182 DOI: 10.1016/j.jhepr.2021.100264] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
540 Bouzbib C, Cluzel P, Sultanik P, Bernard-Chabert B, Massard J, Benosman H, Mallet M, Tripon S, Conti F, Thabut D, Rudler M. Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS era. Clin Res Hepatol Gastroenterol 2021;45:101593. [PMID: 33667917 DOI: 10.1016/j.clinre.2020.101593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
541 Tonon M, Rosi S, Gambino CG, Piano S, Calvino V, Romano A, Martini A, Pontisso P, Angeli P. Natural history of acute kidney disease in patients with cirrhosis. Journal of Hepatology 2021;74:578-83. [DOI: 10.1016/j.jhep.2020.08.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
542 Queck A, Trebicka J. Nichtzirrhotische portale Hypertension – Ursachen und praktisches Management. Gastroenterologe 2021;16:90-101. [DOI: 10.1007/s11377-021-00506-6] [Reference Citation Analysis]
543 Wang X, Wu B. Endoscopic sequential therapy for portal hypertension: Concept and clinical efficacy. Liver Research 2021;5:7-10. [DOI: 10.1016/j.livres.2020.12.004] [Reference Citation Analysis]
544 Wang H, Wen B, Chang X, Wu Q, Wen W, Zhou F, Guo Y, Ji Y, Gu Y, Lai Q, He Q, Li J, Chen J, Hou J. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis. Journal of Hepatology 2021;74:584-92. [DOI: 10.1016/j.jhep.2020.09.034] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 23.0] [Reference Citation Analysis]
545 Luedemann C, Plota J, Nattermann J, Strassburg CP, Lutz P, Goeser F. Renal replacement therapy as bridging-to-recovery in refractory hepatorenal syndrome. Z Gastroenterol 2021;59:331-5. [PMID: 33634437 DOI: 10.1055/a-1369-9859] [Reference Citation Analysis]
546 Dobbermann H, Marquetand C, Marquardt JU, Reil JC. Echocardiographic evidence of an intrapulmonary shunt in a patient with severe liver cirrhosis. Clin Res Cardiol 2021;110:1128-31. [PMID: 33620503 DOI: 10.1007/s00392-021-01817-y] [Reference Citation Analysis]
547 Han Z, He X, Peng S. Neutrophil count to albumin ratio as a prognostic indicator for HBV-associated decompensated cirrhosis. J Clin Lab Anal 2021;35:e23730. [PMID: 33609049 DOI: 10.1002/jcla.23730] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
548 Jones BE, Allegretti AS, Pose E, Mara KC, Ufere NN, Avitabile E, Shah VH, Kamath PS, Ginès P, Simonetto DA. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery. Dig Dis Sci 2021. [PMID: 33604793 DOI: 10.1007/s10620-021-06864-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
549 Sahu T, Mehta A, Ratre YK, Jaiswal A, Vishvakarma NK, Bhaskar LVKS, Verma HK. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings. World J Gastroenterol 2021; 27(6): 449-469 [PMID: 33642821 DOI: 10.3748/wjg.v27.i6.449] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
550 Rajapaksha IG, Gunarathne LS, Angus PW, Herath CB. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. J Clin Med 2021;10:702. [PMID: 33670126 DOI: 10.3390/jcm10040702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
551 Giannella M, Freire M, Rinaldi M, Abdala E, Rubin A, Mularoni A, Gruttadauria S, Grossi P, Shbaklo N, Tandoi F, Ferrarese A, Burra P, Fernandes R, Aranha Camargo LF, Asensio A, Alagna L, Bandera A, Simkins J, Abbo L, Halpern M, Santana Girao E, Valerio M, Muñoz P, Fernandez Yunquera A, Statlender L, Yahav D, Franceschini E, Graziano E, Morelli MC, Cescon M, Viale P, Lewis R. Development of a Risk Prediction Model for Carbapenem-Resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study. Clin Infect Dis 2021:ciab109. [PMID: 33564840 DOI: 10.1093/cid/ciab109] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
552 Meischl T, Rasoul-Rockenschaub S, Győri G, Scheiner B, Trauner M, Soliman T, Berlakovich G, Pinter M. Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma. United European Gastroenterol J 2021;9:209-19. [PMID: 32741316 DOI: 10.1177/2050640620948665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
553 Lee HJ, Kim WH, Jung CW, Suh KS, Lee KH. Different Severity of Clinical Outcomes Between the 2 Subgroups of Stage 1 Acute Kidney Injury After Liver Transplantation. Transplantation 2020;104:2327-33. [PMID: 31996661 DOI: 10.1097/TP.0000000000003135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
554 Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in Patients with Liver Cirrhosis. Nutrients 2021;13:540. [PMID: 33562292 DOI: 10.3390/nu13020540] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
555 Tergast TL, Schultalbers M, Wedemeyer H, Cornberg M, Maasoumy B. IgG, a novel predictor for acute-on-chronic liver failure and survival in patients with decompensated cirrhosis? J Hepatol 2021;75:229-31. [PMID: 33548386 DOI: 10.1016/j.jhep.2021.01.040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
556 Valery PC, Bernardes CM, Mckillen B, Amarasena S, Stuart KA, Hartel G, Clark PJ, Skoien R, Rahman T, Horsfall L, Hayward K, Gupta R, Lee A, Pillay L, Powell EE. The Patient's Perspective in Cirrhosis: Unmet Supportive Care Needs Differ by Disease Severity, Etiology, and Age. Hepatol Commun 2021;5:891-905. [PMID: 34027276 DOI: 10.1002/hep4.1681] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
557 Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021;74:944-951. [PMID: 33563499 DOI: 10.1016/j.jhep.2021.01.032] [Cited by in Crossref: 91] [Cited by in F6Publishing: 105] [Article Influence: 91.0] [Reference Citation Analysis]
558 Carbonneau M, Davyduke T, Congly SE, Ma MM, Newnham K, Den Heyer V, Tandon P, Abraldes JG. Impact of specialized multidisciplinary care on cirrhosis outcomes and acute care utilization. CanLivJ 2021;4:38-50. [DOI: 10.3138/canlivj-2020-0017] [Reference Citation Analysis]
559 Chen M, Wang J, Xiao Y, Wu L, Hu S, Chen S, Yi G, Hu W, Xie X, Zhu Y, Chen Y, Yang Y, Yu H. Automated and real-time validation of gastroesophageal varices under esophagogastroduodenoscopy using a deep convolutional neural network: a multicenter retrospective study (with video). Gastrointestinal Endoscopy 2021;93:422-432.e3. [DOI: 10.1016/j.gie.2020.06.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
560 Reincke M, Thimme R, Bettinger D. Die Leberzirrhose als inflammatorische Multisystemerkrankung. Gastro-News 2021;8:28-37. [DOI: 10.1007/s15036-020-2282-9] [Reference Citation Analysis]
561 Monteiro S, Grandt J, Uschner FE, Kimer N, Madsen JL, Schierwagen R, Klein S, Welsch C, Schäfer L, Jansen C, Claria J, Alcaraz-Quiles J, Arroyo V, Moreau R, Fernandez J, Bendtsen F, Mehta G, Gluud LL, Møller S, Praktiknjo M, Trebicka J. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation. Gut 2021;70:379-87. [PMID: 32241903 DOI: 10.1136/gutjnl-2019-320170] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 26.0] [Reference Citation Analysis]
562 Fediak I, Maksymenko O. ASSESSMENT OF THE FREQUENCY AND RATIONALITY OF PRESCRIBED MEDICINES IN PATIENTS WITH LIVER CIRRHOSIS. Eureka: HS 2021. [DOI: 10.21303/2504-5679.2021.001599] [Reference Citation Analysis]
563 Shin IS, Rim CH. Updating Perspectives on Meta-Analyses in the Field of Radiation Oncology. Medicina (Kaunas) 2021;57:117. [PMID: 33525358 DOI: 10.3390/medicina57020117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
564 Piano S, Tonon M, Angeli P. Changes in the epidemiology and management of bacterial infections in cirrhosis. Clin Mol Hepatol 2021;27:437-45. [PMID: 33504138 DOI: 10.3350/cmh.2020.0329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
565 Henry Z, Patel K, Patton H, Saad W. AGA Clinical Practice Update on Management of Bleeding Gastric Varices: Expert Review. Clin Gastroenterol Hepatol 2021;19:1098-1107.e1. [PMID: 33493693 DOI: 10.1016/j.cgh.2021.01.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
566 Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, Praktiknjo M, Lv Y, Han G, Huber JP, Boettler T, Reincke M, Klinger C, Caca K, Heinzow H, Seifert LL, Weiss KH, Rupp C, Piecha F, Kluwe J, Zipprich A, Luxenburger H, Neumann-Haefelin C, Schmidt A, Jansen C, Meyer C, Uschner FE, Brol MJ, Trebicka J, Rössle M, Thimme R, Schultheiss M. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. J Hepatol 2021;74:1362-72. [PMID: 33508376 DOI: 10.1016/j.jhep.2021.01.023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 36.0] [Reference Citation Analysis]
567 Madoff DC, Cornman-Homonoff J, Fortune BE, Gaba RC, Lipnik AJ, Yarmohammadi H, Ray CE Jr. Management of Refractory Ascites Due to Portal Hypertension: Current Status. Radiology 2021;298:493-504. [PMID: 33497318 DOI: 10.1148/radiol.2021201960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
568 Samuel D. Systemic inflammation and liver cirrhosis complications: Driving or secondary event? How to square the circle? J Hepatol 2021;74:508-10. [PMID: 33478857 DOI: 10.1016/j.jhep.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
569 Ocskay K, Kanjo A, Gede N, Szakács Z, Pár G, Erőss B, Stange J, Mitzner S, Hegyi P, Molnár Z. Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis. Ann Intensive Care 2021;11:10. [PMID: 33462764 DOI: 10.1186/s13613-020-00795-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
570 Morais Rateke EC, Matiollo C, de Andrade Moura EQ, Andrigueti M, Maccali C, Fonseca JS, Canova SMF, Narciso-Schiavon JL, Schiavon LL. Low sodium to potassium ratio in spot urine sample is associated with progression to acute kidney injury and mortality in hospitalized patients with cirrhosis. Dig Liver Dis 2021;53:1159-66. [PMID: 33446446 DOI: 10.1016/j.dld.2020.12.117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
571 Dajti E, Renzulli M, Colecchia A, Bacchi-Reggiani ML, Milandri M, Rossini B, Ravaioli F, Marasco G, Alemanni LV, Ierardi AM, Carrafiello G, Pinzani M, Azzaroli F, Mazzella G, Golfieri R, Festi D. Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients. Dig Liver Dis 2022;54:103-10. [PMID: 33414086 DOI: 10.1016/j.dld.2020.12.114] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
572 Frankova S, Lunova M, Gottfriedova H, Senkerikova R, Neroldova M, Kovac J, Kieslichova E, Lanska V, Urbanek P, Spicak J, Jirsa M, Sperl J. Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis. PLoS One 2021;16:e0244934. [PMID: 33411729 DOI: 10.1371/journal.pone.0244934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
573 Mücke MM, Mayer A, Kessel J, Mücke VT, Bon D, Schwarzkopf K, Rüschenbaum S, Queck A, Göttig S, Vermehren A, Weiler N, Welker MW, Reinheimer C, Hogardt M, Vermehren J, Herrmann E, Kempf VAJ, Zeuzem S, Lange CM. Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis. Clin Infect Dis 2020;70:1916-24. [PMID: 31228250 DOI: 10.1093/cid/ciz540] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
574 Lim J, Kim HI, Kim E, Kim J, An J, Chang S, Kim SO, Lee HC, Lee YS, Shim JH. Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study. BMC Cancer 2021;21:11. [PMID: 33402105 DOI: 10.1186/s12885-020-07708-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
575 Piccolo Serafim L, Simonetto DA. Primary Prophylaxis of Variceal Bleeding in Liver Cirrhosis. Variceal Bleeding in Liver Cirrhosis 2021. [DOI: 10.1007/978-981-15-7249-4_6] [Reference Citation Analysis]
576 Onisai M, Vlădăreanu AM, Iordan I, Enache C, Calapod O, Marin A, Fierbinţeanu-braticevici CG, Tribus L. Hematological alterations in hepatic cirrhosis – a challenge in clinical practice. Oncolog-Hematolog ro 2021;1:36. [DOI: 10.26416/onhe.5.1.2021.4575] [Reference Citation Analysis]
577 Baron MV, Scherer GDLG, dos Santos MP, Santamaria AFM, Brandenburg C, Reinheimer IC, de Mello Pinto MV, Sampaio AR, Sancho AG, Sancho AG, Pacheco EF, Picariello F, de Mello Florentino D, Ott JN, Pinheiro CG, Iketani NKP, Carvalho S, Meyer PF, da Costa BEP. Early Hepatic Encephalopathy after a Transjugular Intrahepatic Portosystemic Shunt Procedure: Case Report. OJGas 2021;11:81-88. [DOI: 10.4236/ojgas.2021.116009] [Reference Citation Analysis]
578 Møller S, Danielsen KV, Bendtsen F. Pathophysiology Behind Cardiopulmonary Complications of Cirrhosis and Portal Hypertension. Anesthesia for Hepatico-Pancreatic-Biliary Surgery and Transplantation 2021. [DOI: 10.1007/978-3-030-51331-3_3] [Reference Citation Analysis]
579 Reis D, Noronha ferreira C. Transjugular Intrahepatic Portosystemic Shunt: A Bridge to Clinical Stability in Decompensated Cirrhosis. GE Port J Gastroenterol 2021;28:2-4. [DOI: 10.1159/000510060] [Reference Citation Analysis]
580 Roy J. Liver Failure and the Kidneys. Liver Diseases in the Pediatric Intensive Care Unit 2021. [DOI: 10.1007/978-3-030-79132-2_5] [Reference Citation Analysis]
581 Ersan V, Isik B. Cost-Effective Therapies for HCC: Resection and Ablation. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_8] [Reference Citation Analysis]
582 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 123] [Cited by in F6Publishing: 134] [Article Influence: 123.0] [Reference Citation Analysis]
583 Bosch J. Small diameter shunts should lead to safe expansion of the use of TIPS. Journal of Hepatology 2021;74:230-4. [DOI: 10.1016/j.jhep.2020.09.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
584 Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, Wilkes EA, Moore K, Leithead JA, Hayes PC, O'Brien AJ, Verma S. Guidelines on the management of ascites in cirrhosis. Gut 2021;70:9-29. [PMID: 33067334 DOI: 10.1136/gutjnl-2020-321790] [Cited by in Crossref: 77] [Cited by in F6Publishing: 84] [Article Influence: 77.0] [Reference Citation Analysis]
585 Qi S, Wu Z, Jia H, Jin B, Li H, Liu C, Chang S, Zhu H, Zhu Y, Lu Z, Li P, Su H, Xiong J, Wang Y, Guo W, Sun G. Digestive System Disease and Sudden Death. Sudden Death 2021. [DOI: 10.1007/978-981-15-7002-5_23] [Reference Citation Analysis]
586 Dix HM, Robinson EM, Dillon JF. Liver Disorders Related to Alcohol and Other Drug Use. Textbook of Addiction Treatment 2021. [DOI: 10.1007/978-3-030-36391-8_77] [Reference Citation Analysis]
587 Lasagni A, Morana G, Strazzabosco M, Fabris L, Cadamuro M. Congenital Cystic Lesions of the Biliary Tree. Diseases of the Liver and Biliary Tree 2021. [DOI: 10.1007/978-3-030-65908-0_2] [Reference Citation Analysis]
588 Caraceni P, Angeli P, Prati D, Bernardi M, Berti P, Bennardello F, Fiorin F, Piccoli P; Italian Association for the Study of the Liver (AISF), on behalf of the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update. Blood Transfus 2021;19:9-13. [PMID: 33370229 DOI: 10.2450/2020.0414-20] [Reference Citation Analysis]
589 Gallo A, Dedionigi C, Civitelli C, Panzeri A, Corradi C, Squizzato A. Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians. J Transl Int Med 2020;8:220-36. [PMID: 33511049 DOI: 10.2478/jtim-2020-0035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
590 Prokopič M, Beuers U. Management of primary sclerosing cholangitis and its complications: an algorithmic approach. Hepatol Int 2021;15:6-20. [PMID: 33377990 DOI: 10.1007/s12072-020-10118-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
591 Abdelsameea E, Alsebaey A, Abdel-Samiee M, Abdel-Razek W, Salama M, Waked I. Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients. Expert Rev Anti Infect Ther 2021;19:1053-9. [PMID: 33307880 DOI: 10.1080/14787210.2021.1864326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
592 Gaspar R, Liberal R, Tavares J, Morgado R, Macedo G. HIPPOCRATES® project: A proof of concept of a collaborative program for hepatitis C virus micro-elimination in a prison setting. World J Hepatol 2020; 12(12): 1314-1325 [PMID: 33442457 DOI: 10.4254/wjh.v12.i12.1314] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
593 Tocia C, Dumitru A, Alexandrescu L, Popescu R, Dumitru E. Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis. World J Hepatol 2020; 12(12): 1267-1275 [PMID: 33442453 DOI: 10.4254/wjh.v12.i12.1267] [Reference Citation Analysis]
594 von Meijenfeldt FA, van den Boom BP, Adelmeijer J, Roberts LN, Lisman T, Bernal W. Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease. J Thromb Haemost 2021;19:664-76. [PMID: 33219597 DOI: 10.1111/jth.15185] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
595 Lingiah VA, Pyrsopoulos NT. Bacterial Infections in Cirrhotic Patients in a Tertiary Care Hospital. J Clin Transl Hepatol 2021;9:32-9. [PMID: 33604253 DOI: 10.14218/JCTH.2020.00076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
596 Cooper M, Pollard A, Pandey A, Bremner S, Macken L, Evans CJ, Austin M, Parnell N, Steer S, Thomson S, Hashim A, Mason L, Verma S. Palliative Long-Term Abdominal Drains Versus Large Volume Paracentesis in Refractory Ascites Due to Cirrhosis (REDUCe Study): Qualitative Outcomes. J Pain Symptom Manage 2021;62:312-325.e2. [PMID: 33348031 DOI: 10.1016/j.jpainsymman.2020.12.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
597 Aquino-Matus J, Uribe M, Chavez-Tapia N. Liver and spleen elastography as predictor of portal hypertension and esophageal varices. Minerva Gastroenterol (Torino) 2021;67:122-8. [PMID: 33337116 DOI: 10.23736/S2724-5985.20.02779-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
598 Zhu DM, Xie J, Ye CY, Qian MY, Xue Y. Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy. Can J Gastroenterol Hepatol 2020;2020:8871024. [PMID: 33381476 DOI: 10.1155/2020/8871024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
599 Durleshter VM, Gabriel’ SA, Korochanskaya NV, Buhtoyarov AY, Markov PV, Murashko DS, Oganesyan OA, Izmailova LG, Basenko MA, Horon'ko YV. Transjugular intrahepatic portosystemic stent-shunt as minimally invasive method of portal hypertension correction in multi-disciplinary clinic. Ann hir gepatol 2020;25:95-106. [DOI: 10.16931/1995-5464.2020495-106] [Reference Citation Analysis]
600 Rodrigues SG, Abraldes JG, Tsochatzis E, Bosch J, Berzigotti A. Royal Free Hospital-estimated glomerular filtration rate for prognostic stratification of first acute kidney injury in cirrhosis. Liver Int 2021;41:819-27. [PMID: 33314543 DOI: 10.1111/liv.14765] [Reference Citation Analysis]
601 Khemichian S, Francoz C, Durand F, Karvellas CJ, Nadim MK. Hepatorenal Syndrome. Crit Care Clin 2021;37:321-34. [PMID: 33752858 DOI: 10.1016/j.ccc.2020.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
602 Wang S, Huang Y, Hu W, Mao H, McAlindon ME, Liu Y, Yang L, Zhang C, Xu M, He C, Dang T, Wu B, Ji D, Zhang L, Mao X, Zhang L, Liu C, Xu D, Li Y, Li G, Han J, Lv F, Liang X, Jin S, Zhang S, Tai FWD, Xu Q, Yang C, Wang G, Wang L, Li B, Yang H, Xie P, Deng L, Ren L, Chang Z, Wang X, Wang S, Gao X, Li J, Zhu L, Wang F, Zhang L, Zhang G, Jiang X, Pan J, Meng W, Li X, Hou J, Dray X, Liao Z, Qi X. Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study. Lancet Reg Health West Pac 2021;6:100072. [PMID: 34327406 DOI: 10.1016/j.lanwpc.2020.100072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
603 Adachi T, Takaki A, Sato S, Tobita H, Kobashi H, Kinomura M, Nakatsuka A, Oyama A, Wada N, Sakata M, Takeuchi Y, Yasunaka T, Onishi H, Shiraha H, Okada H. High expression of a vascular stricture-related marker is predictive of an early response to tolvaptan, and a low fractional excretion of sodium is predictive of a poor long-term survival after tolvaptan administration for liver cirrhosis. Hepatol Res 2020;50:1347-54. [PMID: 32939957 DOI: 10.1111/hepr.13573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
604 Weiskirchen R. Commentary on "Re-regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signaling via interaction with Gli1". Br J Pharmacol 2021;178:378-80. [PMID: 33085773 DOI: 10.1111/bph.15282] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
605 Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ, Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version) . World J Gastroenterol 2020; 26(45): 7088-7103 [PMID: 33362370 DOI: 10.3748/wjg.v26.i45.7088] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
606 Jiang J, Wang J, Yang Z. The Use of Moxisaxin for Treatment of a Decompensated Cirrhosis Patient with Severe Pulmonary Infection. Jundishapur J Microbiol 2020;13. [DOI: 10.5812/jjm.103240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
607 Rodrigues DM, Djerboua M, Flemming JA. Intravenous Albumin in Patients With Cirrhosis: Evaluation of Practice Patterns and Secular Trends of Usage in Ontario 2000 to 2017. J Can Assoc Gastroenterol 2021;4:179-85. [PMID: 34337318 DOI: 10.1093/jcag/gwaa027] [Reference Citation Analysis]
608 Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N. Anti-fibrotic treatments for chronic liver diseases: The present and the future. Clin Mol Hepatol 2021;27:413-24. [PMID: 33317250 DOI: 10.3350/cmh.2020.0187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
609 Pfisterer N, Schmidbauer C, Riedl F, Maieron A, Stadlbauer V, Hennlich B, Schwarzer R, Puespoek A, Bucsics T, Effenberger M, Bota S, Gschwantler M, Peck-Radosavljevic M, Mandorfer M, Madl C, Trauner M, Reiberger T. Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria. Wien Klin Wochenschr. 2021;133:421-431. [PMID: 33270161 DOI: 10.1007/s00508-020-01769-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
610 Yoon KT, Liu H, Lee SS. β-blockers in advanced cirrhosis: More friend than enemy. Clin Mol Hepatol 2021;27:425-36. [PMID: 33317244 DOI: 10.3350/cmh.2020.0234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
611 Mendoza Y, Cocciolillo S, Murgia G, Chen T, Margini C, Sebastiani G, Berzigotti A. Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease. Clinical Gastroenterology and Hepatology 2020;18:3017-3025.e6. [DOI: 10.1016/j.cgh.2020.04.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
612 Spring A, Saran JS, McCarthy S, McCluskey SA. Anesthesia for the Patient with Severe Liver Failure. Adv Anesth 2020;38:251-67. [PMID: 34106838 DOI: 10.1016/j.aan.2020.09.002] [Reference Citation Analysis]
613 Kuftinec G, Estrada JR, Bhamidimarri KR. Spontaneous Bacterial Peritonitis and Secondary Bacterial Peritonitis—a Comprehensive Review. Curr Hepatology Rep 2020;19:486-498. [DOI: 10.1007/s11901-020-00551-9] [Reference Citation Analysis]
614 Kulkarni AV, Arab JP, Premkumar M, Benítez C, Tirumalige Ravikumar S, Kumar P, Sharma M, Reddy DN, Simonetto DA, Rao PN. Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives. Liver Int 2020;40:2888-905. [DOI: 10.1111/liv.14703] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
615 Zhou H, Hu H, Tian M, Chu J, Tian C, Yang Y, Lin S. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices. Gastroenterol Res Pract 2020;2020:4217512. [PMID: 33376483 DOI: 10.1155/2020/4217512] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
616 Chang J, Dumitrache A, Böhling N, Abu-Omar J, Meyer C, Strobel D, Luetkens J, Luu AM, Rockstroh J, Strassburg CP, Trebicka J, Gonzalez-Carmona MA, Marinova M, Praktiknjo M. Alteration of contrast enhanced ultrasound (CEUS) of hepatocellular carcinoma in patients with cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS). Sci Rep 2020;10:20682. [PMID: 33244180 DOI: 10.1038/s41598-020-77801-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
617 Jing J, Sang XX, You SL, Zhu B, Cui YF, Li CY, Wang ZX, Zhao X, Liu XY, Tian M, Ren YB, Yu SM, Xiao XH, Wang JB, Niu M, Wang RL. Metabolomic profiles of breath odor compounds for prognostic prediction in patients with acute-on-chronic liver failure: A pilot study. Hepatol Res 2021;51:490-502. [PMID: 33227168 DOI: 10.1111/hepr.13594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
618 Krassenburg LAP, Maan R, Ramji A, Manns MP, Cornberg M, Wedemeyer H, de Knegt RJ, Hansen BE, Janssen HLA, de Man RA, Feld JJ, van der Meer AJ. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity. J Hepatol 2021;74:1053-63. [PMID: 33242501 DOI: 10.1016/j.jhep.2020.11.021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
619 Yipeng W, Anjiang W, Bimin L, Chenkai H, Size W, Xuan Z. Clinical characteristics and efficacy of endoscopic treatment of gastrointestinal ectopic varices: A single-center study. Saudi J Gastroenterol 2021;27:35-43. [PMID: 33208560 DOI: 10.4103/sjg.SJG_50_20] [Reference Citation Analysis]
620 Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, Giovo I, Uschner FE, Jansen C, Jimenez C, Mookerjee R, Gustot T, Albillos A, Bañares R, Jarcuska P, Steib C, Reiberger T, Acevedo J, Gatti P, Shawcross DL, Zeuzem S, Zipprich A, Piano S, Berg T, Bruns T, Danielsen KV, Coenraad M, Merli M, Stauber R, Zoller H, Ramos JP, Solé C, Soriano G, de Gottardi A, Gronbaek H, Saliba F, Trautwein C, Kani HT, Francque S, Ryder S, Nahon P, Romero-Gomez M, Van Vlierberghe H, Francoz C, Manns M, Garcia-Lopez E, Tufoni M, Amoros A, Pavesi M, Sanchez C, Praktiknjo M, Curto A, Pitarch C, Putignano A, Moreno E, Bernal W, Aguilar F, Clària J, Ponzo P, Vitalis Z, Zaccherini G, Balogh B, Gerbes A, Vargas V, Alessandria C, Bernardi M, Ginès P, Moreau R, Angeli P, Jalan R, Arroyo V; PREDICT STUDY group of the EASL-CLIF CONSORTIUM. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. J Hepatol 2021;74:1097-108. [PMID: 33227350 DOI: 10.1016/j.jhep.2020.11.019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 27.0] [Reference Citation Analysis]
621 Du P, Wang X, Kong L, Riley T 3rd, Jung J. Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014-2017. Am J Prev Med 2021;60:285-93. [PMID: 33221144 DOI: 10.1016/j.amepre.2020.08.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
622 Li C, Su H, Hu J. The periscreen strip is an accurate and rapid method to diagnose spontaneous bacterial peritonitis among patients with acute-on-chronic liver failure. European Journal of Gastroenterology & Hepatology 2021;33:e206-13. [DOI: 10.1097/meg.0000000000002007] [Reference Citation Analysis]
623 Tang J, Wang Y, Han T, Mao Q, Cheng J, Ding H, Shang J, Zhang Q, Niu J, Ji F, Chen C, Jia J, Jiang X, Lv N, Gao Y, Wang Z, Wei Z, Chen Y, Zeng M, Mao Y. Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial. BMC Gastroenterol 2020;20:391. [PMID: 33213378 DOI: 10.1186/s12876-020-01536-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
624 Peschel G, Kraft IC, Ilkhtchoui R, Schmid S, Sinner B, Scherer MN, Mueller-Schilling M, Weigand K. Definition, reasons, and risk factors for mortality of patients listed for liver transplantation - a single-center study. Z Gastroenterol 2020;58:1065-73. [PMID: 33197949 DOI: 10.1055/a-1246-3144] [Reference Citation Analysis]
625 Sharma S, Agarwal S, Kaushal K, Anand A, Gunjan D, Yadav R, Saraya A. Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids. JGH Open 2021;5:81-90. [PMID: 33490617 DOI: 10.1002/jgh3.12451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
626 Hung CC, Hsu YC, Lin KH. Comparing Mortality Risk Predictive Ability of Different Scoring Systems in Cirrhotic Patients with Bacteremia. Emerg Med Int 2020;2020:8596567. [PMID: 33163235 DOI: 10.1155/2020/8596567] [Reference Citation Analysis]
627 Wiedermann CJ. Phases of fluid management and the roles of human albumin solution in perioperative and critically ill patients. Curr Med Res Opin 2020;36:1961-73. [PMID: 33090028 DOI: 10.1080/03007995.2020.1840970] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
628 Allegretti AS, Solà E, Ginès P. Clinical Application of Kidney Biomarkers in Cirrhosis. American Journal of Kidney Diseases 2020;76:710-9. [DOI: 10.1053/j.ajkd.2020.03.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
629 Meine TC, Dewald CLA, Becker LS, Mähringer-Kunz A, Massoumy B, Maschke SK, Kirstein MM, Werncke T, Wacker FK, Meyer BC, Hinrichs JB. Transjugular intrahepatic portosystemic shunt placement: portal vein puncture guided by 3D/2D image registration of contrast-enhanced multi-detector computed tomography and fluoroscopy. Abdom Radiol (NY) 2020;45:3934-43. [PMID: 32451673 DOI: 10.1007/s00261-020-02589-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
630 Guixé-muntet S, Zhu C, Xie W, Gracia-sancho J. Novel therapeutics for portal hypertension and fibrosis in chronic liver disease. Pharmacology & Therapeutics 2020;215:107626. [DOI: 10.1016/j.pharmthera.2020.107626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
631 Mücke MM, Rüschenbaum S, Mayer A, Mücke VT, Schwarzkopf KM, Zeuzem S, Kehrmann J, Scholtysik R, Lange CM. Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study. Gut Pathog 2020;12:51. [PMID: 33133240 DOI: 10.1186/s13099-020-00389-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
632 Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
633 Al-Rifaie A, Min T, Allam D, Smith K, Hurlstone DP, Abdo A, Said E, Donnelly M. Endoscopy training in upper GI bleeding for UK trainees in Khartoum, Sudan: South Yorkshire experience. Frontline Gastroenterol 2020;11:496-7. [PMID: 33101631 DOI: 10.1136/flgastro-2020-101533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
634 Crisan D, Procopet B, Epure A, Stefanescu H, Suciu A, Fodor A, Mois E, Craciun R, Crisan N. Malnutrition and non-compliance to nutritional recommendations in patients with cirrhosis are associated with a lower survival. World J Hepatol 2020; 12(10): 829-840 [PMID: 33200020 DOI: 10.4254/wjh.v12.i10.829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
635 Zaccherini G, Tufoni M, Bernardi M. Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature. Hepat Med 2020;12:153-72. [PMID: 33149707 DOI: 10.2147/HMER.S264231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
636 Amin A, Mookerjee RP. Acute-on-chronic liver failure: definition, prognosis and management. Frontline Gastroenterol 2020;11:458-67. [PMID: 33101624 DOI: 10.1136/flgastro-2018-101103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
637 Magro B, Mazzola A, Munteanu M, Goumard C, Martinez V, Bernard D, Scatton O, Battaglia S, Celsa C, Cammà C, Conti F. Consequences of Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus Carriage in Awaiting Liver Transplant Patients. Liver Transpl 2021;27:43-54. [PMID: 32955790 DOI: 10.1002/lt.25897] [Reference Citation Analysis]
638 Simonetti RG, Perricone G, Robbins HL, Battula NR, Weickert MO, Sutton R, Khan S. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis. Cochrane Database Syst Rev 2020;10:CD000553. [PMID: 33089892 DOI: 10.1002/14651858.CD000553.pub3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
639 Huang CH, Tseng HJ, Amodio P, Chen YL, Wang SF, Chang SH, Hsieh SY, Lin CY. Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Improve Cirrhosis Outcome Prediction: A Modified Seven-Stage Model as a Clinical Alternative to MELD. J Pers Med 2020;10:E186. [PMID: 33105871 DOI: 10.3390/jpm10040186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
640 Henkel S, Vetterly C, Squires R, McKiernan P, Squires J. Pharmacological management of portal hypertension and its complications in children: lessons from adults and opportunities for the future. Expert Opin Pharmacother 2021;22:291-304. [PMID: 33074032 DOI: 10.1080/14656566.2020.1825685] [Reference Citation Analysis]
641 Benz F, Mohr R, Tacke F, Roderburg C. Pulmonary Complications in Patients with Liver Cirrhosis. J Transl Int Med 2020;8:150-8. [PMID: 33062591 DOI: 10.2478/jtim-2020-0024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
642 Carrion AF, Martin P. Keeping Patients with End-Stage Liver Disease Alive While Awaiting Transplant: Management of Complications of Portal Hypertension. Clin Liver Dis 2021;25:103-20. [PMID: 33978573 DOI: 10.1016/j.cld.2020.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
643 Mauro E, Crespo G, Martinez-Garmendia A, Gutierrez-Acevedo MN, Diaz JM, Saidman J, Bermudez C, Ortiz-Patron J, Garcia-Olveira L, Zalazar F, Narvaez A, Spina JC, Orta R, Savluk L, Piano S, Marciano S, Gadano A. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List. Transplantation. 2020;104:e188-e198. [PMID: 32150034 DOI: 10.1097/tp.0000000000003222] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
644 Arora A, Kumar A, Prasad N, Duseja A, Acharya SK, Agarwal SK, Aggarwal R, Anand AC, Bhalla AK, Choudhary NS, Chawla YK, Dhiman RK, Dixit VK, Gopalakrishnan N, Gupta A, Hegde UN, Jasuja S, Jha V, Kher V, Kumar A, Madan K, Maiwall R, Mathur RP, Nayak SL, Pandey G, Pandey R, Puri P, Rai RR, Raju SB, Rana DS, Rao PN, Rathi M, Saraswat VA, Saxena S, Shalimar, Sharma P, Singh SP, Singal AK, Soin AS, Taneja S, Varughese S. INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease. J Clin Exp Hepatol 2021;11:354-86. [PMID: 33994718 DOI: 10.1016/j.jceh.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
645 Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, Mohanan M, Augustine P. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update. World J Gastroenterol 2020; 26(37): 5561-5596 [PMID: 33088154 DOI: 10.3748/wjg.v26.i37.5561] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
646 Simbrunner B, Stadlmann A, Schwabl P, Paternostro R, Bauer DJM, Bucsics T, Scheiner B, Lampichler K, Wöran K, Beer A, Eigenbauer E, Pinter M, Stättermayer AF, Marculescu R, Szekeres T, Trauner M, Mandorfer M, Reiberger T. Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease. Dig Liver Dis 2021;53:345-52. [PMID: 33032973 DOI: 10.1016/j.dld.2020.09.006] [Reference Citation Analysis]
647 Xu X, Liu B, Lin S, Li B, Wu Y, Li Y, Zhu Q, Yang Y, Tang S, Meng F, Chen Y, Yuan S, Shao L, Bernardi M, Yoshida EM, Qi X. Terlipressin May Decrease In-Hospital Mortality of Cirrhotic Patients with Acute Gastrointestinal Bleeding and Renal Dysfunction: A Retrospective Multicenter Observational Study. Adv Ther 2020;37:4396-413. [PMID: 32860184 DOI: 10.1007/s12325-020-01466-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
648 Limdi JK. Indian Journal of Gastroenterology September-October 2020. Indian J Gastroenterol 2020;39:415-8. [PMID: 33226569 DOI: 10.1007/s12664-020-01120-0] [Reference Citation Analysis]
649 Lesmana CRA, Raharjo M, Gani RA. Managing liver cirrhotic complications: Overview of esophageal and gastric varices. Clin Mol Hepatol 2020;26:444-60. [PMID: 33053928 DOI: 10.3350/cmh.2020.0022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
650 Lee YR, Kang MK, Song JE, Kim HJ, Kweon YO, Tak WY, Jang SY, Park JG, Lee C, Hwang JS, Jang BK, Suh JI, Chung WJ, Kim BS, Park SY. Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea. Clin Mol Hepatol. 2020;26:562-576. [PMID: 33053932 DOI: 10.3350/cmh.2020.0126] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
651 Mendizabal M, Piñero F, Ridruejo E, Herz Wolff F, Anders M, Reggiardo V, Ameigeiras B, Palazzo A, Alonso C, Schinoni MI, Videla Zuain MG, Tanno F, Figueroa S, Santos L, Peralta M, Soza A, Vistarini C, Adrover R, Fernández N, Perez D, Hernández N, Estepo C, Bruno A, Descalzi V, Sixto M, Borzi S, Cocozzella D, Zerega A, de Araujo A, Varón A, Rubinstein F, Cheinquer H, Silva M. Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents. Clinical Gastroenterology and Hepatology 2020;18:2554-2563.e3. [DOI: 10.1016/j.cgh.2020.02.044] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
652 Patidar KR, Shamseddeen H, Xu C, Ghabril MS, Nephew LD, Desai AP, Anderson M, El-Achkar TM, Ginès P, Chalasani NP, Orman ES. Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study. Am J Gastroenterol 2020;115:1505-12. [PMID: 32371628 DOI: 10.14309/ajg.0000000000000670] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
653 Zhai XR, Tong JJ, Wang HM, Xu X, Mu XY, Chen J, Liu ZF, Wang Y, Su HB, Hu JH. Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol 2020;20:320. [PMID: 32993547 DOI: 10.1186/s12876-020-01473-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
654 Calès P, Bertrais S, Boursier J, Fouchard I, Oberti F; SNIFF 16 group. Non-selective beta-blockers increase overall and liver mortality in alcoholic cirrhosis with MELD ≥ 12 over 5 years of follow-up. Liver Int 2021;41:168-79. [PMID: 32979020 DOI: 10.1111/liv.14674] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
655 Saab S, Kim NG, Lee EW. Practical Tips on TIPS: When and When Not to Request It. Am J Gastroenterol 2020;115:797-800. [PMID: 32427674 DOI: 10.14309/ajg.0000000000000611] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
656 Sandi BB, Leão GS, de Mattos AA, de Mattos ÂZ. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2021;36:609-17. [PMID: 32914468 DOI: 10.1111/jgh.15253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
657 Yan H, Wang G, Zhu W, Feng K, Zhu W, Wu X, Qiu Z, Chen G, Jiang W, Zhang F, Gao F. Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites. Transl Oncol 2020;13:100864. [PMID: 32950928 DOI: 10.1016/j.tranon.2020.100864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
658 Zhao H, Wang Q, Luo C, Liu L, Xie W. Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges. Biomed Res Int 2020;2020:9609731. [PMID: 33029534 DOI: 10.1155/2020/9609731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
659 Kabbani AR, Schultalbers M, Tergast T, Kimmann M, Stahmeyer J, Manns MP, Cornberg M, Maasoumy B, Becker H. [Influence of a spontaneous bacterial peritonitis, nosocomial infections and acute-on-chronic liver failure on treatment revenues in patients with decompensated cirrhosis in Germany]. Z Gastroenterol 2020;58:855-67. [PMID: 32947631 DOI: 10.1055/a-1217-7549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
660 Schacher FC, Mattos AA, Mulazzani CM, Detanico RB, Favero B, Fonseca BB, Felix PH, Pase THS, Kupski C, Machado MB, Coral GP, Wiltgen D, Mattos AZ. IMPACT OF ACUTE KIDNEY INJURY STAGING ON PROGNOSIS OF PATIENTS WITH CIRRHOSIS. Arq Gastroenterol 2020;57:244-8. [PMID: 32935742 DOI: 10.1590/S0004-2803.202000000-46] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
661 Shin J, Yu JH, Jin YJ, Yim HJ, Jung YK, Yang JM, Song DS, Kim YS, Kim SG, Kim DJ, Suk KT, Yoon EL, Lee SS, Kim CW, Kim HY, Jang JY, Jeong SW. Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding. Clin Mol Hepatol 2020;26:540-53. [PMID: 32937688 DOI: 10.3350/cmh.2020.0034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
662 Simonetto DA, Gines P, Kamath PS. Hepatorenal syndrome: pathophysiology, diagnosis, and management.BMJ. 2020;370:m2687. [PMID: 32928750 DOI: 10.1136/bmj.m2687] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 29.0] [Reference Citation Analysis]
663 Durleshter VM, Gabriel SA, Korochanskaya NV, Kovalevskaya OV, Serikova SN, Markov PV, Usova OA, Murashko DS, Dyn'ko VY, Bukhtoyarov AY, Basenko MA. Managing Liver Cirrhosis: a Multidisciplinary Approach. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2020;30:35-43. [DOI: 10.22416/1382-4376-2020-30-4-35-43] [Reference Citation Analysis]
664 Gao Z, Han Y, Li L, Ding H. Pharmacological management of portal hypertension: current status and future. Chinese Medical Journal 2020;133:2362-2364. [DOI: 10.1097/cm9.0000000000001004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
665 Zhang J, Qiu Y, He X, Mao W, Han Z. Platelet-to-white blood cell ratio: A novel and promising prognostic marker for HBV-associated decompensated cirrhosis. J Clin Lab Anal 2020;34:e23556. [PMID: 32893950 DOI: 10.1002/jcla.23556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
666 Chan BPH, Berzin TM. The Endoscopy Patient as a Vector and Victim. Gastrointest Endosc Clin N Am 2020;30:745-62. [PMID: 32891230 DOI: 10.1016/j.giec.2020.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
667 Falleti E, Cmet S, Cussigh AR, Salvador E, Bitetto D, Fornasiere E, Fumolo E, Fabris C, Toniutto P. Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis. J Clin Exp Hepatol 2021;11:334-42. [PMID: 33994716 DOI: 10.1016/j.jceh.2020.08.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
668 Hudson B. Editorial: palliative long-term abdominal drains in refractory ascites-a step in the right direction, but not the complete solution. Aliment Pharmacol Ther 2020;52:721-2. [PMID: 32886361 DOI: 10.1111/apt.15894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
669 Macken L, Bremner S, Sheridan D, Verma S; REDUCe Study Team. Editorial: palliative long-term abdominal drains in refractory ascites-a step in the right direction, but not the complete solution. Authors' reply. Aliment Pharmacol Ther 2020;52:723-4. [PMID: 32886369 DOI: 10.1111/apt.15928] [Reference Citation Analysis]
670 Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol 2021;74:200-19. [PMID: 32896580 DOI: 10.1016/j.jhep.2020.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
671 Mayr U, Lukas M, Elnegouly M, Vogt C, Bauer U, Ulrich J, Schmid RM, Huber W, Lahmer T. Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis. J Clin Med 2020;9:E2865. [PMID: 32899730 DOI: 10.3390/jcm9092865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
672 Zaccherini G, Weiss E, Moreau R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment. JHEP Rep 2021;3:100176. [PMID: 33205036 DOI: 10.1016/j.jhepr.2020.100176] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
673 John S, Friedman LS. Portal Hypertensive Ascites: Current Status. Curr Hepatology Rep 2020;19:226-234. [DOI: 10.1007/s11901-020-00524-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
674 Allegretti AS, Jamil K, Moore K. Editorial: treating hepatorenal syndrome-a window and the views. Authors' reply. Aliment Pharmacol Ther 2020;52:897. [PMID: 32852830 DOI: 10.1111/apt.15981] [Reference Citation Analysis]
675 Magaz M, Soy G, García-pagán JC. Budd-Chiari Syndrome: Anticoagulation, TIPS, or Transplant. Curr Hepatology Rep 2020;19:197-202. [DOI: 10.1007/s11901-020-00528-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
676 Manchec B, Pham E, Noor M, Pepe J, Feranec N, Contreras F, Ward TJ. Contrast-Enhanced CT May Identify High-Risk Esophageal Varices in Patients With Cirrhosis. American Journal of Roentgenology 2020;215:617-623. [DOI: 10.2214/ajr.19.22474] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
677 Bassegoda O, Solà E, Ginès P. Reply to: “Transition of AKI to CKD in cirrhosis – effect of baseline eGFR and unanswered questions”. Journal of Hepatology 2020;73:738-739. [DOI: 10.1016/j.jhep.2020.04.041] [Reference Citation Analysis]
678 Nakai M, Suda G, Kubo A, Tokuchi Y, Kitagataya T, Yamada R, Shigesawa T, Suzuki K, Nakamura A, Kawagishi N, Ohara M, Umemura M, Sho T, Morikawa K, Ogawa K, Sakamoto N. Durable response without recurrence to Tolvaptan improves long-term survival. J Gastroenterol 2020;55:1150-61. [PMID: 32851487 DOI: 10.1007/s00535-020-01721-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
679 Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Mohta S, Shalimar, Saraya A. Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study. J Clin Exp Hepatol 2021;11:343-53. [PMID: 33994717 DOI: 10.1016/j.jceh.2020.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
680 Leung KK, Deeb M, Hirschfield GM. Review article: pathophysiology and management of primary biliary cholangitis. Aliment Pharmacol Ther. [DOI: 10.1111/apt.16023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
681 Wong RJ, Kachru N, Martinez DJ, Moynihan M, Ozbay AB, Gordon SC. Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases. J Clin Gastroenterol 2021;55:891-902. [PMID: 32815873 DOI: 10.1097/MCG.0000000000001409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
682 Zhou L, Zhong B, Du H, Wang W, Shen J, Zhang S, Li W, Tang H, Zhang P, Yang W, Zhu X. Comparison of embolic agents for varices during transjugular intrahepatic portosystemic shunt for variceal bleeding: Tissue gel or coil? J Interv Med 2020;3:195-200. [PMID: 34805934 DOI: 10.1016/j.jimed.2020.08.008] [Reference Citation Analysis]
683 Ridruejo E, Piñero F, Mendizabal M, Cheinquer H, Wolff FH, Anders M, Reggiardo V, Ameigeiras B, Palazzo A, Alonso C, Schinoni MI, Zuain MGV, Tanno F, Figueroa S, Santos L, Peralta M, Soza A, Vistarini C, Adrover R, Fernández N, Perez D, Hernández N, Estepo C, Bruno A, Descalzi V, Sixto M, Borzi S, Cocozzella D, Zerega A, Araujo A, Varón A, Silva M; Latin American Liver Research Educational and Awareness Network (LALREAN). Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real‐world experience from HCV‐LALREAN cohort. J Med Virol 2020;92:3545-55. [DOI: 10.1002/jmv.26383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
684 Sharma P, Moore K, Ganger D, Grewal P, Brown RS. Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation. Liver Transpl 2020;26:1328-36. [DOI: 10.1002/lt.25834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
685 Moon H, Kim HJ, Woo SM, Park IH, Sim SH. Discrimination of ascitic fluid infection in malignant ascites by polymorphonuclear neutrophil ratio and count: Investigating the validity of count ≥250/mm3 as the one-size-fits-all criterion. Asia Pac J Clin Oncol 2021;17:e87-93. [PMID: 32762145 DOI: 10.1111/ajco.13344] [Reference Citation Analysis]
686 Alsebaey A, Rewisha E, Waked I. Paracentesis-induced circulatory dysfunction: are there albumin alternatives? Egypt Liver Journal 2020;10. [DOI: 10.1186/s43066-020-00047-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
687 Boettler T, Marjot T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Jalan R, Moreau R, Cornberg M, Berg T. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 mo of the pandemic. JHEP Rep. 2020;2:100169. [PMID: 32835190 DOI: 10.1016/j.jhepr.2020.100169] [Cited by in Crossref: 72] [Cited by in F6Publishing: 89] [Article Influence: 36.0] [Reference Citation Analysis]
688 Praktiknjo M, Clees C, Pigliacelli A, Fischer S, Jansen C, Lehmann J, Pohlmann A, Lattanzi B, Krabbe VK, Strassburg CP, Arroyo V, Merli M, Meyer C, Trebicka J. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt. Clin Transl Gastroenterol 2019;10:e00025. [PMID: 30939488 DOI: 10.14309/ctg.0000000000000025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 22.5] [Reference Citation Analysis]
689 Limdi JK. Indian Journal of Gastroenterology July-August 2020. Indian J Gastroenterol 2020;39:311-4. [PMID: 33017038 DOI: 10.1007/s12664-020-01103-1] [Reference Citation Analysis]
690 Terbah R, Gow P, Sinclair M, Testro A. Terlipressin for Type 1 Hepatorenal Syndrome. Dig Dis Sci 2020;65:2454-5. [PMID: 32514642 DOI: 10.1007/s10620-020-06370-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
691 Riva A, Gray EH, Azarian S, Zamalloa A, McPhail MJW, Vincent RP, Williams R, Chokshi S, Patel VC, Edwards LA. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis. JHEP Rep 2020;2:100151. [PMID: 32838247 DOI: 10.1016/j.jhepr.2020.100151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
692 Freitas M, Xavier S, Magalhães R, Magalhães J, Marinho C, Cotter J. LIRER score - a valuable tool to predict medium-long-term outcomes in hepatic cirrhosis decompensation. Scand J Gastroenterol 2020;55:1079-86. [PMID: 32715829 DOI: 10.1080/00365521.2020.1797156] [Reference Citation Analysis]
693 Trebicka J, Gu W, Garcia-Pagán JC, Bosch J, Bañares R. Reply to: "Pre-emptive TIPS for acute variceal bleeding in acute-on-chronic liver failure: Is there enough evidence for a routine recommendation?": pTIPS for variceal bleeding in ACLF patients: when and why? J Hepatol 2020;73:977-9. [PMID: 32690379 DOI: 10.1016/j.jhep.2020.05.037] [Reference Citation Analysis]
694 Rahim MN, Miquel R, Heneghan MA. Approach to the patient with acute severe autoimmune hepatitis. JHEP Rep 2020;2:100149. [PMID: 32995712 DOI: 10.1016/j.jhepr.2020.100149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
695 Li X, Wu J, Mao W. Evaluation of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and red cell distribution width for the prediction of prognosis of patients with hepatitis B virus-related decompensated cirrhosis. J Clin Lab Anal 2020;34:e23478. [PMID: 32666632 DOI: 10.1002/jcla.23478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
696 Garrido I, Liberal R, Gaspar R, Macedo G. Cirrhosis management in a major referral center during COVID-19. JHEP Rep. 2020;2:100146. [PMID: 32838246 DOI: 10.1016/j.jhepr.2020.100146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
697 Cannella R, Giambelluca D, Pellegrinelli A, Cabassa P. Color Doppler Ultrasound in Portal Hypertension: A Closer Look at Left Gastric Vein Hemodynamics. J Ultrasound Med 2021;40:7-14. [PMID: 32657462 DOI: 10.1002/jum.15386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
698 Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52:584-599. [PMID: 32638436 DOI: 10.1111/apt.15916] [Cited by in Crossref: 117] [Cited by in F6Publishing: 128] [Article Influence: 58.5] [Reference Citation Analysis]
699 Boike JR, Flamm SL. Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease. Clin Liver Dis 2020;24:373-88. [PMID: 32620278 DOI: 10.1016/j.cld.2020.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
700 Kim SW, Yoon JS, Park J, Jung YJ, Lee JS, Song J, Lee HA, Seo YS, Lee M, Park JM, Choi DH, Kim MY, Kang SH, Yang JM, Song DS, Chung SW, Kim MA, Jang HJ, Oh H, Lee CH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Lee JH. Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial Peritonitis. Clin Gastroenterol Hepatol 2021;19:976-986.e5. [PMID: 32623007 DOI: 10.1016/j.cgh.2020.06.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
701 Mahmud N, Sundaram V, Kaplan DE, Taddei TH, Goldberg DS. Grade 1 Acute on Chronic Liver Failure Is a Predictor for Subsequent Grade 3 Failure. Hepatology 2020;72:230-9. [PMID: 31677284 DOI: 10.1002/hep.31012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
702 Tufoni M, Baldassarre M, Zaccherini G, Antognoli A, Caraceni P. Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease. Curr Hepatol Rep 2020;:1-12. [PMID: 32837825 DOI: 10.1007/s11901-020-00521-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
703 Tripathi D, Stanley AJ, Hayes PC, Travis S, Armstrong MJ, Tsochatzis EA, Rowe IA, Roslund N, Ireland H, Lomax M, Leithead JA, Mehrzad H, Aspinall RJ, McDonagh J, Patch D. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 2020;69:1173-92. [PMID: 32114503 DOI: 10.1136/gutjnl-2019-320221] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 40.0] [Reference Citation Analysis]
704 Miranda-zazueta G, González-regueiro J, García-juárez I, Moctezuma-velázquez C, López-díaz F, Pérez-gonzález B, Uscanga-domínguez L, Peláez-luna M. Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic. Revista de Gastroenterología de México (English Edition) 2020;85:312-20. [DOI: 10.1016/j.rgmxen.2020.06.002] [Reference Citation Analysis]
705 Verbeek TA, Stine JG, Saner FH, Bezinover D. Osmotic demyelination syndrome: are patients with end-stage liver disease a special risk group? Minerva Anestesiol 2020;86. [DOI: 10.23736/s0375-9393.20.14120-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
706 Llamosas-Falcón L, Shield KD, Gelovany M, Manthey J, Rehm J. Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection - a systematic review. Subst Abuse Treat Prev Policy 2020;15:45. [PMID: 32605584 DOI: 10.1186/s13011-020-00287-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
707 Faulkes RE, Chauhan A, Knox E, Johnston T, Thompson F, Ferguson J. Review article: chronic liver disease and pregnancy. Aliment Pharmacol Ther 2020;52:420-9. [PMID: 32598048 DOI: 10.1111/apt.15908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
708 Liu PH, Hsu CY, Su CW, Huang YH, Hou MC, Rich NE, Fujiwara N, Hoshida Y, Singal AG, Huo TI. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver Int 2020;40:2522-34. [PMID: 32511831 DOI: 10.1111/liv.14560] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
709 Will V, Rodrigues SG, Stirnimann G, Gottardi A, Bosch J, Berzigotti A. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications. United European Gastroenterol J 2020;8:961-9. [PMID: 32588789 DOI: 10.1177/2050640620938525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
710 Stockhoff L, Schultalbers M, Tergast TL, Hinrichs JB, Gerbel S, Meine TC, Manns MP, Simon N, Cornberg M, Meyer BC, Maasoumy B. Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites. PLoS One 2020;15:e0235199. [PMID: 32584874 DOI: 10.1371/journal.pone.0235199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
711 Stahl K, Busch M, Fuge J, Schneider A, Manns MP, Seeliger B, Schmidt JJ, Wiesner O, Schmidt BMW, Taubert R, Vondran FWR, Hoeper MM, David S. Therapeutic plasma exchange in acute on chronic liver failure. J Clin Apher. 2020;35:316-327. [PMID: 32583446 DOI: 10.1002/jca.21799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
712 Horvath A, Durdevic M, Leber B, di Vora K, Rainer F, Krones E, Douschan P, Spindelboeck W, Durchschein F, Zollner G, Stauber RE, Fickert P, Stiegler P, Stadlbauer V. Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis. Nutrients 2020;12:E1874. [PMID: 32585997 DOI: 10.3390/nu12061874] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
713 Mohammed BS, Aidoo M. Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines? Int J Hepatol 2020;2020:9750194. [PMID: 32550025 DOI: 10.1155/2020/9750194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
714 Miranda-Zazueta G, González-Regueiro JA, García-Juárez I, Moctezuma-Velázquez C, López-Díaz FJ, Pérez-González B, Uscanga-Domínguez LF, Peláez-Luna M. Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Position statement within the framework of the SARS-CoV-2 (COVID-19) pandemic. Rev Gastroenterol Mex (Engl Ed) 2020;85:312-20. [PMID: 32620315 DOI: 10.1016/j.rgmx.2020.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
715 Crismale JF, Friedman SL. Acute Liver Injury and Decompensated Cirrhosis. Med Clin North Am 2020;104:647-62. [PMID: 32505258 DOI: 10.1016/j.mcna.2020.02.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
716 Kumar R, Kerbert AJC, Sheikh MF, Roth N, Calvao JAF, Mesquita MD, Barreira AI, Gurm HS, Ramsahye K, Mookerjee RP, Yu D, Davies NH, Mehta G, Agarwal B, Patch D, Jalan R. Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding. J Hepatol 2021;74:66-79. [PMID: 32561318 DOI: 10.1016/j.jhep.2020.06.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
717 Gerussi A, Rigamonti C, Elia C, Cazzagon N, Floreani A, Pozzi R, Pozzoni P, Claar E, Pasulo L, Fagiuoli S, Cristoferi L, Carbone M, Invernizzi P. Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients. Hepatol Commun. 2020;. [PMID: 32838102 DOI: 10.1002/hep4.1557] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 18.0] [Reference Citation Analysis]
718 Santos S, Dantas E, Veloso Gomes F, Luz JH, Vasco Costa N, Bilhim T, Calinas F, Martins A, Coimbra É. Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension. GE Port J Gastroenterol 2020;28:5-12. [PMID: 33564700 DOI: 10.1159/000507894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
719 Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, Perricone G, Massironi S, Spinetti A, Buscarini E, Viganò M, Carriero C, Fagiuoli S, Aghemo A, Belli LS, Lucà M, Pedaci M, Rimondi A, Rumi MG, Invernizzi P, Bonfanti P, Lampertico P. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol 2020;73:1063-71. [PMID: 32526252 DOI: 10.1016/j.jhep.2020.06.001] [Cited by in Crossref: 188] [Cited by in F6Publishing: 204] [Article Influence: 94.0] [Reference Citation Analysis]
720 Ueno M, Kayahara T, Sunami T, Takayama H, Takabatake H, Morimoto Y, Yamamoto H, Mizuno M. Universal antibiotic prophylaxis may no longer be necessary for patients with acute variceal bleeding: A retrospective observational study. Medicine (Baltimore) 2020;99:e19981. [PMID: 32443300 DOI: 10.1097/MD.0000000000019981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
721 Mattos AA, Wiltgen D, Jotz RF, Dornelles CMR, Fernandes MV, Mattos ÂZ. Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis. Ann Hepatol 2020;19:451-7. [PMID: 32533951 DOI: 10.1016/j.aohep.2020.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
722 Jepsen P, Kraglund F, West J, Villadsen GE, Sørensen HT, Vilstrup H. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis. J Hepatol 2020;73:1030-6. [PMID: 32512015 DOI: 10.1016/j.jhep.2020.05.043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
723 Moore K, Jamil K, Verleger K, Luo L, Kebede N, Heisen M, Corman S, Leonardi R, Bakker R, Maï C, Shamseddine N, Huang X, Allegretti AS. Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Aliment Pharmacol Ther 2020;52:351-8. [DOI: 10.1111/apt.15836] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
724 del Río Izquierdo J, Velilla Aparicio E, Usón Peirón C, Caravaca Gámez C, Carrión Martín L. Mujer de 52 años de edad con cirrosis hepática que consulta por edemas y ascitis de dos meses de evolución. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:707.e1-707.e5. [DOI: 10.1016/j.med.2020.06.026] [Reference Citation Analysis]
725 Macken L, Bremner S, Gage H, Touray M, Williams P, Crook D, Mason L, Lambert D, Evans CJ, Cooper M, Timeyin J, Steer S, Austin M, Parnell N, Thomson SJ, Sheridan D, Wright M, Isaacs P, Hashim A, Verma S. Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis. Aliment Pharmacol Ther 2020;52:107-22. [DOI: 10.1111/apt.15802] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
726 Bernardi M, Angeli P, Claria J, Moreau R, Gines P, Jalan R, Caraceni P, Fernandez J, Gerbes AL, O'Brien AJ, Trebicka J, Thevenot T, Arroyo V. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut 2020;69:1127-38. [PMID: 32102926 DOI: 10.1136/gutjnl-2019-318843] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 43.5] [Reference Citation Analysis]
727 Yao Y, Yang D, Huang Y, Dong M. Predictive value of insulin-like growth factor 1-Child-Turcotte-Pugh score for mortality in patients with decompensated cirrhosis. Clin Chim Acta 2020;505:141-7. [PMID: 32119835 DOI: 10.1016/j.cca.2020.02.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
728 Wong F. Latest Treatment of Acute Kidney Injury in Cirrhosis. Curr Treat Options Gastro 2020;18:281-94. [DOI: 10.1007/s11938-020-00292-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
729 Praktiknjo M, Simón-talero M, Römer J, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Maurer MH, Zipprich A, Triolo M, Maleux G, Fialla AD, Dam C, Vidal-gonzález J, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, López M, Jansen C, Chang J, Schierwagen R, Uschner F, Kukuk G, Meyer C, Thomas D, Wolter K, Strassburg CP, Laleman W, La Mura V, Ripoll C, Berzigotti A, Calleja JL, Tandon P, Hernandez-gea V, Reiberger T, Albillos A, Tsochatzis EA, Krag A, Genescà J, Trebicka J, Quiroga S, Yu D, Téllez L, Mandorfer M, Garcia-pagan JC, Berbel C, Ferrusquia J, Ble M, Garcia-criado MA, Belmonte E, Ney M, Margini C, Casu S, Murgia G, Ludwig C, Stangl F. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. Journal of Hepatology 2020;72:1140-50. [DOI: 10.1016/j.jhep.2019.12.021] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 29.5] [Reference Citation Analysis]
730 Khokhar MA, O'Beirne J. Transjugular Intrahepatic Portosystemic Shunts for Hepatorenal Syndrome: TIPping the Scales in Whose Favor? Dig Dis Sci 2020;65:3069-71. [PMID: 32472258 DOI: 10.1007/s10620-020-06351-x] [Reference Citation Analysis]
731 APASL Covid-19 Task Force. Lau G, Sharma M. Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations. Hepatol Int. 2020;14:415-428. [PMID: 32447721 DOI: 10.1007/s12072-020-10054-w] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 22.5] [Reference Citation Analysis]
732 García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep 2020;2:100122. [PMID: 32671331 DOI: 10.1016/j.jhepr.2020.100122] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 15.5] [Reference Citation Analysis]
733 Matiollo C, Rateke ECM, de Oliveira KG, Turnes BL, da Silva TE, Maccali C, Latini AS, Narciso-Schiavon JL, Schiavon LL. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis. Dig Liver Dis 2020;52:753-60. [PMID: 32434738 DOI: 10.1016/j.dld.2020.03.024] [Reference Citation Analysis]
734 Qi X, Wang J, Li X, Wang Z, Liu Y, Yang H, Li X, Shi J, Xiang H, Liu T, Kawada N, Maruyama H, Jiang Z, Wang F, Takehara T, Rockey DC, Sarin SK; COVID-Cirrhosis-CHESS Group. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China. Hepatol Int. 2020;14:478-482. [PMID: 32440857 DOI: 10.1007/s12072-020-10051-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
735 Liu J, Gao Y, Wang X, Qian Z, Chen J, Huang Y, Meng Z, Lu X, Deng G, Liu F, Zhang Z, Li H, Zheng X. Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies. Yonsei Med J 2020;61:145-53. [PMID: 31997623 DOI: 10.3349/ymj.2020.61.2.145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
736 You H, Peng L, Zhao J, Fei Y, Wang Q, Zhang W, Li M, Zeng X. Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis. J Immunol Res 2020;2020:2156762. [PMID: 32537465 DOI: 10.1155/2020/2156762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
737 Muley M, Vespasiani-Gentilucci U, De Vincentis A, Santonico M, Pennazza G, Sanguedolce S, De Luca C, Plotti F, Picardi A, Antonelli-Incalzi R. Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study. PLoS One 2020;15:e0233350. [PMID: 32437441 DOI: 10.1371/journal.pone.0233350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
738 Jeong J, Jung K, Seo KI, Yun BC, Han BH, Lee SU, Moon W. Propofol alone prevents worsening hepatic encephalopathy rather than midazolam alone or combined sedation after esophagogastroduodenoscopy in compensated or decompensated cirrhotic patients. Eur J Gastroenterol Hepatol 2020;32:1054-61. [PMID: 32433420 DOI: 10.1097/MEG.0000000000001755] [Reference Citation Analysis]
739 Maevskaya MV, Zharkova MS. Role of human albumin in the management of liver cirrhosis. Medicinskij sovet 2020. [DOI: 10.21518/2079-701x-2020-5-62-69.] [Reference Citation Analysis]
740 Li S, Zhang C, Lin LL, Wang Q, Zuo HX, Zhan AL, Luo J, Niu YM, Zhong GQ. Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis. Front Pharmacol 2020;11:603. [PMID: 32581776 DOI: 10.3389/fphar.2020.00603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
741 Simbrunner B, Marculescu R, Scheiner B, Schwabl P, Bucsics T, Stadlmann A, Bauer DJM, Paternostro R, Eigenbauer E, Pinter M, Stättermayer AF, Trauner M, Mandorfer M, Reiberger T. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease. Liver Int 2020;40:1713-24. [PMID: 32358998 DOI: 10.1111/liv.14498] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
742 Kedarisetty CK, Bhargav VY, Karthikeyan M, Sathiyasekaran BW, Venkataraman J. The Predicament of the PREDICT Study!! J Clin Exp Hepatol 2020;10:271. [PMID: 32405184 DOI: 10.1016/j.jceh.2019.11.007] [Reference Citation Analysis]
743 Bajaj JS, O'Leary JG, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Lai J, Fallon MB, Thuluvath PJ, Vargas HE, Maliakkal B, Subramanian RM, Thacker LR, Reddy KR. Insurance Status But Not Race and Ethnicity Are Associated With Outcomes in a Large Hospitalized Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol 2021;19:565-572.e5. [PMID: 32389884 DOI: 10.1016/j.cgh.2020.04.081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
744 Louissaint J, Lok AS, Fortune BE, Tapper EB. Acceptance and use of a smartphone application in cirrhosis. Liver Int 2020;40:1556-63. [DOI: 10.1111/liv.14494] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
745 Sakaida I, Terai S, Kurosaki M, Okada M, Hirano T, Fukuta Y. Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study). J Gastroenterol 2020;55:800-10. [PMID: 32388692 DOI: 10.1007/s00535-020-01691-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
746 Kulkarni AV, Kumar P, Singh S, Sharma M, Talukdar R, Murthy VH, Singh V, Reddy ND, Rao NP. Prevention of paracentesis‐induced circulatory dysfunction—A systematic review and network meta‐analysis. GastroHep 2020;2:92-101. [DOI: 10.1002/ygh2.395] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
747 Ballester-Clau R, Torres Vicente G, Cucala Ramos M, Aracil Blanch C, Miñana Calafat JM, Pijoan Comas E, Reñé Espinet JM, Planella de Rubinat M. Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding. Front Med (Lausanne) 2020;7:128. [PMID: 32363194 DOI: 10.3389/fmed.2020.00128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
748 Mattos ÂZ, Leão GS, Mattos AA. Albumin for Infections Other Than Spontaneous Bacterial Peritonitis: Still Not an Answer. Clinical Gastroenterology and Hepatology 2020;18:1247-8. [DOI: 10.1016/j.cgh.2019.11.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
749 Ballestri S, Capitelli M, Fontana MC, Arioli D, Romagnoli E, Graziosi C, Lonardo A, Marietta M, Dentali F, Cioni G. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. Adv Ther 2020;37:1910-32. [PMID: 32285340 DOI: 10.1007/s12325-020-01307-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
750 Schmid S, Scherm S, Haderer M, Gülow K, Müller-schilling M. Infektionen bei Leberzirrhose – von bakterieller Translokation über spontan-bakterielle Peritonitis und Pneumonie zum akut-auf-chronischen Leberversagen. Gastroenterologe 2020;15:201-210. [DOI: 10.1007/s11377-020-00439-6] [Reference Citation Analysis]
751 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis. J Clin Exp Hepatol 2020;10:339-76. [PMID: 32655238 DOI: 10.1016/j.jceh.2020.04.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
752 Bothou C, Rüschenbaum S, Kubesch A, Quenstedt L, Schwarzkopf K, Welsch C, Zeuzem S, Welzel TM, Lange CM. Anemia and Systemic Inflammation Rather than Arterial Circulatory Dysfunction Predict Decompensation of Liver Cirrhosis. J Clin Med 2020;9:E1263. [PMID: 32357568 DOI: 10.3390/jcm9051263] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
753 Vorobioff JD, Contreras F, Tanno F, Hernández L, Bessone F, Colombato L, Adi J, Fassio E, Felgueres M, Fernández G, Gaite L, Gibelli D, Darrichon HG, Lafage M, Lombardo D, López S, Mateo A, Mendizábal M, Pecoraro J, Ruf A, Ruiz P, Severini J, Stieben T, Sixto M, Zárate F, Barraza SB, Sierra ID, Pacheco VR, Roblero JP, Rojas JO, González PR, Rodríguez DSM, Sierralta A, Manchego AU, Valdes E, Yaquich P, Wolff R, Valdivia FB, Gallegos RC, Galloso R, Marcelo JS, Montes P, Tenorio L, Veramendi I, Alava E, Armijos X, Benalcazar G, Carrera E, Pazmiño GF, Díaz EM, Garassini M, Marrero RP, Infante M, Suárez DP, Gutiérrez JC, Reyes CMV, Serrano YM, Hernández RH, Martínez OM, González TP, Andara MT, Hernández MS, Gerona S, García I, Tijera F, López EP, Torres K, Garzón M. A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management. Ann Hepatol 2020;19:396-403. [PMID: 32418749 DOI: 10.1016/j.aohep.2020.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
754 Grensemann J, Busse D, König C, Roedl K, Jäger W, Jarczak D, Iwersen-Bergmann S, Manthey C, Kluge S, Kloft C, Fuhrmann V. Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study. Ann Intensive Care 2020;10:48. [PMID: 32323030 DOI: 10.1186/s13613-020-00666-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
755 Shen M, Vaidya S, Okoronkwo N, Alder E, Ahlawat S. Isolated Gastric Fundal Varices Caused by Diffuse Large B-Cell Lymphoma. ACG Case Rep J 2019;6:e00267. [PMID: 32309472 DOI: 10.14309/crj.0000000000000267] [Reference Citation Analysis]
756 Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ikeda N, Aizawa N, Nishimura T, Iijima H, Nishiguchi S. Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases. Diagnostics (Basel) 2020;10:E238. [PMID: 32325995 DOI: 10.3390/diagnostics10040238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
757 Benz F, Bogen A, Praktiknjo M, Jansen C, Meyer C, Wree A, Demir M, Loosen S, Vucur M, Schierwagen R, Tacke F, Trebicka J, Roderburg C. Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis. PLoS One 2020;15:e0231701. [PMID: 32302330 DOI: 10.1371/journal.pone.0231701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
758 Basssegoda O, Cardenas A. Readmission after TIPS: an up-to-date landscape. Gastroenterol Rep (Oxf) 2020;8:83-4. [PMID: 32280466 DOI: 10.1093/gastro/goz063] [Reference Citation Analysis]
759 Sigal SH, Sherman Z, Jesudian A. Clinical Implications of Thrombocytopenia for the Cirrhotic Patient. Hepat Med. 2020;12:49-60. [PMID: 32341665 DOI: 10.2147/hmer.s244596] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
760 Tapper EB, Asrani SK. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. J Hepatol. 2020;73:441-445. [PMID: 32298769 DOI: 10.1016/j.jhep.2020.04.005] [Cited by in Crossref: 116] [Cited by in F6Publishing: 91] [Article Influence: 58.0] [Reference Citation Analysis]
761 Emdin CA, Haas ME, Khera AV, Aragam K, Chaffin M, Klarin D, Hindy G, Jiang L, Wei WQ, Feng Q, Karjalainen J, Havulinna A, Kiiskinen T, Bick A, Ardissino D, Wilson JG, Schunkert H, McPherson R, Watkins H, Elosua R, Bown MJ, Samani NJ, Baber U, Erdmann J, Gupta N, Danesh J, Saleheen D, Chang KM, Vujkovic M, Voight B, Damrauer S, Lynch J, Kaplan D, Serper M, Tsao P, Mercader J, Hanis C, Daly M, Denny J, Gabriel S, Kathiresan S; Million Veteran Program. A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease. PLoS Genet 2020;16:e1008629. [PMID: 32282858 DOI: 10.1371/journal.pgen.1008629] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 29.5] [Reference Citation Analysis]
762 Soni H, Kumar-m P, Sharma V, Bellam BL, Mishra S, Mahendru D, Mandavdhare HS, Medhi B, Dutta U, Singh V. Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis. Hepatol Int 2020;14:399-413. [DOI: 10.1007/s12072-020-10025-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
763 Tonon M, Piano S, Gambino CG, Romano A, Pilutti C, Incicco S, Brocca A, Sticca A, Bolognesi M, Angeli P. Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020;. [PMID: 32272250 DOI: 10.1016/j.cgh.2020.03.065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
764 Huelin P, del Pozo C, Cabezas J, Crespo J. Protocolo diagnóstico y tratamiento de la insuficiencia renal en el paciente cirrótico. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:346-349. [DOI: 10.1016/j.med.2020.04.006] [Reference Citation Analysis]
765 Xu X, Xu S, Primignani M, De Stefano V, He Y, Yi F, Guo X, Valla D, Qi X. Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study. Adv Ther 2020;37:1452-63. [PMID: 32076942 DOI: 10.1007/s12325-020-01250-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
766 Soualy A, Walter A, Sutter O, Nault JC. Acute pericarditis: A rare complication of gastric variceal obturation with cyanoacrylate glue. Clin Res Hepatol Gastroenterol. 2020;44:e25-e28. [PMID: 31401042 DOI: 10.1016/j.clinre.2019.06.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
767 Fábrega E, Huelin P, Fortea J, Crespo J. Ascitis. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:327-337. [DOI: 10.1016/j.med.2020.04.004] [Reference Citation Analysis]
768 Sehgal R, Singh H, Singh IP. Comparative study of spironolactone and eplerenone in management of ascites in patients of cirrhosis of liver. European Journal of Gastroenterology & Hepatology 2020;32:535-9. [DOI: 10.1097/meg.0000000000001678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
769 Cabezas J, Llerena S, Cuadrado A, Fábrega E. Protocolo diagnóstico y tratamiento del deterioro cognitivo en el paciente cirrótico. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:355-358. [DOI: 10.1016/j.med.2020.04.008] [Reference Citation Analysis]
770 Cuadrado A, Arias M, Llerena S, Crespo J. Protocolo diagnóstico y tratamiento del síndrome febril en el paciente cirrótico. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:359-363. [DOI: 10.1016/j.med.2020.04.009] [Reference Citation Analysis]
771 Arias-loste M, Iruzubieta P, de Lope CR, Fábrega E. Protocolo diagnóstico y tratamiento de la disnea en el paciente cirrótico. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:350-354. [DOI: 10.1016/j.med.2020.04.007] [Reference Citation Analysis]
772 Møller S, Kimer N, Barløse M, Bendtsen F. Pathophysiological-based treatments of complications of cirrhosis. Scand J Gastroenterol 2020;55:383-94. [PMID: 32233873 DOI: 10.1080/00365521.2020.1744709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
773 Huelin P, Puente A, Cuadrado A, Fábrega E. Manifestaciones extrahepáticas de la cirrosis. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:338-345. [DOI: 10.1016/j.med.2020.04.005] [Reference Citation Analysis]
774 Asif SJ, Gondal M, Parveen S, Mushtaq S, Awan S, Hussain T. The pattern of microbial flora in Spontaneous bacterial peritonitis in Cirrhotic patients. JRMC 2020. [DOI: 10.37939/jrmc/vol24.iss1.13] [Reference Citation Analysis]
775 Praktiknjo M, Monteiro S, Grandt J, Kimer N, Madsen JL, Werge MP, William P, Brol MJ, Turco L, Schierwagen R, Chang J, Klein S, Uschner FE, Welsch C, Moreau R, Schepis F, Bendtsen F, Gluud LL, Møller S, Trebicka J. Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure. Liver Int 2020;40:1457-66. [PMID: 32162397 DOI: 10.1111/liv.14433] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
776 Tufoni M, Zaccherini G, Caraceni P, Bernardi M. Albumin: Indications in chronic liver disease. United European Gastroenterol J 2020;8:528-35. [PMID: 32213034 DOI: 10.1177/2050640620910339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
777 Soulaidopoulos S, Goulis I, Cholongitas E. Pulmonary manifestations of chronic liver disease: a comprehensive review. Ann Gastroenterol 2020;33:237-49. [PMID: 32382226 DOI: 10.20524/aog.2020.0474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
778 Francoz C. Acute kidney injury in cirrhosis: An immediate threat but also a ticking time bomb. J Hepatol. 2020;72:1043-1045. [PMID: 32197803 DOI: 10.1016/j.jhep.2020.02.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
779 Song HJ, Jiang X, Henry L, Nguyen MH, Park H. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis. Eur J Clin Pharmacol 2020;76:851-66. [PMID: 32172363 DOI: 10.1007/s00228-020-02854-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
780 Dibas M, Rajab AM, Zaghloul MS, Atiah MJ, Aljundi S, Amir A, Saquib N. Ascitic calprotectin for the diagnosis of spontaneous bacterial peritonitis: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2020;32:1075-83. [DOI: 10.1097/meg.0000000000001709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
781 Schultalbers M, Tergast TL, Simon N, Kabbani AR, Kimmann M, Zu Siederdissen CH, Gerbel S, Manns MP, Cornberg M, Maasoumy B. Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites. United European Gastroenterol J 2020;8:567-76. [PMID: 32213043 DOI: 10.1177/2050640620913732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
782 Favresse J, Boland L, Schellen M, Fervaille C, Wuestenberghs F, Camboni A, Chatelain B, Mullier F, Defour JP, Jacqmin H. Two-site evaluation of a new workflow for the detection of malignant cells on the Sysmex XN-1000 body fluid analyzer. Int J Lab Hematol 2020;42:544-51. [PMID: 32163671 DOI: 10.1111/ijlh.13187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
783 Pandhi MB, Kuei AJ, Lipnik AJ, Gaba RC. Emergent Transjugular Intrahepatic Portosystemic Shunt Creation in Acute Variceal Bleeding. Semin Intervent Radiol 2020;37:3-13. [PMID: 32139965 DOI: 10.1055/s-0039-3402015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
784 Shiba S, Chu PS, Nakamoto N, Yamataka K, Taniki N, Ojiro K, Yamaguchi A, Morikawa R, Yoshida A, Ikura A, Ebinuma H, Saito H, Kanai T. Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study. BMC Gastroenterol 2020;20:53. [PMID: 32138675 DOI: 10.1186/s12876-020-01205-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
785 Wu M, Wu L, Jin J, Wang J, Li S, Zeng J, Guo H, Zheng J, Chen S, Zheng R. Liver Stiffness Measured with Two-dimensional Shear-Wave Elastography Is Predictive of Liver-related Events in Patients with Chronic Liver Disease Due to Hepatis B Viral Infection. Radiology 2020;295:353-60. [PMID: 32125254 DOI: 10.1148/radiol.2020191481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
786 Jagarlamudi N, Wong F. Acute kidney injury: prediction, prognostication and optimisation for liver transplant. Hepatol Int 2020;14:167-79. [DOI: 10.1007/s12072-020-10018-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
787 Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Ahmed A. Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005–2014. Dig Dis Sci 2021;66:296-307. [DOI: 10.1007/s10620-020-06162-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
788 Balzaretti P. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis. Ital J Emerg Med 2020;9. [DOI: 10.23736/s2532-1285.20.00010-5] [Reference Citation Analysis]
789 González-olivares C, Figueroa-tubió A, Villajos LT. Protocolo diagnóstico de hipertransaminasemia y fiebre. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:291-295. [DOI: 10.1016/j.med.2020.03.008] [Reference Citation Analysis]
790 Wang AJ, Wang J, Zheng XL, Liao WD, Yu HQ, Gong Y, Gan N, You Y, Guo GH, Xie BS, Zhong JW, Hong JB, Liu L, Shu X, Zhu Y, Li BM, Zhu X. Second‐look endoscopy‐guided therapy under sedation prevents early rebleeding after variceal ligation for acute variceal bleeding. J Dig Dis 2020;21:170-8. [DOI: 10.1111/1751-2980.12847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
791 Fernandez-Lorente L, Martin-Moreno PL, Arteaga J. Acute kidney failure in the cirrhotic patient: management, kidney biopsy and dual kidney liver transplantation indication. Nephrol Dial Transplant 2020;35:408-10. [PMID: 31608944 DOI: 10.1093/ndt/gfz068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
792 Fabrellas N, Carol M, Palacio E, Aban M, Lanzillotti T, Nicolao G, Chiappa MT, Esnault V, Graf-Dirmeier S, Helder J, Gossard A, Lopez M, Cervera M, Dols LL; LiverHope Consortium Investigators. Nursing Care of Patients With Cirrhosis: The LiverHope Nursing Project. Hepatology 2020;71:1106-16. [PMID: 31944340 DOI: 10.1002/hep.31117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
793 Shalimar, Rout G, Kumar R, Singh AD, Sharma S, Gunjan D, Saraya A, Nayak B, Acharya SK. Persistent or incident hyperammonemia is associated with poor outcomes in acute decompensation and acute-on-chronic liver failure. JGH Open 2020;4:843-50. [PMID: 33102753 DOI: 10.1002/jgh3.12314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
794 Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S. Serum Zinc Level Grading System: A Useful Model for Composite Hepatic Events in Hepatitis C Virus-Associated Liver Cirrhosis. J Clin Med 2020;9:E643. [PMID: 32121095 DOI: 10.3390/jcm9030643] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
795 Kuo PL, Schrack JA, Shardell MD, Levine M, Moore AZ, An Y, Elango P, Karikkineth A, Tanaka T, de Cabo R, Zukley LM, AlGhatrif M, Chia CW, Simonsick EM, Egan JM, Resnick SM, Ferrucci L. A roadmap to build a phenotypic metric of ageing: insights from the Baltimore Longitudinal Study of Aging. J Intern Med 2020;287:373-94. [PMID: 32107805 DOI: 10.1111/joim.13024] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 23.0] [Reference Citation Analysis]
796 Xu X, Lin S, Yang Y, Chen Y, Liu B, Li B, Wu Y, Meng F, Zhu Q, Li Y, Tang S, Yuan S, Shao L, Qi X. Development of hyponatremia after terlipressin in cirrhotic patients with acute gastrointestinal bleeding: a retrospective multicenter observational study. Expert Opin Drug Saf 2020;19:641-7. [PMID: 32101054 DOI: 10.1080/14740338.2020.1734558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
797 Reichert MC, Ripoll C, Casper M, Greinert R, Vandieken E, Grünhage F, Appenrodt B, Zipprich A, Lammert F. Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated Cirrhosis. Clin Transl Gastroenterol 2019;10:e00002. [PMID: 30702490 DOI: 10.14309/ctg.0000000000000002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
798 Ferrarese A, Morelli MC, Carrai P, Milana M, Angelico M, Perricone G, Belli LS, Marrone G, Grieco A, Martini S, Manini MA, Fagiuoli S, Toniutto P, Galeota Lanza A, Bhoori S, Petta S, Giannini EG, Burra P. Outcomes of Liver Transplant for Adults With Wilson's Disease. Liver Transpl 2020;26:507-16. [PMID: 31901209 DOI: 10.1002/lt.25714] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
799 Rudler M, Mallet M, Sultanik P, Bouzbib C, Thabut D. Optimal management of ascites. Liver Int 2020;40:128-35. [DOI: 10.1111/liv.14361] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
800 Maraolo AE, Scotto R, Zappulo E, Pinchera B, Schiano Moriello N, Nappa S, Buonomo AR, Gentile I. Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials. Expert Rev Anti Infect Ther 2020;18:191-202. [PMID: 32011191 DOI: 10.1080/14787210.2020.1725473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
801 Spring A, Saran JS, McCarthy S, McCluskey SA. Anesthesia for the Patient with Severe Liver Failure. Anesthesiol Clin 2020;38:35-50. [PMID: 32008656 DOI: 10.1016/j.anclin.2019.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
802 Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: Evidence-based indications and limitations. JHEP Rep 2020;2:100063. [PMID: 32039404 DOI: 10.1016/j.jhepr.2019.12.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 21.5] [Reference Citation Analysis]
803 Braun G. Management von gastrointestinalen Blutungen auf der Intensivstation. Gastroenterologe 2020;15:34-40. [DOI: 10.1007/s11377-020-00420-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
804 Bocos JM, Rayado GG, Mallada GH. Protocolo diagnóstico y terapéutico de la hemorragia digestiva alta en urgencias. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:158-162. [DOI: 10.1016/j.med.2020.01.025] [Reference Citation Analysis]
805 Paugam-burtz C, Levesque E, Louvet A, Thabut D, Amathieu R, Bureau C, Camus C, Chanques G, Faure S, Ferrandière M, Francoz C, Galbois A, Gustot T, Ichai C, Ichai P, Jaber S, Lescot T, Moreau R, Roullet S, Saliba F, Thévenot T, Velly L, Weiss E. Management of liver failure in general intensive care unit. Anaesthesia Critical Care & Pain Medicine 2020;39:143-61. [DOI: 10.1016/j.accpm.2019.06.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
806 Laredo V, Cortés L, Abad D, Lorente S. Afectación gástrica en enfermedades sistémicas y hepáticas. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:126-135. [DOI: 10.1016/j.med.2020.01.021] [Reference Citation Analysis]
807 Kimer N, Grønbæk H, Fred RG, Hansen T, Deshmukh AS, Mann M, Bendtsen F. Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial. BMJ Open 2020;10:e035284. [PMID: 31980514 DOI: 10.1136/bmjopen-2019-035284] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
808 Magaz M, Baiges A, Hernández-Gea V. Precision medicine in variceal bleeding: Are we there yet? J Hepatol. 2020;72:774-784. [PMID: 31981725 DOI: 10.1016/j.jhep.2020.01.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
809 Li H, Wieser A, Zhang J, Liss I, Markwardt D, Hornung R, Neumann-Cip AC, Mayerle J, Gerbes A, Steib CJ. Patients with cirrhosis and SBP: Increase in multidrug-resistant organisms and complications. Eur J Clin Invest 2020;50:e13198. [PMID: 31886517 DOI: 10.1111/eci.13198] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
810 Federico A, Caprio GG, Dalise AM, Barbieri M, Dallio M, Loguercio C, Paolisso G, Rizzo MR. Cirrhosis and frailty assessment in elderly patients: A paradoxical result. Medicine (Baltimore) 2020;99:e18501. [PMID: 31914020 DOI: 10.1097/MD.0000000000018501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
811 Bruha R, Vitek L, Smid V. Osteopontin - A potential biomarker of advanced liver disease. Ann Hepatol 2020;19:344-52. [PMID: 32005637 DOI: 10.1016/j.aohep.2020.01.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
812 Benmassaoud A, Freeman SC, Roccarina D, Plaz Torres MC, Sutton AJ, Cooper NJ, Iogna Prat L, Cowlin M, Milne EJ, Hawkins N, Davidson BR, Pavlov CS, Thorburn D, Tsochatzis E, Gurusamy KS. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2020;1:CD013123. [PMID: 31978257 DOI: 10.1002/14651858.CD013123.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
813 Komolafe O, Roberts D, Freeman SC, Wilson P, Sutton AJ, Cooper NJ, Pavlov CS, Milne EJ, Hawkins N, Cowlin M, Thorburn D, Davidson BR, Tsochatzis E, Gurusamy KS. Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2020;1:CD013125. [PMID: 31978256 DOI: 10.1002/14651858.CD013125.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
814 Kulkarni AV, Kumar P, Rao NP, Reddy N. Terlipressin-induced ischaemic skin necrosis. BMJ Case Rep 2020;13:e233089. [PMID: 31948983 DOI: 10.1136/bcr-2019-233089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
815 Bassegoda O, Huelin P, Ariza X, Solé C, Juanola A, Gratacós-Ginès J, Carol M, Graupera I, Pose E, Napoleone L, Albertos S, de Prada G, Cervera M, Fernández J, Fabrellas N, Poch E, Solà E, Ginès P. Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes. J Hepatol 2020;72:1132-9. [PMID: 31953138 DOI: 10.1016/j.jhep.2019.12.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
816 Ibidapo-Obe O, Stengel S, Köse-Vogel N, Quickert S, Reuken PA, Busch M, Bauer M, Stallmach A, Bruns T. Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation. Cell Mol Gastroenterol Hepatol 2020;9:661-77. [PMID: 31954178 DOI: 10.1016/j.jcmgh.2020.01.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
817 Simbrunner B, Beer A, Wöran K, Schmitz F, Primas C, Wewalka M, Pinter M, Dolak W, Scheiner B, Puespoek A, Trauner M, Oberhuber G, Mandorfer M, Reiberger T. Portal hypertensive gastropathy is associated with iron deficiency anemia. Wien Klin Wochenschr 2020;132:1-11. [PMID: 31912289 DOI: 10.1007/s00508-019-01593-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
818 Cullaro G, Sharma R, Trebicka J, Cárdenas A, Verna EC. Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes. Liver Transpl 2020;26:283-93. [PMID: 31714011 DOI: 10.1002/lt.25678] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
819 Guedes RR, Kieling CO, dos Santos JL, da Rocha C, Schwengber F, Adami MR, Chedid MF, Vieira SMG. Severity of Ascites Is Associated with Increased Mortality in Patients with Cirrhosis Secondary to Biliary Atresia. Dig Dis Sci 2020;65:3369-77. [DOI: 10.1007/s10620-019-06029-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
820 Xiao Y, Howell J, van Gemert C, Thompson AJ, Seaman CP, McCulloch K, Scott N, Hellard ME. Enhancing the hepatitis B care cascade in Australia: A cost-effectiveness model. J Viral Hepat 2020;27:526-36. [PMID: 31856377 DOI: 10.1111/jvh.13252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
821 Ginès P, Ariza X. Hepatorenal Syndrome. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65716-1] [